XML 21 R9.htm IDEA: XBRL DOCUMENT
v3.25.1

CONSOLIDATED SCHEDULE OF INVESTMENTS € in Thousands, £ in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | ---
Mar. 31, 2025 USD ($) shares | Dec. 31, 2024 USD ($) shares | Mar. 31, 2025 GBP (£) shares | Mar. 31, 2025 EUR (€) shares | Dec. 31, 2024 GBP (£) shares
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment, basis spread, variable rate |  | 7.50% |  | 7.50% |  | 7.50% |  | 7.50% |  | 7.50% |
Investment cost |  | $ 3,995,082 |  | $ 3,708,877 |  |  |  |  |  |  |
Investments, at fair value: |  | 3,924,450 |  | $ 3,659,978 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | 238 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [1],[3] | Dec. 27, 2022 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [1] | 69,239 |  |  |  | 69,239 |  | 69,239 |  |  |
Investment, Identifier [Axis]: Debt Investment Communications & Networking (1.38%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.38% |  |  |  |  |  | 1.38% |
Investment cost | [5] |  |  | $ 27,693 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 27,491 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services (18.03%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 18.03% |  |  |  |  |  | 18.03% |
Investment cost | [5] |  |  | $ 358,347 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 358,786 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Altumint, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6] |  |  | 2027-12 |  |  |  |  |  | 2027-12 |
Investment, basis spread, variable rate | [6],[7] |  |  | 3.65% |  |  |  |  |  | 3.65% |
Investment, interest rate, floor | [6],[7] |  |  | 12.15% |  |  |  |  |  | 12.15% |
Investment exit fee | [6],[7] |  |  | 2.50% |  |  |  |  |  | 2.50% |
Principal amount | [6] |  |  | $ 10,000 |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | 9,916 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 10,140 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Carwow LTD, Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[9],[10] |  |  | 2027-12 |  |  |  |  |  | 2027-12 |
Investment, basis spread, variable rate | [7],[8],[9],[10] |  |  | 4.70% |  |  |  |  |  | 4.70% |
Investment, interest rate, floor | [7],[8],[9],[10] |  |  | 11.45% |  |  |  |  |  | 11.45% |
Investment, interest rate, paid in kind | [7],[8],[9],[10] |  |  | 1.45% |  |  |  |  |  | 1.45% |
Investment exit fee | [7],[8],[9],[10] |  |  | 4.95% |  |  |  |  |  | 4.95% |
Principal amount | £ | [8],[9],[10] |  |  |  |  |  |  |  |  | £ 20,361 |
Investment cost | [5],[8],[9],[10] |  |  | $ 27,818 |  |  |  |  |  |  |
Investments, at fair value: | [8],[9],[10] |  |  | $ 25,264 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and GoEuro Travel GmbH, Senior Secured, Maturity Date November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10],[11] |  |  | 2029-11 |  |  |  |  |  | 2029-11 |
Investment, basis spread, variable rate | [7],[9],[10],[11] |  |  | 3.45% |  |  |  |  |  | 3.45% |
Investment, interest rate, floor | [7],[9],[10],[11] |  |  | 10.45% |  |  |  |  |  | 10.45% |
Investment exit fee | [7],[9],[10],[11] |  |  | 4.50% |  |  |  |  |  | 4.50% |
Principal amount | [9],[10],[11] |  |  | $ 48,750 |  |  |  |  |  |  |
Investment cost | [5],[9],[10],[11] |  |  | 48,276 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10],[11] |  |  | $ 48,276 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[12],[13] |  |  | 2026-07 |  |  |  |  |  | 2026-07 |
Investment, basis spread, variable rate | [7],[8],[12],[13] |  |  | 2.50% |  |  |  |  |  | 2.50% |
Investment, interest rate, floor | [7],[8],[12],[13] |  |  | 10.75% |  |  |  |  |  | 10.75% |
Investment, interest rate, paid in kind | [7],[8],[12],[13] |  |  | 0.50% |  |  |  |  |  | 0.50% |
Investment exit fee | [7],[8],[12],[13] |  |  | 3.00% |  |  |  |  |  | 3.00% |
Principal amount | [8],[12],[13] |  |  | $ 78,038 |  |  |  |  |  |  |
Investment cost | [5],[8],[12],[13] |  |  | 77,438 |  |  |  |  |  |  |
Investments, at fair value: | [8],[12],[13] |  |  | $ 79,691 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[13],[14] |  |  | 2026-05 |  |  |  |  |  | 2026-05 |
Investment, basis spread, variable rate | [7],[8],[13],[14] |  |  | 7.00% |  |  |  |  |  | 7.00% |
Investment, interest rate, floor | [7],[8],[13],[14] |  |  | 10.50% |  |  |  |  |  | 10.50% |
Investment, interest rate, paid in kind | [7],[8],[13],[14] |  |  | 0.50% |  |  |  |  |  | 0.50% |
Investment exit fee | [7],[8],[13],[14] |  |  | 4.00% |  |  |  |  |  | 4.00% |
Principal amount | [8],[13],[14] |  |  | $ 25,327 |  |  |  |  |  |  |
Investment cost | [5],[8],[13],[14] |  |  | 25,413 |  |  |  |  |  |  |
Investments, at fair value: | [8],[13],[14] |  |  | $ 25,821 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Skyword, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[15] |  |  | 2027-11 |  |  |  |  |  | 2027-11 |
Investment, basis spread, variable rate | [7],[8],[15] |  |  | 2.75% |  |  |  |  |  | 2.75% |
Investment, interest rate, floor | [7],[8],[15] |  |  | 9.25% |  |  |  |  |  | 9.25% |
Investment, interest rate, paid in kind | [7],[8],[15] |  |  | 1.75% |  |  |  |  |  | 1.75% |
Investment exit fee | [7],[8],[15] |  |  | 3.00% |  |  |  |  |  | 3.00% |
Principal amount | [8],[15] |  |  | $ 6,587 |  |  |  |  |  |  |
Investment cost | [5],[8],[15] |  |  | 6,715 |  |  |  |  |  |  |
Investments, at fair value: | [8],[15] |  |  | $ 6,637 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [16] |  |  | 2027-01 |  |  |  |  |  | 2027-01 |
Investment, interest rate, paid in cash | [7],[16] |  |  | 8.25% |  |  |  |  |  | 8.25% |
Principal amount | [16] |  |  | $ 8,250 |  |  |  |  |  |  |
Investment cost | [5],[16] |  |  | 8,250 |  |  |  |  |  |  |
Investments, at fair value: | [16] |  |  | $ 8,027 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Thumbtack, Inc., Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[11],[14] |  |  | 2028-03 |  |  |  |  |  | 2028-03 |
Investment, basis spread, variable rate | [7],[8],[11],[14] |  |  | 2.45% |  |  |  |  |  | 2.45% |
Investment, interest rate, floor | [7],[8],[11],[14] |  |  | 10.95% |  |  |  |  |  | 10.95% |
Investment, interest rate, paid in kind | [7],[8],[11],[14] |  |  | 1.50% |  |  |  |  |  | 1.50% |
Principal amount | [8],[11],[14] |  |  | $ 20,918 |  |  |  |  |  |  |
Investment cost | [5],[8],[11],[14] |  |  | 20,561 |  |  |  |  |  |  |
Investments, at fair value: | [8],[11],[14] |  |  | 21,192 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total SeatGeek, Inc |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 103,365 |  |  |  |  |  |  |
Investment cost | [5] |  |  | 102,851 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 105,512 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total Veem, Inc., |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 10,360 |  |  |  |  |  |  |
Investment cost | [5] |  |  | 10,720 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 10,664 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.00%, Floor rate 12.00%, PIK Interest 1.25%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[15] |  |  | 2027-03 |  |  |  |  |  | 2027-03 |
Investment, basis spread, variable rate | [7],[8],[15] |  |  | 4.00% |  |  |  |  |  | 4.00% |
Investment, interest rate, floor | [7],[8],[15] |  |  | 12.00% |  |  |  |  |  | 12.00% |
Investment, interest rate, paid in kind | [7],[8],[15] |  |  | 1.25% |  |  |  |  |  | 1.25% |
Investment exit fee | [7],[8],[15] |  |  | 4.50% |  |  |  |  |  | 4.50% |
Principal amount | [8],[15] |  |  | $ 5,172 |  |  |  |  |  |  |
Investment cost | [5],[8],[15] |  |  | 5,350 |  |  |  |  |  |  |
Investments, at fair value: | [8],[15] |  |  | $ 5,322 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.70%, Floor rate 12.70%, PIK Interest 1.50%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[12] |  |  | 2027-03 |  |  |  |  |  | 2027-03 |
Investment, basis spread, variable rate | [7],[8],[12] |  |  | 4.70% |  |  |  |  |  | 4.70% |
Investment, interest rate, floor | [7],[8],[12] |  |  | 12.70% |  |  |  |  |  | 12.70% |
Investment, interest rate, paid in kind | [7],[8],[12] |  |  | 1.50% |  |  |  |  |  | 1.50% |
Investment exit fee | [7],[8],[12] |  |  | 4.50% |  |  |  |  |  | 4.50% |
Principal amount | [8],[12] |  |  | $ 5,188 |  |  |  |  |  |  |
Investment cost | [5],[8],[12] |  |  | 5,370 |  |  |  |  |  |  |
Investments, at fair value: | [8],[12] |  |  | $ 5,342 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services (2.98%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 2.98% |  |  |  |  |  | 2.98% |
Investment cost | [5] |  |  | $ 59,130 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 59,386 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [16],[17] |  |  | 2025-06 |  |  |  |  |  | 2025-06 |
Investment, interest rate, paid in cash | [7],[16],[17] |  |  | 5.00% |  |  |  |  |  | 5.00% |
Principal amount | [16],[17] |  |  | $ 12,000 |  |  |  |  |  |  |
Investment cost | [5],[16],[17] |  |  | 12,000 |  |  |  |  |  |  |
Investments, at fair value: | [16],[17] |  |  | $ 12,000 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Next Insurance, Inc., Senior Secured, Maturity Date February 2028, Prime - 1.50%, Floor rate 4.75%, PIK Interest 5.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[15],[18] |  |  | 2028-02 |  |  |  |  |  | 2028-02 |
Investment, basis spread, variable rate | [7],[8],[15],[18] |  |  | (1.50%) |  |  |  |  |  | (1.50%) |
Investment, interest rate, floor | [7],[8],[15],[18] |  |  | 4.75% |  |  |  |  |  | 4.75% |
Investment, interest rate, paid in kind | [7],[8],[15],[18] |  |  | 5.50% |  |  |  |  |  | 5.50% |
Principal amount | [8],[15],[18] |  |  | $ 11,070 |  |  |  |  |  |  |
Investment cost | [5],[8],[15],[18] |  |  | 10,918 |  |  |  |  |  |  |
Investments, at fair value: | [8],[15],[18] |  |  | 11,174 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 36,569 |  |  |  |  |  |  |
Investment cost | [5] |  |  | 36,212 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 36,212 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Akero Therapeutics, Inc., Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[11],[15] |  |  | 2027-03 |  |  |  |  |  | 2027-03 |
Investment, basis spread, variable rate | [7],[9],[11],[15] |  |  | 3.65% |  |  |  |  |  | 3.65% |
Investment, interest rate, floor | [7],[9],[11],[15] |  |  | 7.65% |  |  |  |  |  | 7.65% |
Investment exit fee | [7],[9],[11],[15] |  |  | 5.85% |  |  |  |  |  | 5.85% |
Principal amount | [9],[11],[15] |  |  | $ 17,500 |  |  |  |  |  |  |
Investment cost | [5],[9],[11],[15] |  |  | 17,706 |  |  |  |  |  |  |
Investments, at fair value: | [9],[11],[15] |  |  | $ 18,005 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6] |  |  | 2027-01 |  |  |  |  |  | 2027-01 |
Investment, basis spread, variable rate | [6],[7] |  |  | 2.50% |  |  |  |  |  | 2.50% |
Investment, interest rate, floor | [6],[7] |  |  | 9.50% |  |  |  |  |  | 9.50% |
Investment, interest rate, cap | [6],[7] |  |  | 10.75% |  |  |  |  |  | 10.75% |
Investment exit fee | [6],[7] |  |  | 5.85% |  |  |  |  |  | 5.85% |
Principal amount | [6] |  |  | $ 24,000 |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | 24,640 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 24,940 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [15] |  |  | 2027-02 |  |  |  |  |  | 2027-02 |
Investment, basis spread, variable rate | [7],[15] |  |  | 2.75% |  |  |  |  |  | 2.75% |
Investment, interest rate, floor | [7],[15] |  |  | 8.75% |  |  |  |  |  | 8.75% |
Investment exit fee | [7],[15] |  |  | 5.00% |  |  |  |  |  | 5.00% |
Principal amount | [15] |  |  | $ 18,200 |  |  |  |  |  |  |
Investment cost | [5],[15] |  |  | 18,299 |  |  |  |  |  |  |
Investments, at fair value: | [15] |  |  | $ 18,340 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [15] |  |  | 2027-07 |  |  |  |  |  | 2027-07 |
Investment, basis spread, variable rate | [7],[15] |  |  | 1.90% |  |  |  |  |  | 1.90% |
Investment, interest rate, floor | [7],[15] |  |  | 10.15% |  |  |  |  |  | 10.15% |
Investment exit fee | [7],[15] |  |  | 7.50% |  |  |  |  |  | 7.50% |
Principal amount | [15] |  |  | $ 45,000 |  |  |  |  |  |  |
Investment cost | [5],[15] |  |  | 45,431 |  |  |  |  |  |  |
Investments, at fair value: | [15] |  |  | $ 45,741 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[11] |  |  | 2027-09 |  |  |  |  |  | 2027-09 |
Investment, basis spread, variable rate | [6],[7],[11] |  |  | 0.70% |  |  |  |  |  | 0.70% |
Investment, interest rate, floor | [6],[7],[11] |  |  | 9.20% |  |  |  |  |  | 9.20% |
Investment exit fee | [6],[7],[11] |  |  | 5.95% |  |  |  |  |  | 5.95% |
Principal amount | [6],[11] |  |  | $ 30,000 |  |  |  |  |  |  |
Investment cost | [5],[6],[11] |  |  | 29,742 |  |  |  |  |  |  |
Investments, at fair value: | [6],[11] |  |  | $ 30,587 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11],[19] |  |  | 2028-03 |  |  |  |  |  | 2028-03 |
Investment, basis spread, variable rate | [7],[11],[19] |  |  | 7.88% |  |  |  |  |  | 7.88% |
Investment, interest rate, floor | [7],[11],[19] |  |  | 8.88% |  |  |  |  |  | 8.88% |
Principal amount | [11],[19] |  |  | $ 27,206 |  |  |  |  |  |  |
Investment cost | [5],[11],[19] |  |  | 26,726 |  |  |  |  |  |  |
Investments, at fair value: | [11],[19] |  |  | $ 27,399 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11],[19] |  |  | 2027-07 |  |  |  |  |  | 2027-07 |
Investment, basis spread, variable rate | [7],[11],[19] |  |  | 8.93% |  |  |  |  |  | 8.93% |
Investment, interest rate, floor | [7],[11],[19] |  |  | 9.93% |  |  |  |  |  | 9.93% |
Principal amount | [11],[19] |  |  | $ 13,145 |  |  |  |  |  |  |
Investment cost | [5],[11],[19] |  |  | 12,974 |  |  |  |  |  |  |
Investments, at fair value: | [11],[19] |  |  | 13,145 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investment Software and Total 3GTMS, LLC |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 19,473 |  |  |  |  |  |  |
Investment cost | [5] |  |  | 19,453 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 19,453 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments (186.90%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 186.90% |  |  |  | 186.90% |  | 186.90% |  |  |
Investment cost | [2] | $ 3,785,290 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,739,234 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (1.69%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 1.69% |  |  |  | 1.69% |  | 1.69% |  |  |
Investment cost | [2] | $ 33,032 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 33,739 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (1.70%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.70% |  |  |  |  |  | 1.70% |
Investment cost | [5] |  |  | $ 32,801 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 33,788 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 7.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-01 | [21],[22] | 2027-01 | [12],[15] | 2027-01 | [21],[22] | 2027-01 | [21],[22] | 2027-01 | [12],[15]
Investment, basis spread, variable rate |  | 2.15% | [21],[22],[23] | 2.15% | [7],[12],[15] | 2.15% | [21],[22],[23] | 2.15% | [21],[22],[23] | 2.15% | [7],[12],[15]
Investment, interest rate, floor |  | 9.15% | [21],[22],[23] | 9.15% | [7],[12],[15] | 9.15% | [21],[22],[23] | 9.15% | [21],[22],[23] | 9.15% | [7],[12],[15]
Investment exit fee |  | 7.85% | [21],[22],[23] | 7.85% | [7],[12],[15] | 7.85% | [21],[22],[23] | 7.85% | [21],[22],[23] | 7.85% | [7],[12],[15]
Principal amount |  | $ 32,000 | [21],[22] | $ 32,000 | [12],[15] |  |  |  |  |  |
Investment cost |  | 33,032 | [2],[21],[22] | 32,801 | [5],[12],[15] |  |  |  |  |  |
Investments, at fair value: |  | $ 33,739 | [21],[22] | $ 33,788 | [12],[15] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications & Networking (1.37%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 1.37% |  |  |  | 1.37% |  | 1.37% |  |  |
Investment cost | [2] | $ 27,886 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 27,443 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[24],[25],[26] | 2028-12 |  |  |  | 2028-12 |  | 2028-12 |  |  |
Investment, basis spread, variable rate | [22],[23],[24],[25],[26] | 1.80% |  |  |  | 1.80% |  | 1.80% |  |  |
Investment, interest rate, floor | [22],[23],[24],[25],[26] | 9.30% |  |  |  | 9.30% |  | 9.30% |  |  |
Investment, interest rate, paid in kind | [22],[23],[24],[25],[26] | 1.25% |  |  |  | 1.25% |  | 1.25% |  |  |
Investment exit fee | [22],[23],[24],[25],[26] | 6.73% |  |  |  | 6.73% |  | 6.73% |  |  |
Principal amount | [22],[24],[25],[26] | $ 28,003 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[24],[25],[26] | 27,886 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[24],[25],[26] | $ 27,443 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11],[18] |  |  | 2028-12 |  |  |  |  |  | 2028-12 |
Investment, basis spread, variable rate | [7],[11],[18] |  |  | 1.80% |  |  |  |  |  | 1.80% |
Investment, interest rate, floor | [7],[11],[18] |  |  | 9.30% |  |  |  |  |  | 9.30% |
Investment, interest rate, paid in kind | [7],[11],[18] |  |  | 1.25% |  |  |  |  |  | 1.25% |
Investment exit fee | [7],[11],[18] |  |  | 6.73% |  |  |  |  |  | 6.73% |
Principal amount | [11],[18] |  |  | $ 27,926 |  |  |  |  |  |  |
Investment cost | [5],[11],[18] |  |  | 27,693 |  |  |  |  |  |  |
Investments, at fair value: | [11],[18] |  |  | $ 27,491 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (18.03%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 18.03% |  |  |  | 18.03% |  | 18.03% |  |  |
Investment cost | [2] | $ 360,998 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 360,788 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Altumint, Inc. Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2027-12 |  |  |  | 2027-12 |  | 2027-12 |  |  |
Investment, basis spread, variable rate | [1],[23] | 3.65% |  |  |  | 3.65% |  | 3.65% |  |  |
Investment, interest rate, floor | [1],[23] | 12.15% |  |  |  | 12.15% |  | 12.15% |  |  |
Investment exit fee | [1],[23] | 2.50% |  |  |  | 2.50% |  | 2.50% |  |  |
Principal amount | [1] | $ 10,000 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | 9,940 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 10,127 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[27],[28] | 2027-12 |  |  |  | 2027-12 |  | 2027-12 |  |  |
Investment, basis spread, variable rate | [23],[25],[27],[28] | 4.70% |  |  |  | 4.70% |  | 4.70% |  |  |
Investment, interest rate, floor | [23],[25],[27],[28] | 11.45% |  |  |  | 11.45% |  | 11.45% |  |  |
Investment, interest rate, paid in kind | [23],[25],[27],[28] | 1.45% |  |  |  | 1.45% |  | 1.45% |  |  |
Investment exit fee | [23],[25],[27],[28] | 4.95% |  |  |  | 4.95% |  | 4.95% |  |  |
Principal amount | £ | [25],[27],[28] |  |  |  |  | £ 20,435 |  |  |  |  |
Investment cost | [2],[25],[27],[28] | $ 27,981 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[27],[28] | $ 26,219 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and GoEuro Travel GmbH. Senior Secured, Maturity Date November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26],[27],[28] | 2029-11 |  |  |  | 2029-11 |  | 2029-11 |  |  |
Investment, basis spread, variable rate | [23],[26],[27],[28] | 3.45% |  |  |  | 3.45% |  | 3.45% |  |  |
Investment, interest rate, floor | [23],[26],[27],[28] | 10.45% |  |  |  | 10.45% |  | 10.45% |  |  |
Investment exit fee | [23],[26],[27],[28] | 4.50% |  |  |  | 4.50% |  | 4.50% |  |  |
Principal amount | [26],[27],[28] | $ 48,750 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[27],[28] | 48,387 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26],[27],[28] | $ 48,387 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 11.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[29] | 2028-05 |  |  |  | 2028-05 |  | 2028-05 |  |  |
Investment, interest rate, paid in kind | [23],[25],[29] | 11.50% |  |  |  | 11.50% |  | 11.50% |  |  |
Principal amount | [25],[29] | $ 26,426 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[29] | 26,425 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[29] | $ 27,673 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, Maturity Date May 2028, PIK Interest 11.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[30] |  |  | 2028-05 |  |  |  |  |  | 2028-05 |
Investment, interest rate, paid in kind | [7],[8],[30] |  |  | 11.50% |  |  |  |  |  | 11.50% |
Principal amount | [8],[30] |  |  | $ 25,687 |  |  |  |  |  |  |
Investment cost | [5],[8],[30] |  |  | 25,687 |  |  |  |  |  |  |
Investments, at fair value: | [8],[30] |  |  | $ 26,869 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date October 2028, 1-month SOFR + 0.00%, Floor rate 1.00%, PIK Interest 7.00%, 5.33% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[27],[28] | 2028-10 |  |  |  | 2028-10 |  | 2028-10 |  |  |
Investment, basis spread, variable rate | [23],[25],[27],[28] | 0.00% |  |  |  | 0.00% |  | 0.00% |  |  |
Investment, interest rate, floor | [23],[25],[27],[28] | 1.00% |  |  |  | 1.00% |  | 1.00% |  |  |
Investment, interest rate, paid in kind | [23],[25],[27],[28] | 7.00% |  |  |  | 7.00% |  | 7.00% |  |  |
Investment exit fee | [23],[25],[27],[28] | 5.33% |  |  |  | 5.33% |  | 5.33% |  |  |
Principal amount | [25],[27],[28] | $ 13,536 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[27],[28] | 13,874 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[27],[28] | $ 13,148 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, Maturity Date August 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 2.89% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] |  |  | 2025-08 |  |  |  |  |  | 2025-08 |
Investment, basis spread, variable rate | [7],[9],[10] |  |  | 8.86% |  |  |  |  |  | 8.86% |
Investment, interest rate, floor | [7],[9],[10] |  |  | 9.75% |  |  |  |  |  | 9.75% |
Investment exit fee | [7],[9],[10] |  |  | 2.89% |  |  |  |  |  | 2.89% |
Principal amount | [9],[10] |  |  | $ 13,011 |  |  |  |  |  |  |
Investment cost | [5],[9],[10] |  |  | 13,276 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 12,994 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10],[15] |  |  | 2026-10 |  |  |  |  |  | 2026-10 |
Investment, basis spread, variable rate | [7],[9],[10],[15] |  |  | 2.55% |  |  |  |  |  | 2.55% |
Investment, interest rate, floor | [7],[9],[10],[15] |  |  | 11.05% |  |  |  |  |  | 11.05% |
Investment exit fee | [7],[9],[10],[15] |  |  | 2.95% |  |  |  |  |  | 2.95% |
Principal amount | [9],[10],[15] |  |  | $ 3,325 |  |  |  |  |  |  |
Investment cost | [5],[9],[10],[15] |  |  | 3,282 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10],[15] |  |  | $ 3,340 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd. Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[27],[28] | 2026-10 |  |  |  | 2026-10 |  | 2026-10 |  |  |
Investment, basis spread, variable rate | [21],[23],[27],[28] | 2.55% |  |  |  | 2.55% |  | 2.55% |  |  |
Investment, interest rate, floor | [21],[23],[27],[28] | 11.05% |  |  |  | 11.05% |  | 11.05% |  |  |
Investment exit fee | [21],[23],[27],[28] | 2.95% |  |  |  | 2.95% |  | 2.95% |  |  |
Principal amount | [21],[27],[28] | $ 3,325 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[27],[28] | 3,300 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[27],[28] | $ 3,347 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-12 | [1] | 2026-12 | [6] | 2026-12 | [1] | 2026-12 | [1] | 2026-12 | [6]
Investment, basis spread, variable rate |  | 4.40% | [1],[23] | 4.40% | [6],[7] | 4.40% | [1],[23] | 4.40% | [1],[23] | 4.40% | [6],[7]
Investment, interest rate, floor |  | 10.65% | [1],[23] | 10.65% | [6],[7] | 10.65% | [1],[23] | 10.65% | [1],[23] | 10.65% | [6],[7]
Investment exit fee |  | 2.95% | [1],[23] | 2.95% | [6],[7] | 2.95% | [1],[23] | 2.95% | [1],[23] | 2.95% | [6],[7]
Principal amount |  | $ 15,000 | [1] | $ 15,000 | [6] |  |  |  |  |  |
Investment cost |  | 15,145 | [1],[2] | 15,093 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 15,198 | [1] | $ 15,176 | [6] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-12 | [1],[21],[25] | 2026-12 | [6],[8],[15] | 2026-12 | [1],[21],[25] | 2026-12 | [1],[21],[25] | 2026-12 | [6],[8],[15]
Investment, basis spread, variable rate |  | 5.50% | [1],[21],[23],[25] | 5.50% | [6],[7],[8],[15] | 5.50% | [1],[21],[23],[25] | 5.50% | [1],[21],[23],[25] | 5.50% | [6],[7],[8],[15]
Investment, interest rate, floor |  | 6.50% | [1],[21],[23],[25] | 6.50% | [6],[7],[8],[15] | 6.50% | [1],[21],[23],[25] | 6.50% | [1],[21],[23],[25] | 6.50% | [6],[7],[8],[15]
Investment, interest rate, paid in kind |  | 4.00% | [1],[21],[23],[25] | 4.00% | [6],[7],[8],[15] | 4.00% | [1],[21],[23],[25] | 4.00% | [1],[21],[23],[25] | 4.00% | [6],[7],[8],[15]
Principal amount |  | $ 30,374 | [1],[21],[25] | $ 30,073 | [6],[8],[15] |  |  |  |  |  |
Investment cost |  | 30,148 | [1],[2],[21],[25] | 29,798 | [5],[6],[8],[15] |  |  |  |  |  |
Investments, at fair value: |  | $ 29,473 | [1],[21],[25] | $ 29,678 | [6],[8],[15] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 3-month SOFR + 8.27%, Floor rate 9.27% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [19] |  |  | 2027-04 |  |  |  |  |  | 2027-04 |
Investment, basis spread, variable rate | [7],[19] |  |  | 8.27% |  |  |  |  |  | 8.27% |
Investment, interest rate, floor | [7],[19] |  |  | 9.27% |  |  |  |  |  | 9.27% |
Principal amount | [19] |  |  | $ 36,493 |  |  |  |  |  |  |
Investment cost | [5],[19] |  |  | 36,104 |  |  |  |  |  |  |
Investments, at fair value: | [19] |  |  | $ 35,017 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date March 2028, 3-month SOFR + 8.27%, Floor rate 9.27% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [31] | 2028-03 |  |  |  | 2028-03 |  | 2028-03 |  |  |
Investment, basis spread, variable rate | [23],[31] | 8.27% |  |  |  | 8.27% |  | 8.27% |  |  |
Investment, interest rate, floor | [23],[31] | 9.27% |  |  |  | 9.27% |  | 9.27% |  |  |
Principal amount | [31] | $ 36,401 |  |  |  |  |  |  |  |  |
Investment cost | [2],[31] | 36,047 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [31] | $ 35,175 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[32],[33] | 2026-05 |  |  |  | 2026-05 |  | 2026-05 |  |  |
Investment, basis spread, variable rate | [23],[25],[32],[33] | 7.00% |  |  |  | 7.00% |  | 7.00% |  |  |
Investment, interest rate, floor | [23],[25],[32],[33] | 10.50% |  |  |  | 10.50% |  | 10.50% |  |  |
Investment, interest rate, paid in kind | [23],[25],[32],[33] | 0.50% |  |  |  | 0.50% |  | 0.50% |  |  |
Investment exit fee | [23],[25],[32],[33] | 4.00% |  |  |  | 4.00% |  | 4.00% |  |  |
Principal amount | [25],[32],[33] | $ 25,359 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[32],[33] | 25,514 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[32],[33] | $ 25,832 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[25] | 2027-11 |  |  |  | 2027-11 |  | 2027-11 |  |  |
Investment, basis spread, variable rate | [21],[23],[25] | 2.75% |  |  |  | 2.75% |  | 2.75% |  |  |
Investment, interest rate, floor | [21],[23],[25] | 9.25% |  |  |  | 9.25% |  | 9.25% |  |  |
Investment, interest rate, paid in kind | [21],[23],[25] | 1.75% |  |  |  | 1.75% |  | 1.75% |  |  |
Investment exit fee | [21],[23],[25] | 3.00% |  |  |  | 3.00% |  | 3.00% |  |  |
Principal amount | [21],[25] | $ 6,616 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[25] | 6,760 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[25] | $ 6,691 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [34] | 2027-01 |  |  |  | 2027-01 |  | 2027-01 |  |  |
Investment, interest rate, paid in cash | [23],[34] | 8.25% |  |  |  | 8.25% |  | 8.25% |  |  |
Principal amount | [34] | $ 8,250 |  |  |  |  |  |  |  |  |
Investment cost | [2],[34] | 8,250 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [34] | $ 8,032 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[26],[32] | 2028-03 |  |  |  | 2028-03 |  | 2028-03 |  |  |
Investment, basis spread, variable rate | [23],[25],[26],[32] | 2.45% |  |  |  | 2.45% |  | 2.45% |  |  |
Investment, interest rate, floor | [23],[25],[26],[32] | 10.95% |  |  |  | 10.95% |  | 10.95% |  |  |
Investment, interest rate, paid in kind | [23],[25],[26],[32] | 1.50% |  |  |  | 1.50% |  | 1.50% |  |  |
Principal amount | [25],[26],[32] | $ 20,996 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[26],[32] | 20,661 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[26],[32] | 21,208 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total SeatGeek, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 103,494 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 103,258 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 105,402 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.00%, Floor rate 12.00%, PIK Interest 1.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[25] | 2027-03 |  |  |  | 2027-03 |  | 2027-03 |  |  |
Investment, basis spread, variable rate | [21],[23],[25] | 4.00% |  |  |  | 4.00% |  | 4.00% |  |  |
Investment, interest rate, floor | [21],[23],[25] | 12.00% |  |  |  | 12.00% |  | 12.00% |  |  |
Investment, interest rate, paid in kind | [21],[23],[25] | 1.25% |  |  |  | 1.25% |  | 1.25% |  |  |
Principal amount | [21],[25] | $ 5,413 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[25] | 5,401 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[25] | $ 5,342 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.70%, Floor rate 12.70%, PIK Interest 1.50%. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[25] | 2027-03 |  |  |  | 2027-03 |  | 2027-03 |  |  |
Investment, basis spread, variable rate | [22],[23],[25] | 4.70% |  |  |  | 4.70% |  | 4.70% |  |  |
Investment, interest rate, floor | [22],[23],[25] | 12.70% |  |  |  | 12.70% |  | 12.70% |  |  |
Investment, interest rate, paid in kind | [22],[23],[25] | 1.50% |  |  |  | 1.50% |  | 1.50% |  |  |
Principal amount | [22],[25] | $ 5,433 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[25] | 5,421 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[25] | $ 5,366 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[25],[33] | 2026-07 |  |  |  | 2026-07 |  | 2026-07 |  |  |
Investment, basis spread, variable rate | [22],[23],[25],[33] | 2.50% |  |  |  | 2.50% |  | 2.50% |  |  |
Investment, interest rate, floor | [22],[23],[25],[33] | 10.75% |  |  |  | 10.75% |  | 10.75% |  |  |
Investment, interest rate, paid in kind | [22],[23],[25],[33] | 0.50% |  |  |  | 0.50% |  | 0.50% |  |  |
Investment exit fee | [22],[23],[25],[33] | 3.00% |  |  |  | 3.00% |  | 3.00% |  |  |
Principal amount | [22],[25],[33] | $ 78,135 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[25],[33] | 77,744 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[25],[33] | 79,570 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, and Total Veem, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 10,846 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 10,822 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 10,708 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.42%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 2.42% |  |  |  | 2.42% |  | 2.42% |  |  |
Investment cost | [2] | $ 47,870 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 48,452 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date September 2026, FIXED 11.95% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [16],[35] |  |  | 2026-09 |  |  |  |  |  | 2026-09 |
Investment, interest rate, paid in cash | [7],[16],[35] |  |  | 11.95% |  |  |  |  |  | 11.95% |
Principal amount | [16],[35] |  |  | $ 10,000 |  |  |  |  |  |  |
Investment cost | [5],[16],[35] |  |  | 9,875 |  |  |  |  |  |  |
Investments, at fair value: | [16],[35] |  |  | $ 9,875 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date September 2026, FIXED 3.45%, PIK Interest 8.05% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-09 | [25],[34],[36] | 2026-09 | [8],[16],[35] | 2026-09 | [25],[34],[36] | 2026-09 | [25],[34],[36] | 2026-09 | [8],[16],[35]
Investment, interest rate, paid in kind |  | 8.05% | [23],[25],[34],[36] | 8.05% | [7],[8],[16],[35] | 8.05% | [23],[25],[34],[36] | 8.05% | [23],[25],[34],[36] | 8.05% | [7],[8],[16],[35]
Investment, interest rate, paid in cash |  | 3.45% | [23],[25],[34],[36] | 3.45% | [7],[8],[16],[35] | 3.45% | [23],[25],[34],[36] | 3.45% | [23],[25],[34],[36] | 3.45% | [7],[8],[16],[35]
Principal amount |  | $ 27,104 | [25],[34],[36] | $ 26,569 | [8],[16],[35] |  |  |  |  |  |
Investment cost |  | 26,899 | [2],[25],[34],[36] | 26,337 | [5],[8],[16],[35] |  |  |  |  |  |
Investments, at fair value: |  | $ 26,899 | [25],[34],[36] | $ 26,337 | [8],[16],[35] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime -(1.50%), Floor rate 4.75%, PIK Interest 5.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[24],[25] | 2028-02 |  |  |  | 2028-02 |  | 2028-02 |  |  |
Investment, basis spread, variable rate | [21],[23],[24],[25] | (1.50%) |  |  |  | (1.50%) |  | (1.50%) |  |  |
Investment, interest rate, floor | [21],[23],[24],[25] | 4.75% |  |  |  | 4.75% |  | 4.75% |  |  |
Investment, interest rate, paid in kind | [21],[23],[24],[25] | 5.50% |  |  |  | 5.50% |  | 5.50% |  |  |
Principal amount | [21],[24],[25] | $ 11,223 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[24],[25] | 11,080 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[24],[25] | 11,662 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Total Gibraltar Acquisition, LLC,. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 37,104 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 36,790 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 36,790 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Unsecured, Maturity Date September 2026, Fixed 11.95% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [34],[36] | 2026-09 |  |  |  | 2026-09 |  | 2026-09 |  |  |
Investment, interest rate, paid in cash | [23],[34],[36] | 11.95% |  |  |  | 11.95% |  | 11.95% |  |  |
Principal amount | [34],[36] | $ 10,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[34],[36] | 9,891 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [34],[36] | $ 9,891 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (52.10%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 52.10% |  |  |  |  |  | 52.10% |
Investment cost | [5] |  |  | $ 1,022,084 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 1,036,554 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (53.38%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 53.38% |  |  |  | 53.38% |  | 53.38% |  |  |
Investment cost | [2] | $ 1,066,208 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,067,984 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V., Senior Secured, Maturity Date August 2026, Prime + 4.30%, Floor rate 9.05%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-08 | [27],[28] | 2026-08 | [9],[10],[11] | 2026-08 | [27],[28] | 2026-08 | [27],[28] | 2026-08 | [9],[10],[11]
Investment, basis spread, variable rate |  | 4.30% | [23],[27],[28] | 4.30% | [7],[9],[10],[11] | 4.30% | [23],[27],[28] | 4.30% | [23],[27],[28] | 4.30% | [7],[9],[10],[11]
Investment, interest rate, floor |  | 9.05% | [23],[27],[28] | 9.05% | [7],[9],[10],[11] | 9.05% | [23],[27],[28] | 9.05% | [23],[27],[28] | 9.05% | [7],[9],[10],[11]
Investment exit fee |  | 6.95% | [23],[27],[28] | 6.95% | [7],[9],[10],[11] | 6.95% | [23],[27],[28] | 6.95% | [23],[27],[28] | 6.95% | [7],[9],[10],[11]
Principal amount |  | $ 14,000 | [27],[28] | $ 14,000 | [9],[10],[11] |  |  |  |  |  |
Investment cost |  | 14,538 | [2],[27],[28] | 14,442 | [5],[9],[10],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 14,452 | [27],[28] | $ 14,385 | [9],[10],[11] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc, Inc., Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[9],[10],[14] |  |  | 2029-06 |  |  |  |  |  | 2029-06 |
Investment, basis spread, variable rate | [7],[8],[9],[10],[14] |  |  | 1.15% |  |  |  |  |  | 1.15% |
Investment, interest rate, floor | [7],[8],[9],[10],[14] |  |  | 9.65% |  |  |  |  |  | 9.65% |
Investment, interest rate, paid in kind | [7],[8],[9],[10],[14] |  |  | 2.00% |  |  |  |  |  | 2.00% |
Investment exit fee | [7],[8],[9],[10],[14] |  |  | 5.85% |  |  |  |  |  | 5.85% |
Principal amount | [8],[9],[10],[14] |  |  | $ 30,260 |  |  |  |  |  |  |
Investment cost | [5],[8],[9],[10],[14] |  |  | 30,121 |  |  |  |  |  |  |
Investments, at fair value: | [8],[9],[10],[14] |  |  | $ 31,198 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc. Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[27],[28],[32] | 2029-06 |  |  |  | 2029-06 |  | 2029-06 |  |  |
Investment, basis spread, variable rate | [23],[25],[27],[28],[32] | 1.15% |  |  |  | 1.15% |  | 1.15% |  |  |
Investment, interest rate, floor | [23],[25],[27],[28],[32] | 9.65% |  |  |  | 9.65% |  | 9.65% |  |  |
Investment, interest rate, paid in kind | [23],[25],[27],[28],[32] | 2.00% |  |  |  | 2.00% |  | 2.00% |  |  |
Investment exit fee | [23],[25],[27],[28],[32] | 5.85% |  |  |  | 5.85% |  | 5.85% |  |  |
Principal amount | [25],[27],[28],[32] | $ 15,167 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[27],[28],[32] | 15,126 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[27],[28],[32] | $ 15,050 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[26],[27] | 2027-03 |  |  |  | 2027-03 |  | 2027-03 |  |  |
Investment, basis spread, variable rate | [21],[23],[26],[27] | 3.65% |  |  |  | 3.65% |  | 3.65% |  |  |
Investment, interest rate, floor | [21],[23],[26],[27] | 7.65% |  |  |  | 7.65% |  | 7.65% |  |  |
Investment exit fee | [21],[23],[26],[27] | 5.85% |  |  |  | 5.85% |  | 5.85% |  |  |
Principal amount | [21],[26],[27] | $ 17,500 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[26],[27] | 17,811 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[26],[27] | $ 17,994 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [32] | 2026-04 |  |  |  | 2026-04 |  | 2026-04 |  |  |
Investment, basis spread, variable rate | [23],[32] | 3.10% |  |  |  | 3.10% |  | 3.10% |  |  |
Investment, interest rate, floor | [23],[32] | 11.10% |  |  |  | 11.10% |  | 11.10% |  |  |
Investment exit fee | [23],[32] | 8.90% |  |  |  | 8.90% |  | 8.90% |  |  |
Principal amount | [32] | $ 15,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[32] | 15,093 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [32] | $ 15,134 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [14] |  |  | 2026-04 |  |  |  |  |  | 2026-04 |
Investment, basis spread, variable rate | [7],[14] |  |  | 3.10% |  |  |  |  |  | 3.10% |
Investment, interest rate, floor | [7],[14] |  |  | 11.10% |  |  |  |  |  | 11.10% |
Investment exit fee | [7],[14] |  |  | 8.90% |  |  |  |  |  | 8.90% |
Principal amount | [14] |  |  | $ 15,000 |  |  |  |  |  |  |
Investment cost | [5],[14] |  |  | 15,046 |  |  |  |  |  |  |
Investments, at fair value: | [14] |  |  | $ 15,153 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alector, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[9],[11],[37] |  |  | 2028-12 |  |  |  |  |  | 2028-12 |
Investment, basis spread, variable rate | [6],[7],[9],[11],[37] |  |  | 1.05% |  |  |  |  |  | 1.05% |
Investment, interest rate, floor | [6],[7],[9],[11],[37] |  |  | 8.05% |  |  |  |  |  | 8.05% |
Investment exit fee | [6],[7],[9],[11],[37] |  |  | 4.75% |  |  |  |  |  | 4.75% |
Principal amount | [6],[9],[11],[37] |  |  | $ 7,000 |  |  |  |  |  |  |
Investment cost | [5],[6],[9],[11],[37] |  |  | 6,930 |  |  |  |  |  |  |
Investments, at fair value: | [6],[9],[11],[37] |  |  | $ 6,930 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alector, Inc.. Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[26],[27],[38] | 2028-12 |  |  |  | 2028-12 |  | 2028-12 |  |  |
Investment, basis spread, variable rate | [1],[23],[26],[27],[38] | 1.05% |  |  |  | 1.05% |  | 1.05% |  |  |
Investment, interest rate, floor | [1],[23],[26],[27],[38] | 8.05% |  |  |  | 8.05% |  | 8.05% |  |  |
Investment exit fee | [1],[23],[26],[27],[38] | 4.75% |  |  |  | 4.75% |  | 4.75% |  |  |
Principal amount | [1],[26],[27],[38] | $ 7,000 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[26],[27],[38] | 6,957 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[26],[27],[38] | $ 6,957 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25] | 2027-01 |  |  |  | 2027-01 |  | 2027-01 |  |  |
Investment, basis spread, variable rate | [1],[23],[25] | 2.50% |  |  |  | 2.50% |  | 2.50% |  |  |
Investment, interest rate, floor | [1],[23],[25] | 9.50% |  |  |  | 9.50% |  | 9.50% |  |  |
Investment, interest rate, cap | [1],[23],[25] | 10.75% |  |  |  | 10.75% |  | 10.75% |  |  |
Investment exit fee | [1],[23],[25] | 5.85% |  |  |  | 5.85% |  | 5.85% |  |  |
Principal amount | [1],[25] | $ 22,458 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25] | 23,247 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25] | $ 13,095 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2029, Prime + 1.95%, Floor rate 10.45%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[26],[27],[38] | 2029-09 |  |  |  | 2029-09 |  | 2029-09 |  |  |
Investment, basis spread, variable rate | [1],[23],[26],[27],[38] | 1.95% |  |  |  | 1.95% |  | 1.95% |  |  |
Investment, interest rate, floor | [1],[23],[26],[27],[38] | 10.45% |  |  |  | 10.45% |  | 10.45% |  |  |
Investment exit fee | [1],[23],[26],[27],[38] | 7.75% |  |  |  | 7.75% |  | 7.75% |  |  |
Principal amount | [1],[26],[27],[38] | $ 37,500 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[26],[27],[38] | 37,511 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[26],[27],[38] | $ 38,913 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2029, Prime + 1.95%, Floor rate 10.45%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[9],[11],[37] |  |  | 2029-09 |  |  |  |  |  | 2029-09 |
Investment, basis spread, variable rate | [6],[7],[9],[11],[37] |  |  | 1.95% |  |  |  |  |  | 1.95% |
Investment, interest rate, floor | [6],[7],[9],[11],[37] |  |  | 10.45% |  |  |  |  |  | 10.45% |
Investment exit fee | [6],[7],[9],[11],[37] |  |  | 7.75% |  |  |  |  |  | 7.75% |
Principal amount | [6],[9],[11],[37] |  |  | $ 37,500 |  |  |  |  |  |  |
Investment cost | [5],[6],[9],[11],[37] |  |  | 37,379 |  |  |  |  |  |  |
Investments, at fair value: | [6],[9],[11],[37] |  |  | $ 37,379 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[27],[32],[33] | 2028-01 |  |  |  | 2028-01 |  | 2028-01 |  |  |
Investment, basis spread, variable rate | [22],[23],[27],[32],[33] | 2.20% |  |  |  | 2.20% |  | 2.20% |  |  |
Investment, interest rate, floor | [22],[23],[27],[32],[33] | 9.95% |  |  |  | 9.95% |  | 9.95% |  |  |
Investment, interest rate, cap | [22],[23],[27],[32],[33] | 10.70% |  |  |  | 10.70% |  | 10.70% |  |  |
Investment exit fee | [22],[23],[27],[32],[33] | 5.78% |  |  |  | 5.78% |  | 5.78% |  |  |
Principal amount | [22],[27],[32],[33] | $ 143,350 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[27],[32],[33] | 145,929 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[27],[32],[33] | $ 153,070 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Senior Secured, Maturity Date January 2028, Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[12],[13],[14] |  |  | 2028-01 |  |  |  |  |  | 2028-01 |
Investment, basis spread, variable rate | [7],[9],[12],[13],[14] |  |  | 2.20% |  |  |  |  |  | 2.20% |
Investment, interest rate, floor | [7],[9],[12],[13],[14] |  |  | 9.95% |  |  |  |  |  | 9.95% |
Investment, interest rate, cap | [7],[9],[12],[13],[14] |  |  | 10.70% |  |  |  |  |  | 10.70% |
Investment exit fee | [7],[9],[12],[13],[14] |  |  | 5.78% |  |  |  |  |  | 5.78% |
Principal amount | [9],[12],[13],[14] |  |  | $ 143,350 |  |  |  |  |  |  |
Investment cost | [5],[9],[12],[13],[14] |  |  | 145,451 |  |  |  |  |  |  |
Investments, at fair value: | [9],[12],[13],[14] |  |  | $ 152,945 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-10 | [25] | 2028-10 | [8] | 2028-10 | [25] | 2028-10 | [25] | 2028-10 | [8]
Investment, basis spread, variable rate |  | 2.45% | [23],[25] | 2.45% | [7],[8] | 2.45% | [23],[25] | 2.45% | [23],[25] | 2.45% | [7],[8]
Investment, interest rate, floor |  | 10.95% | [23],[25] | 10.95% | [7],[8] | 10.95% | [23],[25] | 10.95% | [23],[25] | 10.95% | [7],[8]
Investment, interest rate, paid in kind |  | 1.10% | [23],[25] | 1.10% | [7],[8] | 1.10% | [23],[25] | 1.10% | [23],[25] | 1.10% | [7],[8]
Investment exit fee |  | 5.45% | [23],[25] | 5.45% | [7],[8] | 5.45% | [23],[25] | 5.45% | [23],[25] | 5.45% | [7],[8]
Principal amount |  | $ 53,339 | [25] | $ 53,192 | [8] |  |  |  |  |  |
Investment cost |  | 53,669 | [2],[25] | 53,374 | [5],[8] |  |  |  |  |  |
Investments, at fair value: |  | $ 55,350 | [25] | $ 55,626 | [8] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [25],[27],[28],[32] | 2027-07 | [8],[9],[10],[14] | 2027-07 | [25],[27],[28],[32] | 2027-07 | [25],[27],[28],[32] | 2027-07 | [8],[9],[10],[14]
Investment, basis spread, variable rate |  | 1.50% | [23],[25],[27],[28],[32] | 1.50% | [7],[8],[9],[10],[14] | 1.50% | [23],[25],[27],[28],[32] | 1.50% | [23],[25],[27],[28],[32] | 1.50% | [7],[8],[9],[10],[14]
Investment, interest rate, floor |  | 9.75% | [23],[25],[27],[28],[32] | 9.75% | [7],[8],[9],[10],[14] | 9.75% | [23],[25],[27],[28],[32] | 9.75% | [23],[25],[27],[28],[32] | 9.75% | [7],[8],[9],[10],[14]
Investment, interest rate, paid in kind |  | 1.40% | [23],[25],[27],[28],[32] | 1.40% | [7],[8],[9],[10],[14] | 1.40% | [23],[25],[27],[28],[32] | 1.40% | [23],[25],[27],[28],[32] | 1.40% | [7],[8],[9],[10],[14]
Investment exit fee |  | 4.75% | [23],[25],[27],[28],[32] | 4.75% | [7],[8],[9],[10],[14] | 4.75% | [23],[25],[27],[28],[32] | 4.75% | [23],[25],[27],[28],[32] | 4.75% | [7],[8],[9],[10],[14]
Principal amount |  | $ 24,576 | [25],[27],[28],[32] | $ 24,490 | [8],[9],[10],[14] |  |  |  |  |  |
Investment cost |  | 24,826 | [2],[25],[27],[28],[32] | 24,613 | [5],[8],[9],[10],[14] |  |  |  |  |  |
Investments, at fair value: |  | $ 25,453 | [25],[27],[28],[32] | $ 25,608 | [8],[9],[10],[14] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21] | 2026-09 |  |  |  | 2026-09 |  | 2026-09 |  |  |
Investment, basis spread, variable rate | [21],[23] | 5.70% |  |  |  | 5.70% |  | 5.70% |  |  |
Investment, interest rate, floor | [21],[23] | 8.95% |  |  |  | 8.95% |  | 8.95% |  |  |
Investment exit fee | [21],[23] | 7.75% |  |  |  | 7.75% |  | 7.75% |  |  |
Principal amount | [21] | $ 86,925 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21] | 90,906 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21] | $ 90,279 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc., Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [13],[15] |  |  | 2026-09 |  |  |  |  |  | 2026-09 |
Investment, basis spread, variable rate | [7],[13],[15] |  |  | 5.70% |  |  |  |  |  | 5.70% |
Investment, interest rate, floor | [7],[13],[15] |  |  | 8.95% |  |  |  |  |  | 8.95% |
Investment exit fee | [7],[13],[15] |  |  | 7.75% |  |  |  |  |  | 7.75% |
Principal amount | [13],[15] |  |  | $ 105,225 |  |  |  |  |  |  |
Investment cost | [5],[13],[15] |  |  | 109,543 |  |  |  |  |  |  |
Investments, at fair value: | [13],[15] |  |  | $ 109,178 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Disc Medicine, Inc., Senior Secured, Maturity Date December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-12 | [1],[26],[27],[38] | 2029-12 | [6],[9],[11],[37] | 2029-12 | [1],[26],[27],[38] | 2029-12 | [1],[26],[27],[38] | 2029-12 | [6],[9],[11],[37]
Investment, basis spread, variable rate |  | 1.75% | [1],[23],[26],[27],[38] | 1.75% | [6],[7],[9],[11],[37] | 1.75% | [1],[23],[26],[27],[38] | 1.75% | [1],[23],[26],[27],[38] | 1.75% | [6],[7],[9],[11],[37]
Investment, interest rate, floor |  | 8.25% | [1],[23],[26],[27],[38] | 8.25% | [6],[7],[9],[11],[37] | 8.25% | [1],[23],[26],[27],[38] | 8.25% | [1],[23],[26],[27],[38] | 8.25% | [6],[7],[9],[11],[37]
Investment exit fee |  | 6.75% | [1],[23],[26],[27],[38] | 6.75% | [6],[7],[9],[11],[37] | 6.75% | [1],[23],[26],[27],[38] | 6.75% | [1],[23],[26],[27],[38] | 6.75% | [6],[7],[9],[11],[37]
Principal amount |  | $ 22,500 | [1],[26],[27],[38] | $ 22,500 | [6],[9],[11],[37] |  |  |  |  |  |
Investment cost |  | 22,433 | [1],[2],[26],[27],[38] | 22,363 | [5],[6],[9],[11],[37] |  |  |  |  |  |
Investments, at fair value: |  | $ 22,755 | [1],[26],[27],[38] | $ 22,363 | [6],[9],[11],[37] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc., Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6] |  |  | 2025-04 |  |  |  |  |  | 2025-04 |
Investment, basis spread, variable rate | [6],[7] |  |  | 6.25% |  |  |  |  |  | 6.25% |
Investment, interest rate, floor | [6],[7] |  |  | 9.50% |  |  |  |  |  | 9.50% |
Investment exit fee | [6],[7] |  |  | 4.00% |  |  |  |  |  | 4.00% |
Principal amount | [6] |  |  | $ 489 |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | 988 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 988 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8],[11] |  |  | 2026-02 |  |  |  |  |  | 2026-02 |
Investment, basis spread, variable rate | [6],[7],[8],[11] |  |  | 1.70% |  |  |  |  |  | 1.70% |
Investment, interest rate, floor | [6],[7],[8],[11] |  |  | 9.95% |  |  |  |  |  | 9.95% |
Investment, interest rate, paid in kind | [6],[7],[8],[11] |  |  | 1.50% |  |  |  |  |  | 1.50% |
Investment exit fee | [6],[7],[8],[11] |  |  | 3.00% |  |  |  |  |  | 3.00% |
Principal amount | [6],[8],[11] |  |  | $ 20,404 |  |  |  |  |  |  |
Investment cost | [5],[6],[8],[11] |  |  | 20,484 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8],[11] |  |  | $ 21,014 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date May 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25],[26] | 2026-05 |  |  |  | 2026-05 |  | 2026-05 |  |  |
Investment, basis spread, variable rate | [1],[23],[25],[26] | 1.70% |  |  |  | 1.70% |  | 1.70% |  |  |
Investment, interest rate, floor | [1],[23],[25],[26] | 9.95% |  |  |  | 9.95% |  | 9.95% |  |  |
Investment, interest rate, paid in kind | [1],[23],[25],[26] | 1.50% |  |  |  | 1.50% |  | 1.50% |  |  |
Investment exit fee | [1],[23],[25],[26] | 3.00% |  |  |  | 3.00% |  | 3.00% |  |  |
Principal amount | [1],[25],[26] | $ 20,480 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25],[26] | 20,654 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25],[26] | $ 20,660 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[21] | 2025-05 |  |  |  | 2025-05 |  | 2025-05 |  |  |
Investment, basis spread, variable rate | [1],[21],[23] | 5.40% |  |  |  | 5.40% |  | 5.40% |  |  |
Investment, interest rate, floor | [1],[21],[23] | 8.65% |  |  |  | 8.65% |  | 8.65% |  |  |
Investment exit fee | [1],[21],[23] | 4.95% |  |  |  | 4.95% |  | 4.95% |  |  |
Principal amount | [1],[21] | $ 1,612 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[21] | 2,442 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[21] | $ 2,442 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[15] |  |  | 2025-05 |  |  |  |  |  | 2025-05 |
Investment, basis spread, variable rate | [6],[7],[15] |  |  | 5.40% |  |  |  |  |  | 5.40% |
Investment, interest rate, floor | [6],[7],[15] |  |  | 8.65% |  |  |  |  |  | 8.65% |
Investment exit fee | [6],[7],[15] |  |  | 4.95% |  |  |  |  |  | 4.95% |
Principal amount | [6],[15] |  |  | $ 3,963 |  |  |  |  |  |  |
Investment cost | [5],[6],[15] |  |  | 4,755 |  |  |  |  |  |  |
Investments, at fair value: | [6],[15] |  |  | $ 4,749 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[27] | 2027-11 |  |  |  | 2027-11 |  | 2027-11 |  |  |
Investment, basis spread, variable rate | [1],[23],[27] | 2.40% |  |  |  | 2.40% |  | 2.40% |  |  |
Investment, interest rate, floor | [1],[23],[27] | 8.65% |  |  |  | 8.65% |  | 8.65% |  |  |
Investment exit fee | [1],[23],[27] | 6.05% |  |  |  | 6.05% |  | 6.05% |  |  |
Principal amount | [1],[27] | $ 5,500 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[27] | 5,646 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[27] | $ 5,707 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[9] |  |  | 2027-11 |  |  |  |  |  | 2027-11 |
Investment, basis spread, variable rate | [6],[7],[9] |  |  | 2.40% |  |  |  |  |  | 2.40% |
Investment, interest rate, floor | [6],[7],[9] |  |  | 8.65% |  |  |  |  |  | 8.65% |
Investment exit fee | [6],[7],[9] |  |  | 6.05% |  |  |  |  |  | 6.05% |
Principal amount | [6],[9] |  |  | $ 5,500 |  |  |  |  |  |  |
Investment cost | [5],[6],[9] |  |  | 5,622 |  |  |  |  |  |  |
Investments, at fair value: | [6],[9] |  |  | $ 5,721 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[27] | 2027-05 |  |  |  | 2027-05 |  | 2027-05 |  |  |
Investment, basis spread, variable rate | [21],[23],[27] | 2.45% |  |  |  | 2.45% |  | 2.45% |  |  |
Investment, interest rate, floor | [21],[23],[27] | 8.25% |  |  |  | 8.25% |  | 8.25% |  |  |
Investment exit fee | [21],[23],[27] | 5.35% |  |  |  | 5.35% |  | 5.35% |  |  |
Principal amount | [21],[27] | $ 78,200 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[27] | 80,159 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[27] | $ 82,430 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[15] |  |  | 2027-05 |  |  |  |  |  | 2027-05 |
Investment, basis spread, variable rate | [7],[9],[15] |  |  | 2.45% |  |  |  |  |  | 2.45% |
Investment, interest rate, floor | [7],[9],[15] |  |  | 8.25% |  |  |  |  |  | 8.25% |
Investment exit fee | [7],[9],[15] |  |  | 5.35% |  |  |  |  |  | 5.35% |
Principal amount | [9],[15] |  |  | $ 78,200 |  |  |  |  |  |  |
Investment cost | [5],[9],[15] |  |  | 79,896 |  |  |  |  |  |  |
Investments, at fair value: | [9],[15] |  |  | $ 82,775 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [27],[28] | 2030-04 |  |  |  | 2030-04 |  | 2030-04 |  |  |
Investment, basis spread, variable rate | [23],[27],[28] | 1.45% |  |  |  | 1.45% |  | 1.45% |  |  |
Investment, interest rate, floor | [23],[27],[28] | 8.45% |  |  |  | 8.45% |  | 8.45% |  |  |
Investment exit fee | [23],[27],[28] | 6.95% |  |  |  | 6.95% |  | 6.95% |  |  |
Principal amount | [27],[28] | $ 57,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | 56,421 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 56,421 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and NorthSea Therapeutics, Convertible Debt, Maturity Date December 2025, FIXED 6.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-12 | [27],[28],[29] | 2025-12 | [9],[10],[30] | 2025-12 | [27],[28],[29] | 2025-12 | [27],[28],[29] | 2025-12 | [9],[10],[30]
Investment, interest rate, paid in cash |  | 6.00% | [23],[27],[28],[29] | 6.00% | [7],[9],[10],[30] | 6.00% | [23],[27],[28],[29] | 6.00% | [23],[27],[28],[29] | 6.00% | [7],[9],[10],[30]
Principal amount |  | $ 273 | [27],[28],[29] | $ 273 | [9],[10],[30] |  |  |  |  |  |
Investment cost |  | 273 | [2],[27],[28],[29] | 273 | [5],[9],[10],[30] |  |  |  |  |  |
Investments, at fair value: |  | $ 273 | [27],[28],[29] | $ 273 | [9],[10],[30] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25],[33] | 2027-12 |  |  |  | 2027-12 |  | 2027-12 |  |  |
Investment, basis spread, variable rate | [1],[23],[25],[33] | 1.35% |  |  |  | 1.35% |  | 1.35% |  |  |
Investment, interest rate, floor | [1],[23],[25],[33] | 9.85% |  |  |  | 9.85% |  | 9.85% |  |  |
Investment, interest rate, cap | [1],[23],[25],[33] | 10.35% |  |  |  | 10.35% |  | 10.35% |  |  |
Investment, interest rate, paid in kind | [1],[23],[25],[33] | 2.15% |  |  |  | 2.15% |  | 2.15% |  |  |
Investment exit fee | [1],[23],[25],[33] | 3.00% |  |  |  | 3.00% |  | 3.00% |  |  |
Principal amount | [1],[25],[33] | $ 31,385 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25],[33] | 31,224 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25],[33] | $ 31,510 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 6.22% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8],[9],[12],[13],[37],[39] |  |  | 2027-12 |  |  |  |  |  | 2027-12 |
Investment, basis spread, variable rate | [6],[7],[8],[9],[12],[13],[37],[39] |  |  | 1.35% |  |  |  |  |  | 1.35% |
Investment, interest rate, floor | [6],[7],[8],[9],[12],[13],[37],[39] |  |  | 9.85% |  |  |  |  |  | 9.85% |
Investment, interest rate, cap | [6],[7],[8],[9],[12],[13],[37],[39] |  |  | 10.35% |  |  |  |  |  | 10.35% |
Investment, interest rate, paid in kind | [6],[7],[8],[9],[12],[13],[37],[39] |  |  | 2.15% |  |  |  |  |  | 2.15% |
Investment exit fee | [6],[7],[8],[9],[12],[13],[37],[39] |  |  | 6.22% |  |  |  |  |  | 6.22% |
Principal amount | [6],[8],[9],[12],[13],[37],[39] |  |  | $ 169,234 |  |  |  |  |  |  |
Investment cost | [5],[6],[8],[9],[12],[13],[37],[39] |  |  | 171,805 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8],[9],[12],[13],[37],[39] |  |  | $ 176,130 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 7.06% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[22],[25],[27],[33],[38],[40] | 2027-12 |  |  |  | 2027-12 |  | 2027-12 |  |  |
Investment, basis spread, variable rate | [1],[22],[23],[25],[27],[33],[38],[40] | 1.35% |  |  |  | 1.35% |  | 1.35% |  |  |
Investment, interest rate, floor | [1],[22],[23],[25],[27],[33],[38],[40] | 9.85% |  |  |  | 9.85% |  | 9.85% |  |  |
Investment, interest rate, cap | [1],[22],[23],[25],[27],[33],[38],[40] | 10.35% |  |  |  | 10.35% |  | 10.35% |  |  |
Investment, interest rate, paid in kind | [1],[22],[23],[25],[27],[33],[38],[40] | 2.15% |  |  |  | 2.15% |  | 2.15% |  |  |
Investment exit fee | [1],[22],[23],[25],[27],[33],[38],[40] | 7.06% |  |  |  | 7.06% |  | 7.06% |  |  |
Principal amount | [1],[22],[25],[27],[33],[38],[40] | $ 138,620 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[22],[25],[27],[33],[38],[40] | 141,882 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[22],[25],[27],[33],[38],[40] | $ 142,910 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[22],[25],[27] | 2027-10 |  |  |  | 2027-10 |  | 2027-10 |  |  |
Investment, basis spread, variable rate | [21],[22],[23],[25],[27] | 1.75% |  |  |  | 1.75% |  | 1.75% |  |  |
Investment, interest rate, floor | [21],[22],[23],[25],[27] | 7.25% |  |  |  | 7.25% |  | 7.25% |  |  |
Investment, interest rate, cap | [21],[22],[23],[25],[27] | 9.00% |  |  |  | 9.00% |  | 9.00% |  |  |
Investment, interest rate, paid in kind | [21],[22],[23],[25],[27] | 1.50% |  |  |  | 1.50% |  | 1.50% |  |  |
Investment exit fee | [21],[22],[23],[25],[27] | 4.95% |  |  |  | 4.95% |  | 4.95% |  |  |
Principal amount | [21],[22],[25],[27] | $ 32,009 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[22],[25],[27] | 32,513 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[22],[25],[27] | $ 33,866 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[9],[12],[15] |  |  | 2027-10 |  |  |  |  |  | 2027-10 |
Investment, basis spread, variable rate | [7],[8],[9],[12],[15] |  |  | 1.75% |  |  |  |  |  | 1.75% |
Investment, interest rate, floor | [7],[8],[9],[12],[15] |  |  | 7.25% |  |  |  |  |  | 7.25% |
Investment, interest rate, cap | [7],[8],[9],[12],[15] |  |  | 9.00% |  |  |  |  |  | 9.00% |
Investment, interest rate, paid in kind | [7],[8],[9],[12],[15] |  |  | 1.50% |  |  |  |  |  | 1.50% |
Investment exit fee | [7],[8],[9],[12],[15] |  |  | 4.95% |  |  |  |  |  | 4.95% |
Principal amount | [8],[9],[12],[15] |  |  | $ 31,889 |  |  |  |  |  |  |
Investment cost | [5],[8],[9],[12],[15] |  |  | 32,294 |  |  |  |  |  |  |
Investments, at fair value: | [8],[9],[12],[15] |  |  | $ 33,745 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Savara, Inc.. Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[27],[38] | 2030-04 |  |  |  | 2030-04 |  | 2030-04 |  |  |
Investment, basis spread, variable rate | [1],[23],[27],[38] | 1.45% |  |  |  | 1.45% |  | 1.45% |  |  |
Investment, interest rate, floor | [1],[23],[27],[38] | 7.45% |  |  |  | 7.45% |  | 7.45% |  |  |
Investment exit fee | [1],[23],[27],[38] | 6.95% |  |  |  | 6.95% |  | 6.95% |  |  |
Principal amount | [1],[27],[38] | $ 21,450 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[27],[38] | 21,334 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[27],[38] | $ 21,334 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and SynOx Therapeutics Limited, Senior Secured, Maturity Date May 2027, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-05 | [27],[28],[32] | 2027-05 | [9],[10],[14] | 2027-05 | [27],[28],[32] | 2027-05 | [27],[28],[32] | 2027-05 | [9],[10],[14]
Investment, basis spread, variable rate |  | 1.40% | [23],[27],[28],[32] | 1.40% | [7],[9],[10],[14] | 1.40% | [23],[27],[28],[32] | 1.40% | [23],[27],[28],[32] | 1.40% | [7],[9],[10],[14]
Investment, interest rate, floor |  | 9.90% | [23],[27],[28],[32] | 9.90% | [7],[9],[10],[14] | 9.90% | [23],[27],[28],[32] | 9.90% | [23],[27],[28],[32] | 9.90% | [7],[9],[10],[14]
Investment exit fee |  | 7.25% | [23],[27],[28],[32] | 7.25% | [7],[9],[10],[14] | 7.25% | [23],[27],[28],[32] | 7.25% | [23],[27],[28],[32] | 7.25% | [7],[9],[10],[14]
Principal amount |  | $ 4,500 | [27],[28],[32] | $ 4,500 | [9],[10],[14] |  |  |  |  |  |
Investment cost |  | 4,511 | [2],[27],[28],[32] | 4,471 | [5],[9],[10],[14] |  |  |  |  |  |
Investments, at fair value: |  | 4,579 | [27],[28],[32] | $ 4,573 | [9],[10],[14] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Total Phathom Pharmaceuticals, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 170,005 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 173,106 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 174,420 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-10 | [21],[27] | 2026-10 | [9],[11],[15] | 2026-10 | [21],[27] | 2026-10 | [21],[27] | 2026-10 | [9],[11],[15]
Investment, basis spread, variable rate |  | 4.20% | [21],[23],[27] | 4.20% | [7],[9],[11],[15] | 4.20% | [21],[23],[27] | 4.20% | [21],[23],[27] | 4.20% | [7],[9],[11],[15]
Investment, interest rate, floor |  | 7.45% | [21],[23],[27] | 7.45% | [7],[9],[11],[15] | 7.45% | [21],[23],[27] | 7.45% | [21],[23],[27] | 7.45% | [7],[9],[11],[15]
Investment, interest rate, cap |  | 8.95% | [21],[23],[27] | 8.95% | [7],[9],[11],[15] | 8.95% | [21],[23],[27] | 8.95% | [21],[23],[27] | 8.95% | [7],[9],[11],[15]
Investment exit fee |  | 6.00% | [21],[23],[27] | 6.00% | [7],[9],[11],[15] | 6.00% | [21],[23],[27] | 6.00% | [21],[23],[27] | 6.00% | [7],[9],[11],[15]
Principal amount |  | $ 8,000 | [21],[27] | $ 8,000 | [9],[11],[15] |  |  |  |  |  |
Investment cost |  | 8,268 | [2],[21],[27] | 8,231 | [5],[9],[11],[15] |  |  |  |  |  |
Investments, at fair value: |  | $ 8,481 | [21],[27] | $ 8,523 | [9],[11],[15] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[22],[32] | 2027-07 |  |  |  | 2027-07 |  | 2027-07 |  |  |
Investment, basis spread, variable rate | [21],[22],[23],[32] | 3.15% |  |  |  | 3.15% |  | 3.15% |  |  |
Investment, interest rate, floor | [21],[22],[23],[32] | 10.15% |  |  |  | 10.15% |  | 10.15% |  |  |
Investment exit fee | [21],[22],[23],[32] | 3.72% |  |  |  | 3.72% |  | 3.72% |  |  |
Principal amount | [21],[22],[32] | $ 75,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[22],[32] | 75,735 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[22],[32] | $ 74,933 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [12],[14],[15] |  |  | 2027-07 |  |  |  |  |  | 2027-07 |
Investment, basis spread, variable rate | [7],[12],[14],[15] |  |  | 3.15% |  |  |  |  |  | 3.15% |
Investment, interest rate, floor | [7],[12],[14],[15] |  |  | 10.15% |  |  |  |  |  | 10.15% |
Investment exit fee | [7],[12],[14],[15] |  |  | 3.72% |  |  |  |  |  | 3.72% |
Principal amount | [12],[14],[15] |  |  | $ 75,000 |  |  |  |  |  |  |
Investment cost | [5],[12],[14],[15] |  |  | 75,512 |  |  |  |  |  |  |
Investments, at fair value: | [12],[14],[15] |  |  | $ 75,725 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and bluebird bio, Inc. Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 6.45% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25] | 2029-04 |  |  |  | 2029-04 |  | 2029-04 |  |  |
Investment, basis spread, variable rate | [23],[25] | 1.45% |  |  |  | 1.45% |  | 1.45% |  |  |
Investment, interest rate, floor | [23],[25] | 9.95% |  |  |  | 9.95% |  | 9.95% |  |  |
Investment, interest rate, paid in kind | [23],[25] | 2.45% |  |  |  | 2.45% |  | 2.45% |  |  |
Investment exit fee | [23],[25] | 6.45% |  |  |  | 6.45% |  | 6.45% |  |  |
Principal amount | [25] | $ 66,058 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25] | 64,724 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25] | $ 60,624 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and bluebird bio, Inc., Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 6.45% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8] |  |  | 2029-04 |  |  |  |  |  | 2029-04 |
Investment, basis spread, variable rate | [7],[8] |  |  | 1.45% |  |  |  |  |  | 1.45% |
Investment, interest rate, floor | [7],[8] |  |  | 9.95% |  |  |  |  |  | 9.95% |
Investment, interest rate, paid in kind | [7],[8] |  |  | 2.45% |  |  |  |  |  | 2.45% |
Investment exit fee | [7],[8] |  |  | 6.45% |  |  |  |  |  | 6.45% |
Principal amount | [8] |  |  | $ 65,655 |  |  |  |  |  |  |
Investment cost | [5],[8] |  |  | 64,028 |  |  |  |  |  |  |
Investments, at fair value: | [8] |  |  | $ 55,344 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[27],[28] | 2028-01 |  |  |  | 2028-01 |  | 2028-01 |  |  |
Investment, basis spread, variable rate | [23],[25],[27],[28] | 0.75% |  |  |  | 0.75% |  | 0.75% |  |  |
Investment, interest rate, floor | [23],[25],[27],[28] | 9.25% |  |  |  | 9.25% |  | 9.25% |  |  |
Investment, interest rate, cap | [23],[25],[27],[28] | 9.75% |  |  |  | 9.75% |  | 9.75% |  |  |
Investment, interest rate, paid in kind | [23],[25],[27],[28] | 1.15% |  |  |  | 1.15% |  | 1.15% |  |  |
Investment exit fee | [23],[25],[27],[28] | 5.50% |  |  |  | 5.50% |  | 5.50% |  |  |
Principal amount | [25],[27],[28] | $ 15,970 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[27],[28] | 16,133 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[27],[28] | $ 16,177 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc., Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[9],[10] |  |  | 2028-01 |  |  |  |  |  | 2028-01 |
Investment, basis spread, variable rate | [7],[8],[9],[10] |  |  | 0.75% |  |  |  |  |  | 0.75% |
Investment, interest rate, floor | [7],[8],[9],[10] |  |  | 9.25% |  |  |  |  |  | 9.25% |
Investment, interest rate, cap | [7],[8],[9],[10] |  |  | 9.75% |  |  |  |  |  | 9.75% |
Investment, interest rate, paid in kind | [7],[8],[9],[10] |  |  | 1.15% |  |  |  |  |  | 1.15% |
Investment exit fee | [7],[8],[9],[10] |  |  | 5.50% |  |  |  |  |  | 5.50% |
Principal amount | [8],[9],[10] |  |  | $ 15,924 |  |  |  |  |  |  |
Investment cost | [5],[8],[9],[10] |  |  | 16,015 |  |  |  |  |  |  |
Investments, at fair value: | [8],[9],[10] |  |  | $ 16,149 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-01 | [22],[27],[28],[32] | 2027-01 | [9],[10],[12],[14] | 2027-01 | [22],[27],[28],[32] | 2027-01 | [22],[27],[28],[32] | 2027-01 | [9],[10],[12],[14]
Investment, basis spread, variable rate |  | 4.70% | [22],[23],[27],[28],[32] | 4.70% | [7],[9],[10],[12],[14] | 4.70% | [22],[23],[27],[28],[32] | 4.70% | [22],[23],[27],[28],[32] | 4.70% | [7],[9],[10],[12],[14]
Investment, interest rate, floor |  | 7.95% | [22],[23],[27],[28],[32] | 7.95% | [7],[9],[10],[12],[14] | 7.95% | [22],[23],[27],[28],[32] | 7.95% | [22],[23],[27],[28],[32] | 7.95% | [7],[9],[10],[12],[14]
Investment exit fee |  | 6.10% | [22],[23],[27],[28],[32] | 6.10% | [7],[9],[10],[12],[14] | 6.10% | [22],[23],[27],[28],[32] | 6.10% | [22],[23],[27],[28],[32] | 6.10% | [7],[9],[10],[12],[14]
Principal amount |  | $ 35,000 | [22],[27],[28],[32] | $ 35,000 | [9],[10],[12],[14] |  |  |  |  |  |
Investment cost |  | 36,243 | [2],[22],[27],[28],[32] | 36,102 | [5],[9],[10],[12],[14] |  |  |  |  |  |
Investments, at fair value: |  | $ 37,135 | [22],[27],[28],[32] | $ 37,135 | [9],[10],[12],[14] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (8.13%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 8.13% |  |  |  |  |  | 8.13% |
Investment cost | [5] |  |  | $ 161,468 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 161,687 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (8.20%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 8.20% |  |  |  | 8.20% |  | 8.20% |  |  |
Investment cost | [2] | $ 162,447 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 164,043 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-12 | [1],[26],[38] | 2028-12 | [6],[11],[37] | 2028-12 | [1],[26],[38] | 2028-12 | [1],[26],[38] | 2028-12 | [6],[11],[37]
Investment, basis spread, variable rate |  | 3.00% | [1],[23],[26],[38] | 3.00% | [6],[7],[11],[37] | 3.00% | [1],[23],[26],[38] | 3.00% | [1],[23],[26],[38] | 3.00% | [6],[7],[11],[37]
Investment, interest rate, floor |  | 9.50% | [1],[23],[26],[38] | 9.50% | [6],[7],[11],[37] | 9.50% | [1],[23],[26],[38] | 9.50% | [1],[23],[26],[38] | 9.50% | [6],[7],[11],[37]
Investment exit fee |  | 4.00% | [1],[23],[26],[38] | 4.00% | [6],[7],[11],[37] | 4.00% | [1],[23],[26],[38] | 4.00% | [1],[23],[26],[38] | 4.00% | [6],[7],[11],[37]
Principal amount |  | $ 48,750 | [1],[26],[38] | $ 48,750 | [6],[11],[37] |  |  |  |  |  |
Investment cost |  | 48,665 | [1],[2],[26],[38] | 48,557 | [5],[6],[11],[37] |  |  |  |  |  |
Investments, at fair value: |  | $ 48,981 | [1],[26],[38] | $ 47,986 | [6],[11],[37] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Shield AI, Inc., Senior Secured, Maturity Date February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-02 | [22],[25],[33] | 2029-02 | [8],[12],[13] | 2029-02 | [22],[25],[33] | 2029-02 | [22],[25],[33] | 2029-02 | [8],[12],[13]
Investment, basis spread, variable rate |  | 0.85% | [22],[23],[25],[33] | 0.85% | [7],[8],[12],[13] | 0.85% | [22],[23],[25],[33] | 0.85% | [22],[23],[25],[33] | 0.85% | [7],[8],[12],[13]
Investment, interest rate, floor |  | 6.85% | [22],[23],[25],[33] | 6.85% | [7],[8],[12],[13] | 6.85% | [22],[23],[25],[33] | 6.85% | [22],[23],[25],[33] | 6.85% | [7],[8],[12],[13]
Investment, interest rate, cap |  | 9.60% | [22],[23],[25],[33] | 9.60% | [7],[8],[12],[13] | 9.60% | [22],[23],[25],[33] | 9.60% | [22],[23],[25],[33] | 9.60% | [7],[8],[12],[13]
Investment, interest rate, paid in kind |  | 2.50% | [22],[23],[25],[33] | 2.50% | [7],[8],[12],[13] | 2.50% | [22],[23],[25],[33] | 2.50% | [22],[23],[25],[33] | 2.50% | [7],[8],[12],[13]
Investment exit fee |  | 2.50% | [22],[23],[25],[33] | 2.50% | [7],[8],[12],[13] | 2.50% | [22],[23],[25],[33] | 2.50% | [22],[23],[25],[33] | 2.50% | [7],[8],[12],[13]
Principal amount |  | $ 114,471 | [22],[25],[33] | $ 113,766 | [8],[12],[13] |  |  |  |  |  |
Investment cost |  | 113,782 | [2],[22],[25],[33] | 112,911 | [5],[8],[12],[13] |  |  |  |  |  |
Investments, at fair value: |  | $ 115,062 | [22],[25],[33] | $ 113,701 | [8],[12],[13] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (30.19%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 30.19% |  |  |  |  |  | 30.19% |
Investment cost | [5] |  |  | $ 599,140 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 600,582 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (30.79%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 30.79% |  |  |  | 30.79% |  | 30.79% |  |  |
Investment cost | [2] | $ 619,669 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 615,911 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 3-month SOFR + 5.26%, Floor rate 6.00%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[22],[25],[32] | 2026-11 |  |  |  | 2026-11 |  | 2026-11 |  |  |
Investment, basis spread, variable rate | [21],[22],[23],[25],[32] | 5.26% |  |  |  | 5.26% |  | 5.26% |  |  |
Investment, interest rate, floor | [21],[22],[23],[25],[32] | 6.00% |  |  |  | 6.00% |  | 6.00% |  |  |
Investment, interest rate, paid in kind | [21],[22],[23],[25],[32] | 4.45% |  |  |  | 4.45% |  | 4.45% |  |  |
Principal amount | [21],[22],[25],[32] | $ 73,027 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[22],[25],[32] | 72,543 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[22],[25],[32] | $ 71,114 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 3-month SOFR + 5.26%, Floor rate 6.00%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[12],[14],[15] |  |  | 2026-11 |  |  |  |  |  | 2026-11 |
Investment, basis spread, variable rate | [7],[8],[12],[14],[15] |  |  | 5.26% |  |  |  |  |  | 5.26% |
Investment, interest rate, floor | [7],[8],[12],[14],[15] |  |  | 6.00% |  |  |  |  |  | 6.00% |
Investment, interest rate, paid in kind | [7],[8],[12],[14],[15] |  |  | 4.45% |  |  |  |  |  | 4.45% |
Principal amount | [8],[12],[14],[15] |  |  | $ 72,220 |  |  |  |  |  |  |
Investment cost | [5],[8],[12],[14],[15] |  |  | 71,677 |  |  |  |  |  |  |
Investments, at fair value: | [8],[12],[14],[15] |  |  | $ 70,459 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Convertible Debt, Maturity Date December 2025, FIXED 12.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [30] |  |  | 2025-12 |  |  |  |  |  | 2025-12 |
Investment, interest rate, paid in cash | [7],[30] |  |  | 12.00% |  |  |  |  |  | 12.00% |
Principal amount | [30] |  |  | $ 202 |  |  |  |  |  |  |
Investment cost | [5],[30] |  |  | 202 |  |  |  |  |  |  |
Investments, at fair value: | [30] |  |  | $ 202 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date February 2028, Prime + 3.10%, Floor rate 8.10%, 3.78% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[25],[32] | 2028-02 |  |  |  | 2028-02 |  | 2028-02 |  |  |
Investment, basis spread, variable rate | [21],[23],[25],[32] | 3.10% |  |  |  | 3.10% |  | 3.10% |  |  |
Investment, interest rate, floor | [21],[23],[25],[32] | 8.10% |  |  |  | 8.10% |  | 8.10% |  |  |
Investment exit fee | [21],[23],[25],[32] | 3.78% |  |  |  | 3.78% |  | 3.78% |  |  |
Principal amount | [21],[25],[32] | $ 42,125 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[25],[32] | 42,482 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[25],[32] | $ 40,351 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date June 2026, Prime -1.50%, Floor rate 7.00%, PIK Interest 7.00%, 5.64% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[14],[15] |  |  | 2026-06 |  |  |  |  |  | 2026-06 |
Investment, basis spread, variable rate | [7],[8],[14],[15] |  |  | (1.50%) |  |  |  |  |  | (1.50%) |
Investment, interest rate, floor | [7],[8],[14],[15] |  |  | 7.00% |  |  |  |  |  | 7.00% |
Investment, interest rate, paid in kind | [7],[8],[14],[15] |  |  | 7.00% |  |  |  |  |  | 7.00% |
Investment exit fee | [7],[8],[14],[15] |  |  | 5.64% |  |  |  |  |  | 5.64% |
Principal amount | [8],[14],[15] |  |  | $ 41,473 |  |  |  |  |  |  |
Investment cost | [5],[8],[14],[15] |  |  | 43,348 |  |  |  |  |  |  |
Investments, at fair value: | [8],[14],[15] |  |  | $ 41,610 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC, Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-01 | [21],[24],[26] | 2028-01 | [11],[15],[18] | 2028-01 | [21],[24],[26] | 2028-01 | [21],[24],[26] | 2028-01 | [11],[15],[18]
Investment, basis spread, variable rate |  | 1.45% | [21],[23],[24],[26] | 1.45% | [7],[11],[15],[18] | 1.45% | [21],[23],[24],[26] | 1.45% | [21],[23],[24],[26] | 1.45% | [7],[11],[15],[18]
Investment, interest rate, floor |  | 9.20% | [21],[23],[24],[26] | 9.20% | [7],[11],[15],[18] | 9.20% | [21],[23],[24],[26] | 9.20% | [21],[23],[24],[26] | 9.20% | [7],[11],[15],[18]
Investment exit fee |  | 4.95% | [21],[23],[24],[26] | 4.95% | [7],[11],[15],[18] | 4.95% | [21],[23],[24],[26] | 4.95% | [21],[23],[24],[26] | 4.95% | [7],[11],[15],[18]
Principal amount |  | $ 27,500 | [21],[24],[26] | $ 27,500 | [11],[15],[18] |  |  |  |  |  |
Investment cost |  | 27,814 | [2],[21],[24],[26] | 27,722 | [5],[11],[15],[18] |  |  |  |  |  |
Investments, at fair value: |  | $ 28,113 | [21],[24],[26] | $ 28,207 | [11],[15],[18] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Ennoble Care LLC, Senior Secured, Maturity Date February 2030, Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2030-02 |  |  |  | 2030-02 |  | 2030-02 |  |  |
Investment, basis spread, variable rate | [23] | 2.60% |  |  |  | 2.60% |  | 2.60% |  |  |
Investment, interest rate, floor | [23] | 10.35% |  |  |  | 10.35% |  | 10.35% |  |  |
Investment exit fee | [23] | 7.95% |  |  |  | 7.95% |  | 7.95% |  |  |
Principal amount |  | $ 9,000 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 8,916 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 8,916 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 4.25%, Floor rate 9.50%, PIK Interest 1.55% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[25],[32] | 2026-02 |  |  |  | 2026-02 |  | 2026-02 |  |  |
Investment, basis spread, variable rate | [22],[23],[25],[32] | 4.25% |  |  |  | 4.25% |  | 4.25% |  |  |
Investment, interest rate, floor | [22],[23],[25],[32] | 9.50% |  |  |  | 9.50% |  | 9.50% |  |  |
Investment, interest rate, paid in kind | [22],[23],[25],[32] | 1.55% |  |  |  | 1.55% |  | 1.55% |  |  |
Principal amount | [22],[25],[32] | $ 70,952 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[25],[32] | 70,976 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[25],[32] | $ 70,976 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 4.25%, Floor rate 9.50%, PIK Interest 1.55%, 1.11% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[12],[14] |  |  | 2026-02 |  |  |  |  |  | 2026-02 |
Investment, basis spread, variable rate | [7],[8],[12],[14] |  |  | 4.25% |  |  |  |  |  | 4.25% |
Investment, interest rate, floor | [7],[8],[12],[14] |  |  | 9.50% |  |  |  |  |  | 9.50% |
Investment, interest rate, paid in kind | [7],[8],[12],[14] |  |  | 1.55% |  |  |  |  |  | 1.55% |
Investment exit fee | [7],[8],[12],[14] |  |  | 1.11% |  |  |  |  |  | 1.11% |
Principal amount | [8],[12],[14] |  |  | $ 70,678 |  |  |  |  |  |  |
Investment cost | [5],[8],[12],[14] |  |  | 70,473 |  |  |  |  |  |  |
Investments, at fair value: | [8],[12],[14] |  |  | $ 70,062 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[21],[26] | 2027-07 |  |  |  | 2027-07 |  | 2027-07 |  |  |
Investment, basis spread, variable rate | [1],[21],[23],[26] | 1.95% |  |  |  | 1.95% |  | 1.95% |  |  |
Investment, interest rate, floor | [1],[21],[23],[26] | 9.95% |  |  |  | 9.95% |  | 9.95% |  |  |
Investment exit fee | [1],[21],[23],[26] | 6.85% |  |  |  | 6.85% |  | 6.85% |  |  |
Principal amount | [1],[21],[26] | $ 38,500 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[21],[26] | 39,321 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[21],[26] | $ 39,614 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[11],[15] |  |  | 2027-07 |  |  |  |  |  | 2027-07 |
Investment, basis spread, variable rate | [6],[7],[11],[15] |  |  | 1.95% |  |  |  |  |  | 1.95% |
Investment, interest rate, floor | [6],[7],[11],[15] |  |  | 9.95% |  |  |  |  |  | 9.95% |
Investment exit fee | [6],[7],[11],[15] |  |  | 6.85% |  |  |  |  |  | 6.85% |
Principal amount | [6],[11],[15] |  |  | $ 38,500 |  |  |  |  |  |  |
Investment cost | [5],[6],[11],[15] |  |  | 39,089 |  |  |  |  |  |  |
Investments, at fair value: | [6],[11],[15] |  |  | $ 39,582 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 0.75%, Floor rate 8.75%, PIK Interest 2.25%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[26],[33] | 2029-02 |  |  |  | 2029-02 |  | 2029-02 |  |  |
Investment, basis spread, variable rate | [23],[25],[26],[33] | 0.75% |  |  |  | 0.75% |  | 0.75% |  |  |
Investment, interest rate, floor | [23],[25],[26],[33] | 8.75% |  |  |  | 8.75% |  | 8.75% |  |  |
Investment, interest rate, paid in kind | [23],[25],[26],[33] | 2.25% |  |  |  | 2.25% |  | 2.25% |  |  |
Investment exit fee | [23],[25],[26],[33] | 3.00% |  |  |  | 3.00% |  | 3.00% |  |  |
Principal amount | [25],[26],[33] | $ 168,301 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[26],[33] | 167,702 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[26],[33] | $ 168,880 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 3.00%, Floor rate 11.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-02 | [26],[33] | 2029-02 | [11],[13] | 2029-02 | [26],[33] | 2029-02 | [26],[33] | 2029-02 | [11],[13]
Investment, basis spread, variable rate |  | 3.00% | [23],[26],[33] | 3.00% | [7],[11],[13] | 3.00% | [23],[26],[33] | 3.00% | [23],[26],[33] | 3.00% | [7],[11],[13]
Investment, interest rate, floor |  | 11.00% | [23],[26],[33] | 11.00% | [7],[11],[13] | 11.00% | [23],[26],[33] | 11.00% | [23],[26],[33] | 11.00% | [7],[11],[13]
Principal amount |  | $ 5,000 | [26],[33] | $ 5,000 | [11],[13] |  |  |  |  |  |
Investment cost |  | 5,000 | [2],[26],[33] | 5,000 | [5],[11],[13] |  |  |  |  |  |
Investments, at fair value: |  | $ 5,000 | [26],[33] | $ 5,000 | [11],[13] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime - 0.90%, Floor rate 7.10%, PIK Interest 4.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[11],[13] |  |  | 2029-02 |  |  |  |  |  | 2029-02 |
Investment, basis spread, variable rate | [7],[8],[11],[13] |  |  | (0.90%) |  |  |  |  |  | (0.90%) |
Investment, interest rate, floor | [7],[8],[11],[13] |  |  | 7.10% |  |  |  |  |  | 7.10% |
Investment, interest rate, paid in kind | [7],[8],[11],[13] |  |  | 4.00% |  |  |  |  |  | 4.00% |
Investment exit fee | [7],[8],[11],[13] |  |  | 3.00% |  |  |  |  |  | 3.00% |
Principal amount | [8],[11],[13] |  |  | $ 159,176 |  |  |  |  |  |  |
Investment cost | [5],[8],[11],[13] |  |  | 158,410 |  |  |  |  |  |  |
Investments, at fair value: | [8],[11],[13] |  |  | 161,882 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 164,176 |  |  |  |  |  |  |
Investment cost | [5] |  |  | 163,410 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 166,882 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21] | 2027-02 |  |  |  | 2027-02 |  | 2027-02 |  |  |
Investment, basis spread, variable rate | [21],[23] | 2.75% |  |  |  | 2.75% |  | 2.75% |  |  |
Investment, interest rate, floor | [21],[23] | 8.75% |  |  |  | 8.75% |  | 8.75% |  |  |
Investment exit fee | [21],[23] | 5.00% |  |  |  | 5.00% |  | 5.00% |  |  |
Principal amount | [21] | $ 18,200 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21] | 18,391 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21] | $ 18,402 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc. Senior Secured, Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[25] | 2028-06 |  |  |  | 2028-06 |  | 2028-06 |  |  |
Investment, basis spread, variable rate | [22],[23],[25] | 1.15% |  |  |  | 1.15% |  | 1.15% |  |  |
Investment, interest rate, floor | [22],[23],[25] | 9.65% |  |  |  | 9.65% |  | 9.65% |  |  |
Investment, interest rate, paid in kind | [22],[23],[25] | 2.50% |  |  |  | 2.50% |  | 2.50% |  |  |
Investment exit fee | [22],[23],[25] | 2.50% |  |  |  | 2.50% |  | 2.50% |  |  |
Principal amount | [22],[25] | $ 25,188 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[25] | 24,483 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[25] | $ 24,449 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc., Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[12] |  |  | 2028-06 |  |  |  |  |  | 2028-06 |
Investment, basis spread, variable rate | [7],[8],[12] |  |  | 1.15% |  |  |  |  |  | 1.15% |
Investment, interest rate, floor | [7],[8],[12] |  |  | 9.65% |  |  |  |  |  | 9.65% |
Investment, interest rate, paid in kind | [7],[8],[12] |  |  | 2.50% |  |  |  |  |  | 2.50% |
Investment exit fee | [7],[8],[12] |  |  | 2.50% |  |  |  |  |  | 2.50% |
Principal amount | [8],[12] |  |  | $ 25,031 |  |  |  |  |  |  |
Investment cost | [5],[8],[12] |  |  | 24,236 |  |  |  |  |  |  |
Investments, at fair value: | [8],[12] |  |  | 24,587 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21] | 2027-07 |  |  |  | 2027-07 |  | 2027-07 |  |  |
Investment, basis spread, variable rate | [21],[23] | 1.90% |  |  |  | 1.90% |  | 1.90% |  |  |
Investment, interest rate, floor | [21],[23] | 10.15% |  |  |  | 10.15% |  | 10.15% |  |  |
Investment exit fee | [21],[23] | 7.50% |  |  |  | 7.50% |  | 7.50% |  |  |
Principal amount | [21] | $ 45,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21] | 45,705 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21] | $ 44,769 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1] | 2027-09 |  |  |  | 2027-09 |  | 2027-09 |  |  |
Investment, basis spread, variable rate | [1],[23] | 0.70% |  |  |  | 0.70% |  | 0.70% |  |  |
Investment, interest rate, floor | [1],[23] | 9.20% |  |  |  | 9.20% |  | 9.20% |  |  |
Investment exit fee | [1],[23] | 5.95% |  |  |  | 5.95% |  | 5.95% |  |  |
Principal amount | [1] | $ 30,000 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | 29,905 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 30,521 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Total Carbon Health Technologies, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  | 41,675 |  |  |  |  |  |  |
Investment cost | [5] |  |  | 43,550 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 41,812 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date July 2026, Prime - 2.75% Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[32] | 2026-10 |  |  |  | 2026-10 |  | 2026-10 |  |  |
Investment, basis spread, variable rate | [23],[25],[32] | (2.75%) |  |  |  | (2.75%) |  | (2.75%) |  |  |
Investment, interest rate, floor | [23],[25],[32] | 5.75% |  |  |  | 5.75% |  | 5.75% |  |  |
Investment, interest rate, paid in kind | [23],[25],[32] | 5.35% |  |  |  | 5.35% |  | 5.35% |  |  |
Investment exit fee | [23],[25],[32] | 4.95% |  |  |  | 4.95% |  | 4.95% |  |  |
Principal amount | [25],[32] | $ 37,248 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[32] | 38,018 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[32] | $ 37,396 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date October 2026, Prime - 2.75%, Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[14] |  |  | 2026-10 |  |  |  |  |  | 2026-10 |
Investment, basis spread, variable rate | [7],[8],[14] |  |  | (2.75%) |  |  |  |  |  | (2.75%) |
Investment, interest rate, floor | [7],[8],[14] |  |  | 5.75% |  |  |  |  |  | 5.75% |
Investment, interest rate, paid in kind | [7],[8],[14] |  |  | 5.35% |  |  |  |  |  | 5.35% |
Investment exit fee | [7],[8],[14] |  |  | 4.95% |  |  |  |  |  | 4.95% |
Principal amount | [8],[14] |  |  | $ 36,761 |  |  |  |  |  |  |
Investment cost | [5],[8],[14] |  |  | 37,367 |  |  |  |  |  |  |
Investments, at fair value: | [8],[14] |  |  | $ 36,772 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8],[11] |  |  | 2029-05 |  |  |  |  |  | 2029-05 |
Investment, basis spread, variable rate | [6],[7],[8],[11] |  |  | 0.75% |  |  |  |  |  | 0.75% |
Investment, interest rate, floor | [6],[7],[8],[11] |  |  | 7.75% |  |  |  |  |  | 7.75% |
Investment, interest rate, paid in kind | [6],[7],[8],[11] |  |  | 2.65% |  |  |  |  |  | 2.65% |
Investment exit fee | [6],[7],[8],[11] |  |  | 6.75% |  |  |  |  |  | 6.75% |
Principal amount | [6],[8],[11] |  |  | $ 28,283 |  |  |  |  |  |  |
Investment cost | [5],[6],[8],[11] |  |  | 28,144 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8],[11] |  |  | $ 27,551 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25],[26] | 2029-05 |  |  |  | 2029-05 |  | 2029-05 |  |  |
Investment, basis spread, variable rate | [1],[23],[25],[26] | 0.75% |  |  |  | 0.75% |  | 0.75% |  |  |
Investment, interest rate, floor | [1],[23],[25],[26] | 7.75% |  |  |  | 7.75% |  | 7.75% |  |  |
Investment, interest rate, paid in kind | [1],[23],[25],[26] | 2.65% |  |  |  | 2.65% |  | 2.65% |  |  |
Investment exit fee | [1],[23],[25],[26] | 6.75% |  |  |  | 6.75% |  | 6.75% |  |  |
Principal amount | [1],[25],[26] | $ 28,468 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25],[26] | 28,413 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25],[26] | $ 27,410 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services (1.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 1.02% |  |  |  | 1.02% |  | 1.02% |  |  |
Investment cost | [2] | $ 19,891 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 20,313 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services (1.03%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.03% |  |  |  |  |  | 1.03% |
Investment cost | [5] |  |  | $ 19,741 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 20,445 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [22],[25] | 2027-07 | [8],[11],[12] | 2027-07 | [22],[25] | 2027-07 | [22],[25] | 2027-07 | [8],[11],[12]
Investment, basis spread, variable rate |  | 0.70% | [22],[23],[25] | 0.70% | [7],[8],[11],[12] | 0.70% | [22],[23],[25] | 0.70% | [22],[23],[25] | 0.70% | [7],[8],[11],[12]
Investment, interest rate, floor |  | 8.95% | [22],[23],[25] | 8.95% | [7],[8],[11],[12] | 8.95% | [22],[23],[25] | 8.95% | [22],[23],[25] | 8.95% | [7],[8],[11],[12]
Investment, interest rate, paid in kind |  | 2.00% | [22],[23],[25] | 2.00% | [7],[8],[11],[12] | 2.00% | [22],[23],[25] | 2.00% | [22],[23],[25] | 2.00% | [7],[8],[11],[12]
Investment exit fee |  | 2.95% | [22],[23],[25] | 2.95% | [7],[8],[11],[12] | 2.95% | [22],[23],[25] | 2.95% | [22],[23],[25] | 2.95% | [7],[8],[11],[12]
Principal amount |  | $ 19,878 | [22],[25] | $ 19,779 | [8],[11],[12] |  |  |  |  |  |
Investment cost |  | 19,891 | [2],[22],[25] | 19,741 | [5],[8],[11],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 20,313 | [22],[25] | $ 20,445 | [8],[11],[12] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (0.99%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.99% |  |  |  | 0.99% |  | 0.99% |  |  |
Investment cost | [2] | $ 19,860 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 19,860 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and VulcanForms Inc. Secured, Maturity Date January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [24] | 2028-01 |  |  |  | 2028-01 |  | 2028-01 |  |  |
Investment, basis spread, variable rate | [23],[24] | 4.25% |  |  |  | 4.25% |  | 4.25% |  |  |
Investment, interest rate, floor | [23],[24] | 11.25% |  |  |  | 11.25% |  | 11.25% |  |  |
Investment exit fee | [23],[24] | 4.25% |  |  |  | 4.25% |  | 4.25% |  |  |
Principal amount | [24] | $ 20,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[24] | 19,860 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [24] | $ 19,860 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (3.73%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 3.73% |  |  |  | 3.73% |  | 3.73% |  |  |
Investment cost | [2] | $ 73,799 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 74,672 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (3.74%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 3.74% |  |  |  |  |  | 3.74% |
Investment cost | [5] |  |  | $ 73,400 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 74,386 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[38] | 2028-11 |  |  |  | 2028-11 |  | 2028-11 |  |  |
Investment, basis spread, variable rate | [1],[23],[38] | 2.00% |  |  |  | 2.00% |  | 2.00% |  |  |
Investment, interest rate, floor | [1],[23],[38] | 9.50% |  |  |  | 9.50% |  | 9.50% |  |  |
Investment exit fee | [1],[23],[38] | 6.35% |  |  |  | 6.35% |  | 6.35% |  |  |
Principal amount | [1],[38] | $ 15,000 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[38] | 14,821 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[38] | $ 14,821 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[37] |  |  | 2028-11 |  |  |  |  |  | 2028-11 |
Investment, basis spread, variable rate | [6],[7],[37] |  |  | 2.00% |  |  |  |  |  | 2.00% |
Investment, interest rate, floor | [6],[7],[37] |  |  | 9.50% |  |  |  |  |  | 9.50% |
Investment exit fee | [6],[7],[37] |  |  | 6.35% |  |  |  |  |  | 6.35% |
Principal amount | [6],[37] |  |  | $ 15,000 |  |  |  |  |  |  |
Investment cost | [5],[6],[37] |  |  | 14,740 |  |  |  |  |  |  |
Investments, at fair value: | [6],[37] |  |  | $ 14,740 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date September 2027 Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [32] | 2027-09 |  |  |  | 2027-09 |  | 2027-09 |  |  |
Investment, basis spread, variable rate | [23],[32] | 1.40% |  |  |  | 1.40% |  | 1.40% |  |  |
Investment, interest rate, floor | [23],[32] | 9.90% |  |  |  | 9.90% |  | 9.90% |  |  |
Investment exit fee | [23],[32] | 6.95% |  |  |  | 6.95% |  | 6.95% |  |  |
Principal amount | [32] | $ 30,625 |  |  |  |  |  |  |  |  |
Investment cost | [2],[32] | 31,011 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [32] | $ 31,621 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [14] |  |  | 2027-09 |  |  |  |  |  | 2027-09 |
Investment, basis spread, variable rate | [7],[14] |  |  | 1.40% |  |  |  |  |  | 1.40% |
Investment, interest rate, floor | [7],[14] |  |  | 9.90% |  |  |  |  |  | 9.90% |
Investment exit fee | [7],[14] |  |  | 6.95% |  |  |  |  |  | 6.95% |
Principal amount | [14] |  |  | $ 30,625 |  |  |  |  |  |  |
Investment cost | [5],[14] |  |  | 30,830 |  |  |  |  |  |  |
Investments, at fair value: | [14] |  |  | $ 31,519 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Sight Sciences, Inc., Senior Secured, Maturity Date July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-07 | [38] | 2028-07 | [37] | 2028-07 | [38] | 2028-07 | [38] | 2028-07 | [37]
Investment, basis spread, variable rate |  | 2.35% | [23],[38] | 2.35% | [7],[37] | 2.35% | [23],[38] | 2.35% | [23],[38] | 2.35% | [7],[37]
Investment, interest rate, floor |  | 10.35% | [23],[38] | 10.35% | [7],[37] | 10.35% | [23],[38] | 10.35% | [23],[38] | 10.35% | [7],[37]
Investment exit fee |  | 5.95% | [23],[38] | 5.95% | [7],[37] | 5.95% | [23],[38] | 5.95% | [23],[38] | 5.95% | [7],[37]
Principal amount |  | $ 28,000 | [38] | $ 28,000 | [37] |  |  |  |  |  |
Investment cost |  | 27,967 | [2],[38] | 27,830 | [5],[37] |  |  |  |  |  |
Investments, at fair value: |  | $ 28,230 | [38] | $ 28,127 | [37] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Smartsheet Inc.., Senior Secured, Maturity Date January 2031 , 3-month SOFR + 6.50%, Floor rate 7.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26] | 2031-01 |  |  |  | 2031-01 |  | 2031-01 |  |  |
Investment, basis spread, variable rate | [23],[26] | 6.50% |  |  |  | 6.50% |  | 6.50% |  |  |
Investment, interest rate, floor | [23],[26] | 7.25% |  |  |  | 7.25% |  | 7.25% |  |  |
Principal amount | [26] | $ 46,785 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26] | 45,870 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26] | $ 45,870 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Snappt, Inc., Senior Secured, Maturity Date April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[38] | 2029-04 |  |  |  | 2029-04 |  | 2029-04 |  |  |
Investment, basis spread, variable rate | [1],[23],[38] | 2.35% |  |  |  | 2.35% |  | 2.35% |  |  |
Investment, interest rate, floor | [1],[23],[38] | 8.85% |  |  |  | 8.85% |  | 8.85% |  |  |
Investment, interest rate, paid in kind | [1],[23],[38] | 1.00% |  |  |  | 1.00% |  | 1.00% |  |  |
Investment exit fee | [1],[23],[38] | 4.25% |  |  |  | 4.25% |  | 4.25% |  |  |
Principal amount | [1],[38] | $ 20,000 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[38] | 19,769 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[38] | $ 19,769 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software (52.80%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 52.80% |  |  |  |  |  | 52.80% |
Investment cost | [5] |  |  | $ 1,091,349 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 1,050,563 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software (61.81%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 61.81% |  |  |  | 61.81% |  | 61.81% |  |  |
Investment cost | [2] | $ 1,287,997 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,236,621 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25],[26] | 2027-02 |  |  |  | 2027-02 |  | 2027-02 |  |  |
Investment, basis spread, variable rate | [1],[23],[25],[26] | 0.65% |  |  |  | 0.65% |  | 0.65% |  |  |
Investment, interest rate, floor | [1],[23],[25],[26] | 9.15% |  |  |  | 9.15% |  | 9.15% |  |  |
Investment, interest rate, paid in kind | [1],[23],[25],[26] | 2.00% |  |  |  | 2.00% |  | 2.00% |  |  |
Investment exit fee | [1],[23],[25],[26] | 5.05% |  |  |  | 5.05% |  | 5.05% |  |  |
Principal amount | [1],[25],[26] | $ 36,528 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25],[26] | 36,765 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25],[26] | $ 36,825 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 10.40%, Floor rate 11.30% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11],[14],[19] |  |  | 2025-02 |  |  |  |  |  | 2025-02 |
Investment, basis spread, variable rate | [7],[11],[14],[19] |  |  | 10.40% |  |  |  |  |  | 10.40% |
Investment, interest rate, floor | [7],[11],[14],[19] |  |  | 11.30% |  |  |  |  |  | 11.30% |
Principal amount | [11],[14],[19] |  |  | $ 13,279 |  |  |  |  |  |  |
Investment cost | [5],[11],[14],[19] |  |  | 13,268 |  |  |  |  |  |  |
Investments, at fair value: | [11],[14],[19] |  |  | $ 13,268 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 7.25%, Floor rate 8.15% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11],[19] |  |  | 2025-02 |  |  |  |  |  | 2025-02 |
Investment, basis spread, variable rate | [7],[11],[19] |  |  | 7.25% |  |  |  |  |  | 7.25% |
Investment, interest rate, floor | [7],[11],[19] |  |  | 8.15% |  |  |  |  |  | 8.15% |
Principal amount | [11],[19] |  |  | $ 6,194 |  |  |  |  |  |  |
Investment cost | [5],[11],[19] |  |  | 6,185 |  |  |  |  |  |  |
Investments, at fair value: | [11],[19] |  |  | $ 6,185 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[26],[31] | 2028-05 |  |  |  | 2028-05 |  | 2028-05 |  |  |
Investment, basis spread, variable rate | [21],[23],[26],[31] | 8.14% |  |  |  | 8.14% |  | 8.14% |  |  |
Investment, interest rate, floor | [21],[23],[26],[31] | 9.14% |  |  |  | 9.14% |  | 9.14% |  |  |
Principal amount | [21],[26],[31] | $ 20,310 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[26],[31] | 20,002 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[26],[31] | $ 20,310 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 3-month SOFR + 8.14%, Floor rate 9.14% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [15],[19] |  |  | 2028-05 |  |  |  |  |  | 2028-05 |
Investment, basis spread, variable rate | [7],[15],[19] |  |  | 8.14% |  |  |  |  |  | 8.14% |
Investment, interest rate, floor | [7],[15],[19] |  |  | 9.14% |  |  |  |  |  | 9.14% |
Principal amount | [15],[19] |  |  | $ 21,251 |  |  |  |  |  |  |
Investment cost | [5],[15],[19] |  |  | 20,923 |  |  |  |  |  |  |
Investments, at fair value: | [15],[19] |  |  | $ 21,251 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 6.25%, Floor rate 7.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11] |  |  | 2029-09 |  |  |  |  |  | 2029-09 |
Investment, basis spread, variable rate | [7],[11] |  |  | 6.25% |  |  |  |  |  | 6.25% |
Investment, interest rate, floor | [7],[11] |  |  | 7.25% |  |  |  |  |  | 7.25% |
Principal amount | [11] |  |  | $ 42,564 |  |  |  |  |  |  |
Investment cost | [5],[11] |  |  | 41,704 |  |  |  |  |  |  |
Investments, at fair value: | [11] |  |  | $ 41,628 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 6.50%, Floor rate 7.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26] | 2029-09 |  |  |  | 2029-09 |  | 2029-09 |  |  |
Investment, basis spread, variable rate | [23],[26] | 6.50% |  |  |  | 6.50% |  | 6.50% |  |  |
Investment, interest rate, floor | [23],[26] | 7.50% |  |  |  | 7.50% |  | 7.50% |  |  |
Principal amount | [26] | $ 42,564 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26] | 41,738 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26] | $ 41,783 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and AlphaSense, Inc., Senior Secured, Maturity Date June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-06 | [26],[32] | 2029-06 | [11] | 2029-06 | [26],[32] | 2029-06 | [26],[32] | 2029-06 | [11]
Investment, basis spread, variable rate |  | 6.25% | [23],[26],[32] | 6.25% | [7],[11] | 6.25% | [23],[26],[32] | 6.25% | [23],[26],[32] | 6.25% | [7],[11]
Investment, interest rate, floor |  | 8.25% | [23],[26],[32] | 8.25% | [7],[11] | 8.25% | [23],[26],[32] | 8.25% | [23],[26],[32] | 8.25% | [7],[11]
Principal amount |  | $ 20,000 | [26],[32] | $ 20,000 | [11] |  |  |  |  |  |
Investment cost |  | 19,823 | [2],[26],[32] | 19,816 | [5],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 19,824 | [26],[32] | $ 19,578 | [11] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 3-month SOFR + 10.00%, Floor rate 11.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-02 | [21],[31],[41] | 2027-02 | [15],[19] | 2027-02 | [21],[31],[41] | 2027-02 | [21],[31],[41] | 2027-02 | [15],[19]
Investment, basis spread, variable rate |  | 10.00% | [21],[23],[31],[41] | 10.00% | [7],[15],[19] | 10.00% | [21],[23],[31],[41] | 10.00% | [21],[23],[31],[41] | 10.00% | [7],[15],[19]
Investment, interest rate, floor |  | 11.00% | [21],[23],[31],[41] | 11.00% | [7],[15],[19] | 11.00% | [21],[23],[31],[41] | 11.00% | [21],[23],[31],[41] | 11.00% | [7],[15],[19]
Principal amount |  | $ 11,007 | [21],[31],[41] | $ 11,338 | [15],[19] |  |  |  |  |  |
Investment cost |  | 10,874 | [2],[21],[31],[41] | 11,205 | [5],[15],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 3,404 | [21],[31],[41] | $ 10,556 | [15],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-03 | [22],[25],[26] | 2028-03 | [8],[11],[12] | 2028-03 | [22],[25],[26] | 2028-03 | [22],[25],[26] | 2028-03 | [8],[11],[12]
Investment, basis spread, variable rate |  | 0.00% | [22],[23],[25],[26] | 0.00% | [7],[8],[11],[12] | 0.00% | [22],[23],[25],[26] | 0.00% | [22],[23],[25],[26] | 0.00% | [7],[8],[11],[12]
Investment, interest rate, floor |  | 7.50% | [22],[23],[25],[26] | 7.50% | [7],[8],[11],[12] | 7.50% | [22],[23],[25],[26] | 7.50% | [22],[23],[25],[26] | 7.50% | [7],[8],[11],[12]
Investment, interest rate, paid in kind |  | 2.00% | [22],[23],[25],[26] | 2.00% | [7],[8],[11],[12] | 2.00% | [22],[23],[25],[26] | 2.00% | [22],[23],[25],[26] | 2.00% | [7],[8],[11],[12]
Investment exit fee |  | 2.25% | [22],[23],[25],[26] | 2.25% | [7],[8],[11],[12] | 2.25% | [22],[23],[25],[26] | 2.25% | [22],[23],[25],[26] | 2.25% | [7],[8],[11],[12]
Principal amount |  | $ 50,987 | [22],[25],[26] | $ 50,733 | [8],[11],[12] |  |  |  |  |  |
Investment cost |  | 50,838 | [2],[22],[25],[26] | 50,496 | [5],[8],[11],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 51,220 | [22],[25],[26] | $ 51,357 | [8],[11],[12] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 1.25%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [25],[26] | 2028-03 |  |  |  | 2028-03 |  | 2028-03 |  |  |
Investment, basis spread, variable rate | [23],[25],[26] | 1.25% |  |  |  | 1.25% |  | 1.25% |  |  |
Investment, interest rate, floor | [23],[25],[26] | 7.50% |  |  |  | 7.50% |  | 7.50% |  |  |
Investment, interest rate, paid in kind | [23],[25],[26] | 2.00% |  |  |  | 2.00% |  | 2.00% |  |  |
Investment exit fee | [23],[25],[26] | 2.25% |  |  |  | 2.25% |  | 2.25% |  |  |
Principal amount | [25],[26] | $ 25,276 |  |  |  |  |  |  |  |  |
Investment cost | [2],[25],[26] | 25,141 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [25],[26] | $ 25,048 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime +1.25%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[11] |  |  | 2028-03 |  |  |  |  |  | 2028-03 |
Investment, basis spread, variable rate | [7],[8],[11] |  |  | 1.25% |  |  |  |  |  | 1.25% |
Investment, interest rate, floor | [7],[8],[11] |  |  | 7.50% |  |  |  |  |  | 7.50% |
Investment, interest rate, paid in kind | [7],[8],[11] |  |  | 2.00% |  |  |  |  |  | 2.00% |
Investment exit fee | [7],[8],[11] |  |  | 2.25% |  |  |  |  |  | 2.25% |
Principal amount | [8],[11] |  |  | $ 25,150 |  |  |  |  |  |  |
Investment cost | [5],[8],[11] |  |  | 24,968 |  |  |  |  |  |  |
Investments, at fair value: | [8],[11] |  |  | $ 25,082 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.00%, Floor rate 9.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[26],[31] | 2027-12 |  |  |  | 2027-12 |  | 2027-12 |  |  |
Investment, basis spread, variable rate | [1],[23],[26],[31] | 8.00% |  |  |  | 8.00% |  | 8.00% |  |  |
Investment, interest rate, floor | [1],[23],[26],[31] | 9.00% |  |  |  | 9.00% |  | 9.00% |  |  |
Principal amount | [1],[26],[31] | $ 65,173 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[26],[31] | 63,986 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[26],[31] | $ 64,584 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[11],[19] |  |  | 2027-12 |  |  |  |  |  | 2027-12 |
Investment, basis spread, variable rate | [6],[7],[11],[19] |  |  | 8.01% |  |  |  |  |  | 8.01% |
Investment, interest rate, floor | [6],[7],[11],[19] |  |  | 9.01% |  |  |  |  |  | 9.01% |
Principal amount | [6],[11],[19] |  |  | $ 65,336 |  |  |  |  |  |  |
Investment cost | [5],[6],[11],[19] |  |  | 64,061 |  |  |  |  |  |  |
Investments, at fair value: | [6],[11],[19] |  |  | $ 65,263 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Behavox Limited, Senior Secured, Maturity Date September 2027, Prime - 0.55%, Floor rate 7.45%, PIK Interest 3.00%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-09 | [25],[26],[27],[28] | 2027-09 | [8],[9],[10] | 2027-09 | [25],[26],[27],[28] | 2027-09 | [25],[26],[27],[28] | 2027-09 | [8],[9],[10]
Investment, basis spread, variable rate |  | (0.55%) | [23],[25],[26],[27],[28] | (0.55%) | [7],[8],[9],[10] | (0.55%) | [23],[25],[26],[27],[28] | (0.55%) | [23],[25],[26],[27],[28] | (0.55%) | [7],[8],[9],[10]
Investment, interest rate, floor |  | 7.45% | [23],[25],[26],[27],[28] | 7.45% | [7],[8],[9],[10] | 7.45% | [23],[25],[26],[27],[28] | 7.45% | [23],[25],[26],[27],[28] | 7.45% | [7],[8],[9],[10]
Investment, interest rate, paid in kind |  | 3.00% | [23],[25],[26],[27],[28] | 3.00% | [7],[8],[9],[10] | 3.00% | [23],[25],[26],[27],[28] | 3.00% | [23],[25],[26],[27],[28] | 3.00% | [7],[8],[9],[10]
Investment exit fee |  | 4.95% | [23],[25],[26],[27],[28] | 4.95% | [7],[8],[9],[10] | 4.95% | [23],[25],[26],[27],[28] | 4.95% | [23],[25],[26],[27],[28] | 4.95% | [7],[8],[9],[10]
Principal amount |  | $ 10,626 | [25],[26],[27],[28] | $ 10,550 | [8],[9],[10] |  |  |  |  |  |
Investment cost |  | 10,618 | [2],[25],[26],[27],[28] | 10,534 | [5],[8],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 10,475 | [25],[26],[27],[28] | $ 10,360 | [8],[9],[10] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-09 | [21],[25] | 2028-09 | [8],[15] | 2028-09 | [21],[25] | 2028-09 | [21],[25] | 2028-09 | [8],[15]
Investment, basis spread, variable rate |  | 1.35% | [21],[23],[25] | 1.35% | [7],[8],[15] | 1.35% | [21],[23],[25] | 1.35% | [21],[23],[25] | 1.35% | [7],[8],[15]
Investment, interest rate, floor |  | 9.85% | [21],[23],[25] | 9.85% | [7],[8],[15] | 9.85% | [21],[23],[25] | 9.85% | [21],[23],[25] | 9.85% | [7],[8],[15]
Investment, interest rate, paid in kind |  | 2.50% | [21],[23],[25] | 2.50% | [7],[8],[15] | 2.50% | [21],[23],[25] | 2.50% | [21],[23],[25] | 2.50% | [7],[8],[15]
Investment exit fee |  | 3.95% | [21],[23],[25] | 3.95% | [7],[8],[15] | 3.95% | [21],[23],[25] | 3.95% | [21],[23],[25] | 3.95% | [7],[8],[15]
Principal amount |  | $ 32,209 | [21],[25] | $ 32,009 | [8],[15] |  |  |  |  |  |
Investment cost |  | 31,984 | [2],[21],[25] | 31,704 | [5],[8],[15] |  |  |  |  |  |
Investments, at fair value: |  | $ 32,171 | [21],[25] | $ 31,984 | [8],[15] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Carbyne, Inc., Senior Secured, Maturity Date February 2029, Prime + 3.50%, Floor rate 10.00%, 3.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-02 |  |  |  | 2029-02 |  | 2029-02 |  |  |
Investment, basis spread, variable rate | [23] | 3.50% |  |  |  | 3.50% |  | 3.50% |  |  |
Investment, interest rate, floor | [23] | 10.00% |  |  |  | 10.00% |  | 10.00% |  |  |
Investment exit fee | [23] | 3.50% |  |  |  | 3.50% |  | 3.50% |  |  |
Principal amount |  | $ 7,450 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 7,367 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 7,367 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 8.99%, Floor rate 9.89% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-09 | [31] | 2026-09 | [11],[19] | 2026-09 | [31] | 2026-09 | [31] | 2026-09 | [11],[19]
Investment, basis spread, variable rate |  | 8.99% | [23],[31] | 8.99% | [7],[11],[19] | 8.99% | [23],[31] | 8.99% | [23],[31] | 8.99% | [7],[11],[19]
Investment, interest rate, floor |  | 9.89% | [23],[31] | 9.89% | [7],[11],[19] | 9.89% | [23],[31] | 9.89% | [23],[31] | 9.89% | [7],[11],[19]
Principal amount |  | $ 22,762 | [31] | $ 22,762 | [11],[19] |  |  |  |  |  |
Investment cost |  | 22,548 | [2],[31] | 22,515 | [5],[11],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 22,146 | [31] | $ 22,183 | [11],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[14] |  |  | 2025-03 |  |  |  |  |  | 2025-03 |
Investment, basis spread, variable rate | [7],[8],[14] |  |  | 4.50% |  |  |  |  |  | 4.50% |
Investment, interest rate, floor | [7],[8],[14] |  |  | 8.25% |  |  |  |  |  | 8.25% |
Investment, interest rate, cap | [7],[8],[14] |  |  | 10.25% |  |  |  |  |  | 10.25% |
Investment, interest rate, paid in kind | [7],[8],[14] |  |  | 1.95% |  |  |  |  |  | 1.95% |
Investment exit fee | [7],[8],[14] |  |  | 4.50% |  |  |  |  |  | 4.50% |
Principal amount | [8],[14] |  |  | $ 8,515 |  |  |  |  |  |  |
Investment cost | [5],[8],[14] |  |  | 8,839 |  |  |  |  |  |  |
Investments, at fair value: | [8],[14] |  |  | $ 8,839 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and CoreView USA, Inc., Senior Secured, Maturity Date January 2029, Prime +2.75%, Floor rate 9.25%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-01 | [26],[38] | 2029-01 | [11],[37] | 2029-01 | [26],[38] | 2029-01 | [26],[38] | 2029-01 | [11],[37]
Investment, basis spread, variable rate |  | 2.75% | [23],[26],[38] | 2.75% | [7],[11],[37] | 2.75% | [23],[26],[38] | 2.75% | [23],[26],[38] | 2.75% | [7],[11],[37]
Investment, interest rate, floor |  | 9.25% | [23],[26],[38] | 9.25% | [7],[11],[37] | 9.25% | [23],[26],[38] | 9.25% | [23],[26],[38] | 9.25% | [7],[11],[37]
Investment exit fee |  | 4.95% | [23],[26],[38] | 4.95% | [7],[11],[37] | 4.95% | [23],[26],[38] | 4.95% | [23],[26],[38] | 4.95% | [7],[11],[37]
Principal amount |  | $ 25,000 | [26],[38] | $ 25,000 | [11],[37] |  |  |  |  |  |
Investment cost |  | 24,805 | [2],[26],[38] | 24,731 | [5],[11],[37] |  |  |  |  |  |
Investments, at fair value: |  | $ 24,805 | [26],[38] | $ 24,731 | [11],[37] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Coronet Cyber Security Ltd., Senior Secured, Maturity Date October 2028, Prime - 2.95%, Floor rate 3.55%, PIK Interest 5.85% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-10 | [25],[26] | 2028-10 | [8],[11] | 2028-10 | [25],[26] | 2028-10 | [25],[26] | 2028-10 | [8],[11]
Investment, basis spread, variable rate |  | (2.95%) | [23],[25],[26] | (2.95%) | [7],[8],[11] | (2.95%) | [23],[25],[26] | (2.95%) | [23],[25],[26] | (2.95%) | [7],[8],[11]
Investment, interest rate, floor |  | 3.55% | [23],[25],[26] | 3.55% | [7],[8],[11] | 3.55% | [23],[25],[26] | 3.55% | [23],[25],[26] | 3.55% | [7],[8],[11]
Investment, interest rate, paid in kind |  | 5.85% | [23],[25],[26] | 5.85% | [7],[8],[11] | 5.85% | [23],[25],[26] | 5.85% | [23],[25],[26] | 5.85% | [7],[8],[11]
Principal amount |  | $ 8,718 | [25],[26] | $ 8,591 | [8],[11] |  |  |  |  |  |
Investment cost |  | 8,579 | [2],[25],[26] | 8,446 | [5],[8],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 8,359 | [25],[26] | $ 8,446 | [8],[11] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee, 1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10],[12] |  |  | 2025-10 |  |  |  |  |  | 2025-10 |
Investment, basis spread, variable rate | [7],[9],[10],[12] |  |  | 5.20% |  |  |  |  |  | 5.20% |
Investment, interest rate, floor | [7],[9],[10],[12] |  |  | 9.95% |  |  |  |  |  | 9.95% |
Investment exit fee | [7],[9],[10],[12] |  |  | 4.95% |  |  |  |  |  | 4.95% |
Principal amount | [9],[10],[12] |  |  | $ 5,500 |  |  |  |  |  |  |
Investment cost | [5],[9],[10],[12] |  |  | 5,667 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10],[12] |  |  | $ 5,667 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee, 2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10] |  |  | 2025-10 |  |  |  |  |  | 2025-10 |
Investment, basis spread, variable rate | [7],[9],[10] |  |  | 5.20% |  |  |  |  |  | 5.20% |
Investment, interest rate, floor | [7],[9],[10] |  |  | 9.95% |  |  |  |  |  | 9.95% |
Investment exit fee | [7],[9],[10] |  |  | 4.95% |  |  |  |  |  | 4.95% |
Principal amount | £ | [9],[10] |  |  |  |  |  |  |  |  | £ 1,250 |
Investment cost | [5],[9],[10] |  |  | $ 1,612 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 1,594 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.28% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-12 | [21],[24],[25],[26],[32] | 2027-12 | [8],[11],[14],[15],[18] | 2027-12 | [21],[24],[25],[26],[32] | 2027-12 | [21],[24],[25],[26],[32] | 2027-12 | [8],[11],[14],[15],[18]
Investment, basis spread, variable rate |  | 3.05% | [21],[23],[24],[25],[26],[32] | 3.05% | [7],[8],[11],[14],[15],[18] | 3.05% | [21],[23],[24],[25],[26],[32] | 3.05% | [21],[23],[24],[25],[26],[32] | 3.05% | [7],[8],[11],[14],[15],[18]
Investment, interest rate, floor |  | 11.55% | [21],[23],[24],[25],[26],[32] | 11.55% | [7],[8],[11],[14],[15],[18] | 11.55% | [21],[23],[24],[25],[26],[32] | 11.55% | [21],[23],[24],[25],[26],[32] | 11.55% | [7],[8],[11],[14],[15],[18]
Investment, interest rate, paid in kind |  | 1.10% | [21],[23],[24],[25],[26],[32] | 1.10% | [7],[8],[11],[14],[15],[18] | 1.10% | [21],[23],[24],[25],[26],[32] | 1.10% | [21],[23],[24],[25],[26],[32] | 1.10% | [7],[8],[11],[14],[15],[18]
Investment exit fee |  | 6.28% | [21],[23],[24],[25],[26],[32] | 6.28% | [7],[8],[11],[14],[15],[18] | 6.28% | [21],[23],[24],[25],[26],[32] | 6.28% | [21],[23],[24],[25],[26],[32] | 6.28% | [7],[8],[11],[14],[15],[18]
Principal amount |  | $ 45,601 | [21],[24],[25],[26],[32] | $ 45,476 | [8],[11],[14],[15],[18] |  |  |  |  |  |
Investment cost |  | 46,814 | [2],[21],[24],[25],[26],[32] | 46,450 | [5],[8],[11],[14],[15],[18] |  |  |  |  |  |
Investments, at fair value: |  | $ 47,902 | [21],[24],[25],[26],[32] | $ 47,708 | [8],[11],[14],[15],[18] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-04 | [26],[31] | 2028-04 | [11],[19] | 2028-04 | [26],[31] | 2028-04 | [26],[31] | 2028-04 | [11],[19]
Investment, basis spread, variable rate |  | 8.01% | [23],[26],[31] | 8.01% | [7],[11],[19] | 8.01% | [23],[26],[31] | 8.01% | [23],[26],[31] | 8.01% | [7],[11],[19]
Investment, interest rate, floor |  | 8.76% | [23],[26],[31] | 8.76% | [7],[11],[19] | 8.76% | [23],[26],[31] | 8.76% | [23],[26],[31] | 8.76% | [7],[11],[19]
Principal amount |  | $ 8,628 | [26],[31] | $ 8,896 | [11],[19] |  |  |  |  |  |
Investment cost |  | 8,478 | [2],[26],[31] | 8,758 | [5],[11],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 8,312 | [26],[31] | $ 8,641 | [11],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and DocPlanner, Senior Secured, Maturity Date January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [2],[26],[27],[28] | 2030-01 |  |  |  | 2030-01 |  | 2030-01 |  |  |
Investment, basis spread, variable rate | [2],[23],[26],[27],[28] | 2.75% |  |  |  | 2.75% |  | 2.75% |  |  |
Investment, interest rate, floor | [2],[23],[26],[27],[28] | 9.75% |  |  |  | 9.75% |  | 9.75% |  |  |
Investment exit fee | [2],[23],[26],[27],[28] | 4.25% |  |  |  | 4.25% |  | 4.25% |  |  |
Principal amount | € | [2],[26],[27],[28] |  |  |  |  |  |  | € 68,200 |  |  |
Investment cost | [2],[26],[27],[28] | $ 69,353 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [2],[26],[27],[28] | $ 73,090 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Dragos, Inc., Senior Secured, Maturity Date July 2027, Prime + 2.00%, Floor rate 8.75%, PIK Interest 2.00%, 2.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [25],[26] | 2027-07 | [8],[11] | 2027-07 | [25],[26] | 2027-07 | [25],[26] | 2027-07 | [8],[11]
Investment, basis spread, variable rate |  | 2.00% | [23],[25],[26] | 2.00% | [7],[8],[11] | 2.00% | [23],[25],[26] | 2.00% | [23],[25],[26] | 2.00% | [7],[8],[11]
Investment, interest rate, floor |  | 8.75% | [23],[25],[26] | 8.75% | [7],[8],[11] | 8.75% | [23],[25],[26] | 8.75% | [23],[25],[26] | 8.75% | [7],[8],[11]
Investment, interest rate, paid in kind |  | 2.00% | [23],[25],[26] | 2.00% | [7],[8],[11] | 2.00% | [23],[25],[26] | 2.00% | [23],[25],[26] | 2.00% | [7],[8],[11]
Investment exit fee |  | 2.00% | [23],[25],[26] | 2.00% | [7],[8],[11] | 2.00% | [23],[25],[26] | 2.00% | [23],[25],[26] | 2.00% | [7],[8],[11]
Principal amount |  | $ 13,079 | [25],[26] | $ 13,022 | [8],[11] |  |  |  |  |  |
Investment cost |  | 12,512 | [2],[25],[26] | 12,383 | [5],[8],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 12,544 | [25],[26] | $ 12,431 | [8],[11] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.45%, Floor rate 9.95%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-11 | [21],[26] | 2028-11 | [11],[15] | 2028-11 | [21],[26] | 2028-11 | [21],[26] | 2028-11 | [11],[15]
Investment, basis spread, variable rate |  | 2.45% | [21],[23],[26] | 2.45% | [7],[11],[15] | 2.45% | [21],[23],[26] | 2.45% | [21],[23],[26] | 2.45% | [7],[11],[15]
Investment, interest rate, floor |  | 9.95% | [21],[23],[26] | 9.95% | [7],[11],[15] | 9.95% | [21],[23],[26] | 9.95% | [21],[23],[26] | 9.95% | [7],[11],[15]
Investment exit fee |  | 5.00% | [21],[23],[26] | 5.00% | [7],[11],[15] | 5.00% | [21],[23],[26] | 5.00% | [21],[23],[26] | 5.00% | [7],[11],[15]
Principal amount |  | $ 9,375 | [21],[26] | $ 9,375 | [11],[15] |  |  |  |  |  |
Investment cost |  | 9,292 | [2],[21],[26] | 9,255 | [5],[11],[15] |  |  |  |  |  |
Investments, at fair value: |  | $ 9,286 | [21],[26] | $ 9,274 | [11],[15] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Earnix, Inc., Senior Secured, Maturity Date June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-06 | [25],[26],[32] | 2029-06 | [8],[11],[14] | 2029-06 | [25],[26],[32] | 2029-06 | [25],[26],[32] | 2029-06 | [8],[11],[14]
Investment, basis spread, variable rate |  | (1.15%) | [23],[25],[26],[32] | (1.15%) | [7],[8],[11],[14] | (1.15%) | [23],[25],[26],[32] | (1.15%) | [23],[25],[26],[32] | (1.15%) | [7],[8],[11],[14]
Investment, interest rate, floor |  | 5.35% | [23],[25],[26],[32] | 5.35% | [7],[8],[11],[14] | 5.35% | [23],[25],[26],[32] | 5.35% | [23],[25],[26],[32] | 5.35% | [7],[8],[11],[14]
Investment, interest rate, paid in kind |  | 4.45% | [23],[25],[26],[32] | 4.45% | [7],[8],[11],[14] | 4.45% | [23],[25],[26],[32] | 4.45% | [23],[25],[26],[32] | 4.45% | [7],[8],[11],[14]
Principal amount |  | $ 19,380 | [25],[26],[32] | $ 19,166 | [8],[11],[14] |  |  |  |  |  |
Investment cost |  | 19,082 | [2],[25],[26],[32] | 18,856 | [5],[8],[11],[14] |  |  |  |  |  |
Investments, at fair value: |  | $ 19,161 | [25],[26],[32] | $ 18,838 | [8],[11],[14] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [24],[32] | 2029-04 |  |  |  | 2029-04 |  | 2029-04 |  |  |
Investment, basis spread, variable rate | [23],[24],[32] | 1.75% |  |  |  | 1.75% |  | 1.75% |  |  |
Investment, interest rate, floor | [23],[24],[32] | 9.25% |  |  |  | 9.25% |  | 9.25% |  |  |
Investment, interest rate, paid in kind | [23],[24],[32] | 1.30% |  |  |  | 1.30% |  | 1.30% |  |  |
Investment exit fee | [23],[24],[32] | 3.95% |  |  |  | 3.95% |  | 3.95% |  |  |
Principal amount | [24],[32] | $ 13,456 |  |  |  |  |  |  |  |  |
Investment cost | [2],[24],[32] | 13,020 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [24],[32] | $ 13,020 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[14],[18] |  |  | 2026-03 |  |  |  |  |  | 2026-03 |
Investment, basis spread, variable rate | [7],[8],[14],[18] |  |  | 4.25% |  |  |  |  |  | 4.25% |
Investment, interest rate, floor | [7],[8],[14],[18] |  |  | 9.00% |  |  |  |  |  | 9.00% |
Investment, interest rate, paid in kind | [7],[8],[14],[18] |  |  | 1.95% |  |  |  |  |  | 1.95% |
Investment exit fee | [7],[8],[14],[18] |  |  | 3.95% |  |  |  |  |  | 3.95% |
Principal amount | [8],[14],[18] |  |  | $ 12,878 |  |  |  |  |  |  |
Investment cost | [5],[8],[14],[18] |  |  | 12,860 |  |  |  |  |  |  |
Investments, at fair value: | [8],[14],[18] |  |  | $ 13,215 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11],[19] |  |  | 2027-10 |  |  |  |  |  | 2027-10 |
Investment, basis spread, variable rate | [7],[11],[19] |  |  | 7.80% |  |  |  |  |  | 7.80% |
Investment, interest rate, floor | [7],[11],[19] |  |  | 8.70% |  |  |  |  |  | 8.70% |
Principal amount | [11],[19] |  |  | $ 7,297 |  |  |  |  |  |  |
Investment cost | [5],[11],[19] |  |  | 7,145 |  |  |  |  |  |  |
Investments, at fair value: | [11],[19] |  |  | $ 7,271 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 1-month SOFR + 7.64%, Floor rate 8.54% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-12 | [26],[31],[32] | 2027-12 | [11],[14],[19] | 2027-12 | [26],[31],[32] | 2027-12 | [26],[31],[32] | 2027-12 | [11],[14],[19]
Investment, basis spread, variable rate |  | 7.64% | [23],[26],[31],[32] | 7.64% | [7],[11],[14],[19] | 7.64% | [23],[26],[31],[32] | 7.64% | [23],[26],[31],[32] | 7.64% | [7],[11],[14],[19]
Investment, interest rate, floor |  | 8.54% | [23],[26],[31],[32] | 8.54% | [7],[11],[14],[19] | 8.54% | [23],[26],[31],[32] | 8.54% | [23],[26],[31],[32] | 8.54% | [7],[11],[14],[19]
Principal amount |  | $ 6,983 | [26],[31],[32] | $ 7,000 | [11],[14],[19] |  |  |  |  |  |
Investment cost |  | 6,873 | [2],[26],[31],[32] | 6,882 | [5],[11],[14],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 6,919 | [26],[31],[32] | $ 6,950 | [11],[14],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Harness, Inc., Senior Secured, Maturity Date March 2029, Prime - 2.25%, Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-03 | [24],[25],[26] | 2029-03 | [8],[11],[18] | 2029-03 | [24],[25],[26] | 2029-03 | [24],[25],[26] | 2029-03 | [8],[11],[18]
Investment, basis spread, variable rate |  | (2.25%) | [23],[24],[25],[26] | (2.25%) | [7],[8],[11],[18] | (2.25%) | [23],[24],[25],[26] | (2.25%) | [23],[24],[25],[26] | (2.25%) | [7],[8],[11],[18]
Investment, interest rate, floor |  | 5.25% | [23],[24],[25],[26] | 5.25% | [7],[8],[11],[18] | 5.25% | [23],[24],[25],[26] | 5.25% | [23],[24],[25],[26] | 5.25% | [7],[8],[11],[18]
Investment, interest rate, cap |  | 6.50% | [23],[24],[25],[26] | 6.50% | [7],[8],[11],[18] | 6.50% | [23],[24],[25],[26] | 6.50% | [23],[24],[25],[26] | 6.50% | [7],[8],[11],[18]
Investment, interest rate, paid in kind |  | 6.25% | [23],[24],[25],[26] | 6.25% | [7],[8],[11],[18] | 6.25% | [23],[24],[25],[26] | 6.25% | [23],[24],[25],[26] | 6.25% | [7],[8],[11],[18]
Investment exit fee |  | 1.00% | [23],[24],[25],[26] | 1.00% | [7],[8],[11],[18] | 1.00% | [23],[24],[25],[26] | 1.00% | [23],[24],[25],[26] | 1.00% | [7],[8],[11],[18]
Principal amount |  | $ 29,994 | [24],[25],[26] | $ 18,132 | [8],[11],[18] |  |  |  |  |  |
Investment cost |  | 29,677 | [2],[24],[25],[26] | 17,947 | [5],[8],[11],[18] |  |  |  |  |  |
Investments, at fair value: |  | $ 29,811 | [24],[25],[26] | $ 18,060 | [8],[11],[18] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Khoros, Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2025-01 | [25],[41],[42] | 2025-01 | [8],[43] | 2025-01 | [25],[41],[42] | 2025-01 | [25],[41],[42] | 2025-01 | [8],[43]
Investment, basis spread, variable rate |  | 4.50% | [23],[25],[41],[42] | 4.50% | [7],[8],[43] | 4.50% | [23],[25],[41],[42] | 4.50% | [23],[25],[41],[42] | 4.50% | [7],[8],[43]
Investment, interest rate, floor |  | 5.50% | [23],[25],[41],[42] | 5.50% | [7],[8],[43] | 5.50% | [23],[25],[41],[42] | 5.50% | [23],[25],[41],[42] | 5.50% | [7],[8],[43]
Investment, interest rate, paid in kind |  | 4.50% | [23],[25],[41],[42] | 4.50% | [7],[8],[43] | 4.50% | [23],[25],[41],[42] | 4.50% | [23],[25],[41],[42] | 4.50% | [7],[8],[43]
Principal amount |  | $ 61,341 | [25],[41],[42] | $ 61,341 | [8],[43] |  |  |  |  |  |
Investment cost |  | 61,317 | [2],[25],[41],[42] | 61,317 | [5],[8],[43] |  |  |  |  |  |
Investments, at fair value: |  | $ 16,180 | [25],[41],[42] | $ 18,231 | [8],[43] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS, Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.00%, PIK Interest 1.95%, 2.70% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[9],[10],[12] |  |  | 2026-02 |  |  |  |  |  | 2026-02 |
Investment, basis spread, variable rate | [7],[8],[9],[10],[12] |  |  | 0.25% |  |  |  |  |  | 0.25% |
Investment, interest rate, floor | [7],[8],[9],[10],[12] |  |  | 7.00% |  |  |  |  |  | 7.00% |
Investment, interest rate, paid in kind | [7],[8],[9],[10],[12] |  |  | 1.95% |  |  |  |  |  | 1.95% |
Investment exit fee | [7],[8],[9],[10],[12] |  |  | 2.70% |  |  |  |  |  | 2.70% |
Principal amount | [8],[9],[10],[12] |  |  | $ 8,890 |  |  |  |  |  |  |
Investment cost | [5],[8],[9],[10],[12] |  |  | 8,883 |  |  |  |  |  |  |
Investments, at fair value: | [8],[9],[10],[12] |  |  | $ 9,117 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.00%, PIK Interest 1.95%, 2.70% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[25],[27],[28] | 2026-02 |  |  |  | 2026-02 |  | 2026-02 |  |  |
Investment, basis spread, variable rate | [22],[23],[25],[27],[28] | 0.25% |  |  |  | 0.25% |  | 0.25% |  |  |
Investment, interest rate, floor | [22],[23],[25],[27],[28] | 7.00% |  |  |  | 7.00% |  | 7.00% |  |  |
Investment, interest rate, paid in kind | [22],[23],[25],[27],[28] | 1.95% |  |  |  | 1.95% |  | 1.95% |  |  |
Investment exit fee | [22],[23],[25],[27],[28] | 2.70% |  |  |  | 2.70% |  | 2.70% |  |  |
Principal amount | [22],[25],[27],[28] | $ 8,929 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[25],[27],[28] | 8,974 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[25],[27],[28] | $ 8,974 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC, Senior Secured, Maturity Date August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[11],[12] |  |  | 2028-08 |  |  |  |  |  | 2028-08 |
Investment, basis spread, variable rate | [7],[8],[11],[12] |  |  | 6.25% |  |  |  |  |  | 6.25% |
Investment, interest rate, floor | [7],[8],[11],[12] |  |  | 7.25% |  |  |  |  |  | 7.25% |
Investment, interest rate, paid in kind | [7],[8],[11],[12] |  |  | 2.15% |  |  |  |  |  | 2.15% |
Principal amount | [8],[11],[12] |  |  | $ 15,428 |  |  |  |  |  |  |
Investment cost | [5],[8],[11],[12] |  |  | 15,189 |  |  |  |  |  |  |
Investments, at fair value: | [8],[11],[12] |  |  | $ 15,481 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [22],[25],[26] | 2028-08 |  |  |  | 2028-08 |  | 2028-08 |  |  |
Investment, basis spread, variable rate | [22],[23],[25],[26] | 6.25% |  |  |  | 6.25% |  | 6.25% |  |  |
Investment, interest rate, floor | [22],[23],[25],[26] | 7.25% |  |  |  | 7.25% |  | 7.25% |  |  |
Investment, interest rate, paid in kind | [22],[23],[25],[26] | 2.15% |  |  |  | 2.15% |  | 2.15% |  |  |
Principal amount | [22],[25],[26] | $ 15,512 |  |  |  |  |  |  |  |  |
Investment cost | [2],[22],[25],[26] | 15,285 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [22],[25],[26] | $ 15,515 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26],[31] | 2028-03 |  |  |  | 2028-03 |  | 2028-03 |  |  |
Investment, basis spread, variable rate | [23],[26],[31] | 7.88% |  |  |  | 7.88% |  | 7.88% |  |  |
Investment, interest rate, floor | [23],[26],[31] | 8.88% |  |  |  | 8.88% |  | 8.88% |  |  |
Principal amount | [26],[31] | $ 27,206 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[31] | 26,757 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26],[31] | $ 27,206 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LogRhythm, Inc., Senior Secured, Maturity Date July 2029, 1-month SOFR + 7.50%, Floor rate 8.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11] |  |  | 2029-07 |  |  |  |  |  | 2029-07 |
Investment, basis spread, variable rate | [7],[11] |  |  | 7.50% |  |  |  |  |  | 7.50% |
Investment, interest rate, floor | [7],[11] |  |  | 8.50% |  |  |  |  |  | 8.50% |
Principal amount | [11] |  |  | $ 25,000 |  |  |  |  |  |  |
Investment cost | [5],[11] |  |  | 24,305 |  |  |  |  |  |  |
Investments, at fair value: | [11] |  |  | $ 24,305 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LogRhythm, Inc., Senior Secured, Maturity Date July 2029, 3-month SOFR + 7.50%, Floor rate 8.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26] | 2029-07 |  |  |  | 2029-07 |  | 2029-07 |  |  |
Investment, basis spread, variable rate | [23],[26] | 7.50% |  |  |  | 7.50% |  | 7.50% |  |  |
Investment, interest rate, floor | [23],[26] | 8.50% |  |  |  | 8.50% |  | 8.50% |  |  |
Principal amount | [26] | $ 25,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26] | 24,334 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26] | $ 24,346 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26],[31] | 2027-07 |  |  |  | 2027-07 |  | 2027-07 |  |  |
Investment, basis spread, variable rate | [23],[26],[31] | 8.93% |  |  |  | 8.93% |  | 8.93% |  |  |
Investment, interest rate, floor | [23],[26],[31] | 9.93% |  |  |  | 9.93% |  | 9.93% |  |  |
Principal amount | [26],[31] | $ 13,111 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26],[31] | 12,955 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26],[31] | $ 13,111 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Marigold Group, Inc. (p.k.a. Campaign Monitor Limited), Senior Secured, Maturity Date November 2026, PIK Interest 6-month SOFR + 10.55%, Floor rate 11.55% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[15],[18] |  |  | 2026-11 |  |  |  |  |  | 2026-11 |
Investment, basis spread, variable rate | [7],[8],[15],[18] |  |  | 10.55% |  |  |  |  |  | 10.55% |
Investment, interest rate, floor | [7],[8],[15],[18] |  |  | 11.55% |  |  |  |  |  | 11.55% |
Principal amount | [8],[15],[18] |  |  | $ 38,828 |  |  |  |  |  |  |
Investment cost | [5],[8],[15],[18] |  |  | 38,336 |  |  |  |  |  |  |
Investments, at fair value: | [8],[15],[18] |  |  | $ 32,773 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Marigold Group, Inc., Senior Secured, Maturity Date November 2026, PIK Interest 6-month SOFR + 10.55%, Floor rate 11.55% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [21],[24],[25] | 2026-11 |  |  |  | 2026-11 |  | 2026-11 |  |  |
Investment, basis spread, variable rate | [21],[23],[24],[25] | 10.55% |  |  |  | 10.55% |  | 10.55% |  |  |
Investment, interest rate, floor | [21],[23],[24],[25] | 11.55% |  |  |  | 11.55% |  | 11.55% |  |  |
Principal amount | [21],[24],[25] | $ 40,264 |  |  |  |  |  |  |  |  |
Investment cost | [2],[21],[24],[25] | 39,822 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [21],[24],[25] | $ 34,001 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.21%, Floor rate 10.06% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [19] |  |  | 2025-12 |  |  |  |  |  | 2025-12 |
Investment, basis spread, variable rate | [7],[19] |  |  | 9.21% |  |  |  |  |  | 9.21% |
Investment, interest rate, floor | [7],[19] |  |  | 10.06% |  |  |  |  |  | 10.06% |
Principal amount | [19] |  |  | $ 18,366 |  |  |  |  |  |  |
Investment cost | [5],[19] |  |  | 18,237 |  |  |  |  |  |  |
Investments, at fair value: | [19] |  |  | $ 17,616 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 6-month SOFR + 9.31%, Floor rate 10.06% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [31] | 2025-12 |  |  |  | 2025-12 |  | 2025-12 |  |  |
Investment, basis spread, variable rate | [23],[31] | 9.31% |  |  |  | 9.31% |  | 9.31% |  |  |
Investment, interest rate, floor | [23],[31] | 10.06% |  |  |  | 10.06% |  | 10.06% |  |  |
Principal amount | [31] | $ 18,366 |  |  |  |  |  |  |  |  |
Investment cost | [2],[31] | 18,270 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [31] | $ 17,716 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Morphisec Information Security 2014 Ltd., Senior Secured, Maturity Date October 2027, Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-10 | [27],[28] | 2027-10 | [9],[10] | 2027-10 | [27],[28] | 2027-10 | [27],[28] | 2027-10 | [9],[10]
Investment, basis spread, variable rate |  | 3.45% | [23],[27],[28] | 3.45% | [7],[9],[10] | 3.45% | [23],[27],[28] | 3.45% | [23],[27],[28] | 3.45% | [7],[9],[10]
Investment, interest rate, floor |  | 11.70% | [23],[27],[28] | 11.70% | [7],[9],[10] | 11.70% | [23],[27],[28] | 11.70% | [23],[27],[28] | 11.70% | [7],[9],[10]
Investment exit fee |  | 5.95% | [23],[27],[28] | 5.95% | [7],[9],[10] | 5.95% | [23],[27],[28] | 5.95% | [23],[27],[28] | 5.95% | [7],[9],[10]
Principal amount |  | $ 10,000 | [27],[28] | $ 10,000 | [9],[10] |  |  |  |  |  |
Investment cost |  | 9,926 | [2],[27],[28] | 9,861 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 9,926 | [27],[28] | 9,861 | [9],[10] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Morphisec Information Security 2014 Ltd., Warrant, Acquisition Date 10/1/2024, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[10] |  |  | 104 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 108 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[10],[44] |  |  | Oct. 01, 2024 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[10] |  |  | 200,115 |  |  |  |  |  | 200,115 |
Investment, Identifier [Axis]: Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 1-month SOFR + 6.75%, Floor rate 7.75% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11] |  |  | 2030-11 |  |  |  |  |  | 2030-11 |
Investment, basis spread, variable rate | [7],[11] |  |  | 6.75% |  |  |  |  |  | 6.75% |
Investment, interest rate, floor | [7],[11] |  |  | 7.75% |  |  |  |  |  | 7.75% |
Principal amount | [11] |  |  | $ 21,890 |  |  |  |  |  |  |
Investment cost | [5],[11] |  |  | 21,402 |  |  |  |  |  |  |
Investments, at fair value: | [11] |  |  | $ 21,644 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26] | 2030-11 |  |  |  | 2030-11 |  | 2030-11 |  |  |
Investment, basis spread, variable rate | [23],[26] | 6.75% |  |  |  | 6.75% |  | 6.75% |  |  |
Investment, interest rate, floor | [23],[26] | 7.75% |  |  |  | 7.75% |  | 7.75% |  |  |
Principal amount | [26] | $ 21,890 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26] | 21,417 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26] | $ 21,346 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [26],[31],[32] | 2027-07 | [11],[14],[19] | 2027-07 | [26],[31],[32] | 2027-07 | [26],[31],[32] | 2027-07 | [11],[14],[19]
Investment, basis spread, variable rate |  | 8.05% | [23],[26],[31],[32] | 8.05% | [7],[11],[14],[19] | 8.05% | [23],[26],[31],[32] | 8.05% | [23],[26],[31],[32] | 8.05% | [7],[11],[14],[19]
Investment, interest rate, floor |  | 9.05% | [23],[26],[31],[32] | 9.05% | [7],[11],[14],[19] | 9.05% | [23],[26],[31],[32] | 9.05% | [23],[26],[31],[32] | 9.05% | [7],[11],[14],[19]
Principal amount |  | $ 7,631 | [26],[31],[32] | $ 7,669 | [11],[14],[19] |  |  |  |  |  |
Investment cost |  | 7,493 | [2],[26],[31],[32] | 7,518 | [5],[11],[14],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 7,631 | [26],[31],[32] | $ 7,669 | [11],[14],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and PayIt, LLC, Senior Secured, Maturity Date December 2028, Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-12 | [1],[24],[25],[26],[38] | 2028-12 | [6],[8],[11],[18],[37] | 2028-12 | [1],[24],[25],[26],[38] | 2028-12 | [1],[24],[25],[26],[38] | 2028-12 | [6],[8],[11],[18],[37]
Investment, basis spread, variable rate |  | 1.45% | [1],[23],[24],[25],[26],[38] | 1.45% | [6],[7],[8],[11],[18],[37] | 1.45% | [1],[23],[24],[25],[26],[38] | 1.45% | [1],[23],[24],[25],[26],[38] | 1.45% | [6],[7],[8],[11],[18],[37]
Investment, interest rate, floor |  | 7.95% | [1],[23],[24],[25],[26],[38] | 7.95% | [6],[7],[8],[11],[18],[37] | 7.95% | [1],[23],[24],[25],[26],[38] | 7.95% | [1],[23],[24],[25],[26],[38] | 7.95% | [6],[7],[8],[11],[18],[37]
Investment, interest rate, paid in kind |  | 1.50% | [1],[23],[24],[25],[26],[38] | 1.50% | [6],[7],[8],[11],[18],[37] | 1.50% | [1],[23],[24],[25],[26],[38] | 1.50% | [1],[23],[24],[25],[26],[38] | 1.50% | [6],[7],[8],[11],[18],[37]
Investment exit fee |  | 5.00% | [1],[23],[24],[25],[26],[38] | 5.00% | [6],[7],[8],[11],[18],[37] | 5.00% | [1],[23],[24],[25],[26],[38] | 5.00% | [1],[23],[24],[25],[26],[38] | 5.00% | [6],[7],[8],[11],[18],[37]
Principal amount |  | $ 12,048 | [1],[24],[25],[26],[38] | $ 12,003 | [6],[8],[11],[18],[37] |  |  |  |  |  |
Investment cost |  | 11,961 | [1],[2],[24],[25],[26],[38] | 11,881 | [5],[6],[8],[11],[18],[37] |  |  |  |  |  |
Investments, at fair value: |  | $ 11,961 | [1],[24],[25],[26],[38] | $ 11,881 | [6],[8],[11],[18],[37] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Pindrop Security, Inc., Senior Secured, Maturity Date June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2029-06 | [1],[26] | 2029-06 | [6],[11] | 2029-06 | [1],[26] | 2029-06 | [1],[26] | 2029-06 | [6],[11]
Investment, basis spread, variable rate |  | 3.50% | [1],[23],[26] | 3.50% | [6],[7],[11] | 3.50% | [1],[23],[26] | 3.50% | [1],[23],[26] | 3.50% | [6],[7],[11]
Investment, interest rate, floor |  | 10.00% | [1],[23],[26] | 10.00% | [6],[7],[11] | 10.00% | [1],[23],[26] | 10.00% | [1],[23],[26] | 10.00% | [6],[7],[11]
Investment exit fee |  | 2.00% | [1],[23],[26] | 2.00% | [6],[7],[11] | 2.00% | [1],[23],[26] | 2.00% | [1],[23],[26] | 2.00% | [6],[7],[11]
Principal amount |  | $ 31,000 | [1],[26] | $ 31,000 | [6],[11] |  |  |  |  |  |
Investment cost |  | 30,611 | [1],[2],[26] | 30,566 | [5],[6],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 30,849 | [1],[26] | $ 30,671 | [6],[11] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Remodel Health Holdco, LLC, Senior Secured, Maturity Date December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[37] |  |  | 2028-12 |  |  |  |  |  | 2028-12 |
Investment, basis spread, variable rate | [6],[7],[37] |  |  | 2.35% |  |  |  |  |  | 2.35% |
Investment, interest rate, floor | [6],[7],[37] |  |  | 10.35% |  |  |  |  |  | 10.35% |
Investment exit fee | [6],[7],[37] |  |  | 6.50% |  |  |  |  |  | 6.50% |
Principal amount | [6],[37] |  |  | $ 25,000 |  |  |  |  |  |  |
Investment cost | [5],[6],[37] |  |  | 24,723 |  |  |  |  |  |  |
Investments, at fair value: | [6],[37] |  |  | $ 24,723 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Remodel Health Holdco, LLC., Senior Secured, Maturity Date December 2028 ,Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[38] | 2028-12 |  |  |  | 2028-12 |  | 2028-12 |  |  |
Investment, basis spread, variable rate | [1],[23],[38] | 2.35% |  |  |  | 2.35% |  | 2.35% |  |  |
Investment, interest rate, floor | [1],[23],[38] | 10.35% |  |  |  | 10.35% |  | 10.35% |  |  |
Investment exit fee | [1],[23],[38] | 6.50% |  |  |  | 6.50% |  | 6.50% |  |  |
Principal amount | [1],[38] | $ 25,000 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[38] | 24,818 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[38] | $ 24,399 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8] |  |  | 2027-02 |  |  |  |  |  | 2027-02 |
Investment, basis spread, variable rate | [6],[7],[8] |  |  | 0.65% |  |  |  |  |  | 0.65% |
Investment, interest rate, floor | [6],[7],[8] |  |  | 9.15% |  |  |  |  |  | 9.15% |
Investment, interest rate, paid in kind | [6],[7],[8] |  |  | 2.00% |  |  |  |  |  | 2.00% |
Investment exit fee | [6],[7],[8] |  |  | 5.05% |  |  |  |  |  | 5.05% |
Principal amount | [6],[8] |  |  | $ 36,345 |  |  |  |  |  |  |
Investment cost | [5],[6],[8] |  |  | 36,403 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8] |  |  | $ 36,525 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Semperis Technologies Inc., Senior Secured, Maturity Date April 2028, Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-04 | [24],[25],[26],[32] | 2028-04 | [8],[14],[18] | 2028-04 | [24],[25],[26],[32] | 2028-04 | [24],[25],[26],[32] | 2028-04 | [8],[14],[18]
Investment, basis spread, variable rate |  | (1.75%) | [23],[24],[25],[26],[32] | (1.75%) | [7],[8],[14],[18] | (1.75%) | [23],[24],[25],[26],[32] | (1.75%) | [23],[24],[25],[26],[32] | (1.75%) | [7],[8],[14],[18]
Investment, interest rate, floor |  | 6.75% | [23],[24],[25],[26],[32] | 6.75% | [7],[8],[14],[18] | 6.75% | [23],[24],[25],[26],[32] | 6.75% | [23],[24],[25],[26],[32] | 6.75% | [7],[8],[14],[18]
Investment, interest rate, paid in kind |  | 3.25% | [23],[24],[25],[26],[32] | 3.25% | [7],[8],[14],[18] | 3.25% | [23],[24],[25],[26],[32] | 3.25% | [23],[24],[25],[26],[32] | 3.25% | [7],[8],[14],[18]
Principal amount |  | $ 22,936 | [24],[25],[26],[32] | $ 22,754 | [8],[14],[18] |  |  |  |  |  |
Investment cost |  | 22,787 | [2],[24],[25],[26],[32] | 22,596 | [5],[8],[14],[18] |  |  |  |  |  |
Investments, at fair value: |  | $ 23,464 | [24],[25],[26],[32] | $ 23,066 | [8],[14],[18] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 8.88%, Floor rate 9.78% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-12 | [26],[31] | 2026-12 | [11],[19] | 2026-12 | [26],[31] | 2026-12 | [26],[31] | 2026-12 | [11],[19]
Investment, basis spread, variable rate |  | 8.88% | [23],[26],[31] | 8.88% | [7],[11],[19] | 8.88% | [23],[26],[31] | 8.88% | [23],[26],[31] | 8.88% | [7],[11],[19]
Investment, interest rate, floor |  | 9.78% | [23],[26],[31] | 9.78% | [7],[11],[19] | 9.78% | [23],[26],[31] | 9.78% | [23],[26],[31] | 9.78% | [7],[11],[19]
Principal amount |  | $ 6,000 | [26],[31] | $ 6,000 | [11],[19] |  |  |  |  |  |
Investment cost |  | 5,927 | [2],[26],[31] | 5,918 | [5],[11],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 5,925 | [26],[31] | $ 5,953 | [11],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-03 | [22],[25] | 2027-03 | [8],[12] | 2027-03 | [22],[25] | 2027-03 | [22],[25] | 2027-03 | [8],[12]
Investment, basis spread, variable rate |  | 1.00% | [22],[23],[25] | 1.00% | [7],[8],[12] | 1.00% | [22],[23],[25] | 1.00% | [22],[23],[25] | 1.00% | [7],[8],[12]
Investment, interest rate, floor |  | 8.75% | [22],[23],[25] | 8.75% | [7],[8],[12] | 8.75% | [22],[23],[25] | 8.75% | [22],[23],[25] | 8.75% | [7],[8],[12]
Investment, interest rate, paid in kind |  | 1.95% | [22],[23],[25] | 1.95% | [7],[8],[12] | 1.95% | [22],[23],[25] | 1.95% | [22],[23],[25] | 1.95% | [7],[8],[12]
Investment exit fee |  | 2.95% | [22],[23],[25] | 2.95% | [7],[8],[12] | 2.95% | [22],[23],[25] | 2.95% | [22],[23],[25] | 2.95% | [7],[8],[12]
Principal amount |  | $ 12,919 | [22],[25] | $ 13,087 | [8],[12] |  |  |  |  |  |
Investment cost |  | 13,020 | [2],[22],[25] | 13,152 | [5],[8],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 12,881 | [22],[25] | $ 13,175 | [8],[12] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-07 | [25],[27],[28] | 2027-07 | [8],[9],[10] | 2027-07 | [25],[27],[28] | 2027-07 | [25],[27],[28] | 2027-07 | [8],[9],[10]
Investment, basis spread, variable rate |  | 1.50% | [23],[25],[27],[28] | 1.50% | [7],[8],[9],[10] | 1.50% | [23],[25],[27],[28] | 1.50% | [23],[25],[27],[28] | 1.50% | [7],[8],[9],[10]
Investment, interest rate, floor |  | 9.50% | [23],[25],[27],[28] | 9.50% | [7],[8],[9],[10] | 9.50% | [23],[25],[27],[28] | 9.50% | [23],[25],[27],[28] | 9.50% | [7],[8],[9],[10]
Investment, interest rate, paid in kind |  | 1.95% | [23],[25],[27],[28] | 1.95% | [7],[8],[9],[10] | 1.95% | [23],[25],[27],[28] | 1.95% | [23],[25],[27],[28] | 1.95% | [7],[8],[9],[10]
Investment exit fee |  | 5.95% | [23],[25],[27],[28] | 5.95% | [7],[8],[9],[10] | 5.95% | [23],[25],[27],[28] | 5.95% | [23],[25],[27],[28] | 5.95% | [7],[8],[9],[10]
Principal amount |  | $ 33,638 | [25],[27],[28] | $ 33,760 | [8],[9],[10] |  |  |  |  |  |
Investment cost |  | 34,189 | [2],[25],[27],[28] | 34,152 | [5],[8],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 34,212 | [25],[27],[28] | $ 34,193 | [8],[9],[10] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2028-03 | [21],[26],[31],[32] | 2028-03 | [11],[14],[15],[19] | 2028-03 | [21],[26],[31],[32] | 2028-03 | [21],[26],[31],[32] | 2028-03 | [11],[14],[15],[19]
Investment, basis spread, variable rate |  | 7.25% | [21],[23],[26],[31],[32] | 7.25% | [7],[11],[14],[15],[19] | 7.25% | [21],[23],[26],[31],[32] | 7.25% | [21],[23],[26],[31],[32] | 7.25% | [7],[11],[14],[15],[19]
Investment, interest rate, floor |  | 8.25% | [21],[23],[26],[31],[32] | 8.25% | [7],[11],[14],[15],[19] | 8.25% | [21],[23],[26],[31],[32] | 8.25% | [21],[23],[26],[31],[32] | 8.25% | [7],[11],[14],[15],[19]
Principal amount |  | $ 17,600 | [21],[26],[31],[32] | $ 17,600 | [11],[14],[15],[19] |  |  |  |  |  |
Investment cost |  | 17,342 | [2],[21],[26],[31],[32] | 17,324 | [5],[11],[14],[15],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 17,514 | [21],[26],[31],[32] | $ 17,688 | [11],[14],[15],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date March 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [11] |  |  | 2030-05 |  |  |  |  |  | 2030-05 |
Investment, basis spread, variable rate | [7],[11] |  |  | 6.50% |  |  |  |  |  | 6.50% |
Investment, interest rate, floor | [7],[11] |  |  | 7.50% |  |  |  |  |  | 7.50% |
Principal amount | [11] |  |  | $ 23,000 |  |  |  |  |  |  |
Investment cost | [5],[11] |  |  | 22,521 |  |  |  |  |  |  |
Investments, at fair value: | [11] |  |  | $ 23,113 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 6-month SOFR + 6.50%, Floor rate 7.50% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26] | 2030-05 |  |  |  | 2030-05 |  | 2030-05 |  |  |
Investment, basis spread, variable rate | [23],[26] | 6.50% |  |  |  | 6.50% |  | 6.50% |  |  |
Investment, interest rate, floor | [23],[26] | 7.50% |  |  |  | 7.50% |  | 7.50% |  |  |
Principal amount | [26] | $ 23,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[26] | 22,537 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26] | $ 22,625 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8],[11],[37] |  |  | 2027-08 |  |  |  |  |  | 2027-08 |
Investment, basis spread, variable rate | [6],[7],[8],[11],[37] |  |  | 1.75% |  |  |  |  |  | 1.75% |
Investment, interest rate, floor | [6],[7],[8],[11],[37] |  |  | 10.00% |  |  |  |  |  | 10.00% |
Investment, interest rate, paid in kind | [6],[7],[8],[11],[37] |  |  | 1.95% |  |  |  |  |  | 1.95% |
Investment exit fee | [6],[7],[8],[11],[37] |  |  | 3.45% |  |  |  |  |  | 3.45% |
Principal amount | [6],[8],[11],[37] |  |  | $ 24,345 |  |  |  |  |  |  |
Investment cost | [5],[6],[8],[11],[37] |  |  | 24,031 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8],[11],[37] |  |  | $ 24,935 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25],[26],[38] | 2027-08 |  |  |  | 2027-08 |  | 2027-08 |  |  |
Investment, basis spread, variable rate | [1],[23],[25],[26],[38] | 1.75% |  |  |  | 1.75% |  | 1.75% |  |  |
Investment, interest rate, floor | [1],[23],[25],[26],[38] | 10.00% |  |  |  | 10.00% |  | 10.00% |  |  |
Investment, interest rate, paid in kind | [1],[23],[25],[26],[38] | 1.95% |  |  |  | 1.95% |  | 1.95% |  |  |
Investment exit fee | [1],[23],[25],[26],[38] | 3.45% |  |  |  | 3.45% |  | 3.45% |  |  |
Principal amount | [1],[25],[26],[38] | $ 24,460 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25],[26],[38] | 24,237 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25],[26],[38] | $ 24,686 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and TaxCalc, Senior Secured, Maturity Date November 2029, 3-month SONIA + 8.05%, Floor rate 8.55% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [9],[10],[11],[19] |  |  | 2029-11 |  |  |  |  |  | 2029-11 |
Investment, basis spread, variable rate | [7],[9],[10],[11],[19] |  |  | 8.05% |  |  |  |  |  | 8.05% |
Investment, interest rate, floor | [7],[9],[10],[11],[19] |  |  | 8.55% |  |  |  |  |  | 8.55% |
Principal amount | [9],[10],[11],[19] |  |  | $ 7,500 |  |  |  |  |  |  |
Investment cost | [5],[9],[10],[11],[19] |  |  | 9,518 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10],[11],[19] |  |  | $ 9,198 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and TaxCalc., Senior Secured, Maturity Date November 2029, Daily SONIA + 8.17%, Floor rate 8.67% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [26],[27],[28],[31] | 2029-11 |  |  |  | 2029-11 |  | 2029-11 |  |  |
Investment, basis spread, variable rate | [23],[26],[27],[28],[31] | 8.17% |  |  |  | 8.17% |  | 8.17% |  |  |
Investment, interest rate, floor | [23],[26],[27],[28],[31] | 8.67% |  |  |  | 8.67% |  | 8.67% |  |  |
Principal amount | £ | [26],[27],[28],[31] |  |  |  |  | £ 7,500 |  |  |  |  |
Investment cost | [2],[26],[27],[28],[31] | $ 9,527 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [26],[27],[28],[31] | $ 9,502 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 3-month SOFR + 9.15%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2026-05 | [31] | 2026-05 | [19] | 2026-05 | [31] | 2026-05 | [31] | 2026-05 | [19]
Investment, basis spread, variable rate |  | 9.15% | [23],[31] | 9.15% | [7],[19] | 9.15% | [23],[31] | 9.15% | [23],[31] | 9.15% | [7],[19]
Investment, interest rate, floor |  | 10.00% | [23],[31] | 10.00% | [7],[19] | 10.00% | [23],[31] | 10.00% | [23],[31] | 10.00% | [7],[19]
Principal amount |  | $ 12,254 | [31] | $ 12,324 | [19] |  |  |  |  |  |
Investment cost |  | 12,158 | [2],[31] | 12,208 | [5],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 12,241 | [31] | $ 12,324 | [19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.00%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[9],[10] |  |  | 2027-04 |  |  |  |  |  | 2027-04 |
Investment, basis spread, variable rate | [7],[8],[9],[10] |  |  | 0.45% |  |  |  |  |  | 0.45% |
Investment, interest rate, floor | [7],[8],[9],[10] |  |  | 6.45% |  |  |  |  |  | 6.45% |
Investment, interest rate, paid in kind | [7],[8],[9],[10] |  |  | 2.00% |  |  |  |  |  | 2.00% |
Investment exit fee | [7],[8],[9],[10] |  |  | 3.75% |  |  |  |  |  | 3.75% |
Principal amount | [8],[9],[10] |  |  | $ 42,670 |  |  |  |  |  |  |
Investment cost | [5],[8],[9],[10] |  |  | 42,379 |  |  |  |  |  |  |
Investments, at fair value: | [8],[9],[10] |  |  | 43,448 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [33] | 2029-04 |  |  |  | 2029-04 |  | 2029-04 |  |  |
Investment, basis spread, variable rate | [23],[33] | 0.45% |  |  |  | 0.45% |  | 0.45% |  |  |
Investment, interest rate, floor | [23],[33] | 6.45% |  |  |  | 6.45% |  | 6.45% |  |  |
Investment, interest rate, paid in kind | [23],[33] | 2.30% |  |  |  | 2.30% |  | 2.30% |  |  |
Principal amount | [33] | $ 75,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[33] | 74,571 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [33] | $ 74,571 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [33] | 2029-04 |  |  |  | 2029-04 |  | 2029-04 |  |  |
Investment, basis spread, variable rate | [23],[33] | 0.45% |  |  |  | 0.45% |  | 0.45% |  |  |
Investment, interest rate, floor | [23],[33] | 6.45% |  |  |  | 6.45% |  | 6.45% |  |  |
Investment, interest rate, paid in kind | [23],[33] | 2.30% |  |  |  | 2.30% |  | 2.30% |  |  |
Investment exit fee | [23],[33] | 3.75% |  |  |  | 3.75% |  | 3.75% |  |  |
Principal amount | [33] | $ 42,000 |  |  |  |  |  |  |  |  |
Investment cost | [2],[33] | 41,763 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [33] | 41,763 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Total Armis, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 76,263 |  | 75,883 |  |  |  |  |  |  |
Investment cost |  | 75,979 | [2] | 75,464 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 76,268 |  | 76,439 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Total Cutover, Inc., |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | 7,279 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 7,261 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Total Tipalti Solutions Ltd. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 117,000 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 116,334 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 116,334 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-12 | [21],[26],[27],[28],[31] | 2027-12 | [9],[10],[11],[15],[19] | 2027-12 | [21],[26],[27],[28],[31] | 2027-12 | [21],[26],[27],[28],[31] | 2027-12 | [9],[10],[11],[15],[19]
Investment, basis spread, variable rate |  | 8.03% | [21],[23],[26],[27],[28],[31] | 8.03% | [7],[9],[10],[11],[15],[19] | 8.03% | [21],[23],[26],[27],[28],[31] | 8.03% | [21],[23],[26],[27],[28],[31] | 8.03% | [7],[9],[10],[11],[15],[19]
Investment, interest rate, floor |  | 9.03% | [21],[23],[26],[27],[28],[31] | 9.03% | [7],[9],[10],[11],[15],[19] | 9.03% | [21],[23],[26],[27],[28],[31] | 9.03% | [21],[23],[26],[27],[28],[31] | 9.03% | [7],[9],[10],[11],[15],[19]
Principal amount |  | $ 12,696 | [21],[26],[27],[28],[31] | $ 12,729 | [9],[10],[11],[15],[19] |  |  |  |  |  |
Investment cost |  | 12,505 | [2],[21],[26],[27],[28],[31] | 12,522 | [5],[9],[10],[11],[15],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 12,667 | [21],[26],[27],[28],[31] | $ 12,756 | [9],[10],[11],[15],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-05 | [26],[31] | 2027-05 | [11],[19] | 2027-05 | [26],[31] | 2027-05 | [26],[31] | 2027-05 | [11],[19]
Investment, basis spread, variable rate |  | 8.31% | [23],[26],[31] | 8.31% | [7],[11],[19] | 8.31% | [23],[26],[31] | 8.31% | [23],[26],[31] | 8.31% | [7],[11],[19]
Investment, interest rate, floor |  | 9.31% | [23],[26],[31] | 9.31% | [7],[11],[19] | 9.31% | [23],[26],[31] | 9.31% | [23],[26],[31] | 9.31% | [7],[11],[19]
Principal amount |  | $ 14,790 | [26],[31] | $ 14,790 | [11],[19] |  |  |  |  |  |
Investment cost |  | 14,633 | [2],[26],[31] | 14,618 | [5],[11],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 14,370 | [26],[31] | $ 14,444 | [11],[19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and iGrafx, LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.61%, Floor rate 9.51%, 0.47% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date |  | 2027-05 | [31] | 2027-05 | [19] | 2027-05 | [31] | 2027-05 | [31] | 2027-05 | [19]
Investment, basis spread, variable rate |  | 8.61% | [23],[31] | 8.61% | [7],[19] | 8.61% | [23],[31] | 8.61% | [23],[31] | 8.61% | [7],[19]
Investment, interest rate, floor |  | 9.51% | [23],[31] | 9.51% | [7],[19] | 9.51% | [23],[31] | 9.51% | [23],[31] | 9.51% | [7],[19]
Investment exit fee |  | 0.47% | [23],[31] | 0.47% | [7],[19] | 0.47% | [23],[31] | 0.47% | [23],[31] | 0.47% | [7],[19]
Principal amount |  | $ 4,937 | [31] | $ 4,950 | [19] |  |  |  |  |  |
Investment cost |  | 4,875 | [2],[31] | 4,879 | [5],[19] |  |  |  |  |  |
Investments, at fair value: |  | $ 4,856 | [31] | $ 4,869 | [19] |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Software and iSpot.tv, Inc., Senior Secured, Maturity Date January 2029, Prime + 2.25%, Floor rate 8.75%, PIK Interest 1.00%, 5.70% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [24],[25],[26] | 2029-01 |  |  |  | 2029-01 |  | 2029-01 |  |  |
Investment, basis spread, variable rate | [23],[24],[25],[26] | 2.25% |  |  |  | 2.25% |  | 2.25% |  |  |
Investment, interest rate, floor | [23],[24],[25],[26] | 8.75% |  |  |  | 8.75% |  | 8.75% |  |  |
Investment, interest rate, paid in kind | [23],[24],[25],[26] | 1.00% |  |  |  | 1.00% |  | 1.00% |  |  |
Investment exit fee | [23],[24],[25],[26] | 5.70% |  |  |  | 5.70% |  | 5.70% |  |  |
Principal amount | [24],[25],[26] | $ 8,257 |  |  |  |  |  |  |  |  |
Investment cost | [2],[24],[25],[26] | 8,178 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [24],[25],[26] | $ 8,178 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Space Technologies (2.30%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 2.30% |  |  |  |  |  | 2.30% |
Investment cost | [5] |  |  | $ 45,302 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 45,690 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Space Technologies (2.47%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 2.47% |  |  |  | 2.47% |  | 2.47% |  |  |
Investment cost | [2] | $ 45,767 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 49,505 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Space Technologies and Voyager Space Holdings, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[25],[32] | 2028-07 |  |  |  | 2028-07 |  | 2028-07 |  |  |
Investment, basis spread, variable rate | [1],[23],[25],[32] | 1.25% |  |  |  | 1.25% |  | 1.25% |  |  |
Investment, interest rate, floor | [1],[23],[25],[32] | 9.75% |  |  |  | 9.75% |  | 9.75% |  |  |
Investment, interest rate, paid in kind | [1],[23],[25],[32] | 2.50% |  |  |  | 2.50% |  | 2.50% |  |  |
Investment exit fee | [1],[23],[25],[32] | 5.50% |  |  |  | 5.50% |  | 5.50% |  |  |
Principal amount | [1],[25],[32] | $ 45,724 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[25],[32] | 45,767 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[25],[32] | $ 49,505 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Space Technologies and Voyager Technologies, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8],[14] |  |  | 2028-07 |  |  |  |  |  | 2028-07 |
Investment, basis spread, variable rate | [6],[7],[8],[14] |  |  | 1.25% |  |  |  |  |  | 1.25% |
Investment, interest rate, floor | [6],[7],[8],[14] |  |  | 9.75% |  |  |  |  |  | 9.75% |
Investment, interest rate, paid in kind | [6],[7],[8],[14] |  |  | 2.50% |  |  |  |  |  | 2.50% |
Investment exit fee | [6],[7],[8],[14] |  |  | 5.50% |  |  |  |  |  | 5.50% |
Principal amount | [6],[8],[14] |  |  | $ 45,439 |  |  |  |  |  |  |
Investment cost | [5],[6],[8],[14] |  |  | 45,302 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8],[14] |  |  | $ 45,690 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.99%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.99% |  |  |  | 0.99% |  | 0.99% |  |  |
Investment cost | [2] | $ 19,866 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 19,903 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (1.27%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.27% |  |  |  |  |  | 1.27% |
Investment cost | [5] |  |  | $ 25,086 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 25,243 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [8],[15] |  |  | 2025-05 |  |  |  |  |  | 2025-05 |
Investment, basis spread, variable rate | [7],[8],[15] |  |  | 4.70% |  |  |  |  |  | 4.70% |
Investment, interest rate, floor | [7],[8],[15] |  |  | 7.95% |  |  |  |  |  | 7.95% |
Investment, interest rate, paid in kind | [7],[8],[15] |  |  | 1.45% |  |  |  |  |  | 1.45% |
Investment exit fee | [7],[8],[15] |  |  | 3.95% |  |  |  |  |  | 3.95% |
Principal amount | [8],[15] |  |  | $ 3,984 |  |  |  |  |  |  |
Investment cost | [5],[8],[15] |  |  | 4,102 |  |  |  |  |  |  |
Investments, at fair value: | [8],[15] |  |  | $ 4,141 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.89% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [6],[8],[18] |  |  | 2028-05 |  |  |  |  |  | 2028-05 |
Investment, basis spread, variable rate | [6],[7],[8],[18] |  |  | 2.25% |  |  |  |  |  | 2.25% |
Investment, interest rate, floor | [6],[7],[8],[18] |  |  | 10.75% |  |  |  |  |  | 10.75% |
Investment, interest rate, paid in kind | [6],[7],[8],[18] |  |  | 1.25% |  |  |  |  |  | 1.25% |
Investment exit fee | [6],[7],[8],[18] |  |  | 4.89% |  |  |  |  |  | 4.89% |
Principal amount | [6],[8],[18] |  |  | $ 20,127 |  |  |  |  |  |  |
Investment cost | [5],[6],[8],[18] |  |  | 19,687 |  |  |  |  |  |  |
Investments, at fair value: | [6],[8],[18] |  |  | $ 19,830 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.89% Exit Fee |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [1],[24],[25] | 2028-05 |  |  |  | 2028-05 |  | 2028-05 |  |  |
Investment, basis spread, variable rate | [1],[23],[24],[25] | 2.25% |  |  |  | 2.25% |  | 2.25% |  |  |
Investment, interest rate, floor | [1],[23],[24],[25] | 10.75% |  |  |  | 10.75% |  | 10.75% |  |  |
Investment, interest rate, paid in kind | [1],[23],[24],[25] | 1.25% |  |  |  | 1.25% |  | 1.25% |  |  |
Investment exit fee | [1],[23],[24],[25] | 4.89% |  |  |  | 4.89% |  | 4.89% |  |  |
Principal amount | [1],[24],[25] | $ 20,190 |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[24],[25] | 19,866 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[24],[25] | 19,903 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and SUNation Energy, Inc. (p.k.a. Pineapple Energy LLC), Senior Secured, Maturity Date June 2027, FIXED 10.00% |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Maturity Date | [18] |  |  | 2027-06 |  |  |  |  |  | 2027-06 |
Investment, interest rate, paid in cash | [7],[18] |  |  | 10.00% |  |  |  |  |  | 10.00% |
Principal amount | [18] |  |  | $ 1,296 |  |  |  |  |  |  |
Investment cost | [5],[18] |  |  | 1,297 |  |  |  |  |  |  |
Investments, at fair value: | [18] |  |  | $ 1,272 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Debt Investments Total Marathon Health, LLC |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Principal amount |  | 173,301 |  |  |  |  |  |  |  |  |
Investment cost | [2] | 172,702 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 173,880 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments (6.47%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 6.47% |  |  |  |  |  | 6.47% |
Investment cost | [5] |  |  | $ 157,712 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 128,657 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments (7.34%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 7.34% |  |  |  | 7.34% |  | 7.34% |  |  |
Investment cost | [2] | $ 173,998 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 146,750 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools (0.05%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.05% |  |  |  | 0.05% |  | 0.05% |  |  |
Investment cost | [2] | $ 1,500 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 970 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools (0.07%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.07% |  |  |  |  |  | 0.07% |
Investment cost | [5] |  |  | $ 1,500 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 1,423 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Biotechnology Tools and Alamar Biosciences, Inc., Equity, Acquisition Date 2/21/2024, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 1,500 | [2] | 1,500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 970 |  | $ 1,423 |  |  |  |  |  |  |
Investments owned acquisition date |  | Feb. 21, 2024 | [3] | Feb. 21, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 503,778 |  | 503,778 |  | 503,778 |  | 503,778 |  | 503,778 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.02% |  |  |  | 0.02% |  | 0.02% |  |  |
Investment cost | [2] | $ 1,675 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 366 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.04%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.04% |  |  |  |  |  | 0.04% |
Investment cost | [5] |  |  | $ 1,675 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 783 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | 1,101 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 299 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Jul. 16, 2013 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 130,191 |  |  |  |  |  | 130,191 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 128 | [2] | $ 128 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 19 |  | $ 46 |  |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 30, 2010 | [3] | Apr. 30, 2010 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 42,989 |  | 42,989 |  | 42,989 |  | 42,989 |  | 42,989 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,101 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 172 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Jul. 16, 2013 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 130,191 |  |  |  | 130,191 |  | 130,191 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 433 | [2],[3] | $ 433 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 17 | [3] | $ 17 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 30, 2021 | [3] | Apr. 30, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 12,260 | [3] | 12,260 | [44] | 12,260 | [3] | 12,260 | [3] | 12,260 | [44]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 13 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 421 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Apr. 30, 2010 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 172,328 |  |  |  |  |  | 172,328 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 13 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 158 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Apr. 30, 2010 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 172,328 |  |  |  | 172,328 |  | 172,328 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Total Fabletics, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,229 | [2] | $ 1,229 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 191 |  | $ 345 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 173,180 |  | 173,180 |  | 173,180 |  | 173,180 |  | 173,180 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.38%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.38% |  |  |  |  |  | 0.38% |
Investment cost | [5] |  |  | $ 26,410 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 7,502 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.40%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.40% |  |  |  | 0.40% |  | 0.40% |  |  |
Investment cost | [2] | $ 26,973 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 8,073 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 1,151 | [2],[27],[28] | 1,151 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 632 | [27],[28] | $ 627 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 15, 2021 | [3],[27],[28] | Dec. 15, 2021 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 216,073 | [27],[28] | 216,073 | [9],[10] | 216,073 | [27],[28] | 216,073 | [27],[28] | 216,073 | [9],[10]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Jobandtalent USA, Inc., Equity, Acquisition Date 2/11/2025, Series Preferred Series F |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | $ 563 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 563 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Feb. 11, 2025 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [27],[28] | 47,754 |  |  |  | 47,754 |  | 47,754 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 5,263 | [2],[3] | $ 5,263 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,196 | [3] | $ 1,299 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 26, 2018 | [3] | Dec. 26, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 100,738 | [3] | 100,738 | [44] | 100,738 | [3] | 100,738 | [3] | 100,738 | [44]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 1,000 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 162 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Sep. 17, 2021 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 100,000 |  |  |  |  |  | 100,000 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,000 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 142 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Sep. 17, 2021 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 100,000 |  |  |  | 100,000 |  | 100,000 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,663 | [2] | $ 1,663 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 405 |  | $ 467 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 25, 2016 | [3] | Oct. 25, 2016 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 286,080 |  | 286,080 |  | 286,080 |  | 286,080 |  | 286,080 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 632 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 154 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Oct. 25, 2016 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 108,710 |  |  |  | 108,710 |  | 108,710 |  |  |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 577 | [2],[3] | $ 577 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 266 | [3] | $ 188 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 28, 2013 | [3] | Jun. 28, 2013 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 48,365 | [3] | 48,365 | [44] | 48,365 | [3] | 48,365 | [3] | 48,365 | [44]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 39 | [2] | $ 39 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jul. 31, 2020 | [3] | Jul. 31, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 3,095 |  | 3,095 |  | 3,095 |  | 3,095 |  | 3,095 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000 | [2] | $ 1,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 24, 2022 | [3] | Jan. 24, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 7,063 |  | 7,063 |  | 7,063 |  | 7,063 |  | 7,063 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 13,263 | [2],[34] | $ 13,263 | [5],[16] |  |  |  |  |  |
Investments, at fair value: |  | $ 3,729 | [34] | $ 3,606 | [16] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 29, 2023 | [3],[34] | Dec. 29, 2023 | [16],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 3,235,298 | [34] | 3,235,298 | [16] | 3,235,298 | [34] | 3,235,298 | [34] | 3,235,298 | [16]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 900 | [2],[34] | $ 900 | [5],[16] |  |  |  |  |  |
Investments, at fair value: |  | $ 2 | [34] | $ 7 | [16] |  |  |  |  |  |
Investments owned acquisition date |  | May 23, 2018 | [3],[34] | May 23, 2018 | [16],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 414,994,863 | [34] | 414,994,863 | [16] | 414,994,863 | [34] | 414,994,863 | [34] | 414,994,863 | [16]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 0 | [2],[34] | $ 0 | [5],[16] |  |  |  |  |  |
Investments, at fair value: |  | $ 7 | [34] | $ 17 | [16] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 06, 2016 | [3],[34] | Jun. 06, 2016 | [16],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,000,000 | [34] | 1,000,000 | [16] | 1,000,000 | [34] | 1,000,000 | [34] | 1,000,000 | [16]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,295 | [2] | $ 2,295 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 559 |  | $ 644 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 394,790 |  | 394,790 |  | 394,790 |  | 394,790 |  | 394,790 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 14,163 | [2] | $ 14,163 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 3,738 |  | $ 3,630 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 419,230,161 |  | 419,230,161 |  | 419,230,161 |  | 419,230,161 |  | 419,230,161 |
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Worldremit Group Limited, Equity, Acquisition Date 6/24/2024, Series Preferred Series X |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 922 | [2],[27],[28] | $ 922 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 977 | [27],[28] | $ 952 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 24, 2024 | [3],[27],[28] | Jun. 24, 2024 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 9,737 | [27],[28] | 9,737 | [9],[10] | 9,737 | [27],[28] | 9,737 | [27],[28] | 9,737 | [9],[10]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.70%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 2.70% |  |  |  |  |  | 2.70% |
Investment cost | [5] |  |  | $ 34,444 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 53,645 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (3.38%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 3.38% |  |  |  | 3.38% |  | 3.38% |  |  |
Investment cost | [2] | $ 46,444 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 67,583 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, Equity, Acquisition Date 3/1/2018, Series Member Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[16],[35] |  |  | 34,006 |  |  |  |  |  |  |
Investments, at fair value: | [16],[35] |  |  | $ 23,051 |  |  |  |  |  |  |
Investments owned acquisition date | [16],[35],[44] |  |  | Mar. 01, 2018 |  |  |  |  |  |  |
Shares (in shares) | shares | [16],[35] |  |  | 1 |  |  |  |  |  | 1 |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Equity, Acquisition Date 3/1/2018, Series Member Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[34],[36] | 34,006 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [34],[36] | $ 22,110 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[34],[36] | Mar. 01, 2018 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [34],[36] | 1 |  |  |  | 1 |  | 1 |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 12,035 | [2],[34],[45] | $ 35 | [5],[16],[17] |  |  |  |  |  |
Investments, at fair value: |  | $ 45,017 | [34],[45] | $ 30,190 | [16],[17] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 26, 2021 | [3],[34],[45] | Mar. 26, 2021 | [16],[17],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1 | [34],[45] | 1 | [16],[17] | 1 | [34],[45] | 1 | [34],[45] | 1 | [16],[17]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 403 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 456 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Sep. 30, 2021 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 210,282 |  |  |  | 210,282 |  | 210,282 |  |  |
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 403 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 404 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Sep. 30, 2021 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 210,282 |  |  |  |  |  | 210,282 |
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.00% | [20] | 0.00% | [4] | 0.00% | [20] | 0.00% | [20] | 0.00% | [4]
Investment cost |  | $ 3,638 | [2] | $ 3,638 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 8 |  | 10 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 1,500 | [2],[3] | 1,500 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 1 | [3] | $ 1 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 28, 2014 | [3] | Mar. 28, 2014 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 680 | [3] | 680 | [44] | 680 | [3] | 680 | [3] | 680 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500 | [2] | $ 500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 08, 2015 | [3] | Dec. 08, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 165,000 |  | 165,000 |  | 165,000 |  | 165,000 |  | 165,000 |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 309 | [2],[3] | $ 309 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 3 | [3] | $ 4 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 06, 2015 | [3] | Apr. 06, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 2,498 | [3] | 2,498 | [44] | 2,498 | [3] | 2,498 | [3] | 2,498 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,329 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 4 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Dec. 10, 2018 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 8,836 |  |  |  | 8,836 |  | 8,836 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 1,329 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 5 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Dec. 10, 2018 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 8,836 |  |  |  |  |  | 8,836 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (1.56%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.56% |  |  |  |  |  | 1.56% |
Investment cost | [5] |  |  | $ 36,566 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 31,020 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (1.81%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 1.81% |  |  |  | 1.81% |  | 1.81% |  |  |
Investment cost | [2] | $ 38,817 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 36,181 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 1,000 | [2],[3],[27] | 1,000 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,396 | [3],[27] | $ 959 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 08, 2024 | [3],[27] | Mar. 08, 2024 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 34,483 | [3],[27] | 34,483 | [9],[44] | 34,483 | [3],[27] | 34,483 | [3],[27] | 34,483 | [9],[44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Arcus Biosciences, Inc., Equity, Acquisition Date 2/19/2025, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[27] | $ 2,250 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3],[27] | $ 1,606 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27] | Feb. 19, 2025 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3],[27] | 204,545 |  |  |  | 204,545 |  | 204,545 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000 | [2],[3] | $ 1,000 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 19, 2014 | [3] | Aug. 19, 2014 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 42 | [3] | 42 | [44] | 42 | [3] | 42 | [3] | 42 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[27],[33] | $ 4,165 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3],[27],[33] | $ 14,815 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[33] | May 09, 2022 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3],[27],[33] | 127,021 |  |  |  | 127,021 |  | 127,021 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[13],[44] |  |  | $ 4,165 |  |  |  |  |  |  |
Investments, at fair value: | [9],[13],[44] |  |  | $ 10,747 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[13],[44] |  |  | May 09, 2022 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[13],[44] |  |  | 127,021 |  |  |  |  |  | 127,021 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[10],[44] |  |  | $ 1,871 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10],[44] |  |  | $ 1,373 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[10],[44] |  |  | Oct. 05, 2020 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[10],[44] |  |  | 98,100 |  |  |  |  |  | 98,100 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[27],[28] | $ 1,871 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3],[27],[28] | $ 833 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Oct. 05, 2020 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3],[27],[28] | 98,100 |  |  |  | 98,100 |  | 98,100 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,255 | [2],[3] | $ 2,255 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 7,997 | [3] | $ 6,348 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 21, 2018 | [3] | Jun. 21, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 231,329 | [3] | 231,329 | [44] | 231,329 | [3] | 231,329 | [3] | 231,329 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/06/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[44] |  |  | $ 42 |  |  |  |  |  |  |
Investments, at fair value: | [9],[44] |  |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[44] |  |  | Apr. 06, 2021 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[44] |  |  | 134 |  |  |  |  |  | 134 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000 | [2],[3] | $ 1,000 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 3 | [3] | $ 4 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 08, 2015 | [3] | Jan. 08, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,129 | [3] | 1,129 | [44] | 1,129 | [3] | 1,129 | [3] | 1,129 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 550 | [2],[3],[27] | $ 550 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 259 | [3],[27] | $ 256 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jul. 22, 2015 | [3],[27] | Jul. 22, 2015 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 20,000 | [3],[27] | 20,000 | [9],[44] | 20,000 | [3],[27] | 20,000 | [3],[27] | 20,000 | [9],[44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500 | [2],[3] | $ 500 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 803 | [3] | $ 558 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Jul. 25, 2023 | [3] | Jul. 25, 2023 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 364,963 | [3] | 364,963 | [44] | 364,963 | [3] | 364,963 | [3] | 364,963 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,250 | [1],[2] | $ 4,250 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 217 | [1] | $ 328 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | May 07, 2021 | [1],[3] | May 07, 2021 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 3,466,840 | [1] | 3,466,840 | [6] | 3,466,840 | [1] | 3,466,840 | [1] | 3,466,840 | [6]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 4,000 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 341 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | May 03, 2022 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 235,295 |  |  |  | 235,295 |  | 235,295 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 4,000 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 487 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | May 03, 2022 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 235,295 |  |  |  |  |  | 235,295 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 550 | [2],[3],[27] | $ 550 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 316 | [3],[27] | $ 417 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 16, 2023 | [3],[27] | Jun. 16, 2023 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 47,826 | [3],[27] | 47,826 | [9],[44] | 47,826 | [3],[27] | 47,826 | [3],[27] | 47,826 | [9],[44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 774 | [2],[3],[27] | $ 773 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,689 | [3],[27] | $ 1,574 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 29, 2023 | [3],[27] | Sep. 29, 2023 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 5,100 | [3],[27] | 5,100 | [9],[44] | 5,100 | [3],[27] | 5,100 | [3],[27] | 5,100 | [9],[44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,000 | [2],[27],[28] | $ 2,000 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,134 | [27],[28] | $ 1,241 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 15, 2021 | [27],[28] | Dec. 15, 2021 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 983 | [27],[28] | 983 | [9],[10] | 983 | [27],[28] | 983 | [27],[28] | 983 | [9],[10]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,730 | [2],[3],[27],[33] | $ 1,730 | [5],[9],[13],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 923 | [3],[27],[33] | $ 1,196 | [9],[13],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 09, 2023 | [3],[27],[33] | Jun. 09, 2023 | [9],[13],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 147,233 | [3],[27],[33] | 147,233 | [9],[13],[44] | 147,233 | [3],[27],[33] | 147,233 | [3],[27],[33] | 147,233 | [9],[13],[44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rafael Holdings, Inc. (p.k.a. Cyclo Therapeutics, Inc.), Equity, Acquisition Date 4/6/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3],[27] | $ 42 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3],[27] | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27] | Apr. 06, 2021 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3],[27] | 47 |  |  |  | 47 |  | 47 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,500 | [2],[3] | $ 1,500 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 6 | [3] | $ 12 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 22, 2007 | [3] | Aug. 22, 2007 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 944 | [3] | 944 | [44] | 944 | [3] | 944 | [3] | 944 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 203 | [2],[3] | $ 203 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 31 | [3] | $ 34 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 11, 2015 | [3] | Aug. 11, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 11,119 | [3] | 11,119 | [44] | 11,119 | [3] | 11,119 | [3] | 11,119 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health LLC |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 4,000 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,378 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 680,410 |  |  |  | 680,410 |  | 680,410 |  |  |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 4,000 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 1,896 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 680,410 |  |  |  |  |  | 680,410 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000 | [2] | $ 1,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 630 |  | $ 762 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 31, 2022 | [3] | Oct. 31, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 170,102 |  | 170,102 |  | 170,102 |  | 170,102 |  | 170,102 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 3,000 | [2] | $ 3,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 748 |  | $ 1,134 |  |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 11, 2020 | [3] | Dec. 11, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 510,308 |  | 510,308 |  | 510,308 |  | 510,308 |  | 510,308 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,500 | [2] | $ 1,500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,446 |  | $ 1,519 |  |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 06, 2023 | [3] | Sep. 06, 2023 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 208,588 |  | 208,588 |  | 208,588 |  | 208,588 |  | 208,588 |
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 400 | [2],[3],[27] | $ 400 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 436 | [3],[27] | $ 619 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 06, 2023 | [3],[27] | Nov. 06, 2023 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 32,310 | [3],[27] | 32,310 | [9],[44] | 32,310 | [3],[27] | 32,310 | [3],[27] | 32,310 | [9],[44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,945 | [2],[3] | $ 2,945 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 370 | [3] | $ 1,149 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 26, 2019 | [3] | Nov. 26, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,566,064 | [3] | 1,566,064 | [44] | 1,566,064 | [3] | 1,566,064 | [3] | 1,566,064 | [44]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 332 | [2],[3],[27],[28] | $ 332 | [5],[9],[10],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 182 | [3],[27],[28] | $ 303 | [9],[10],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 31, 2019 | [3],[27],[28] | Jan. 31, 2019 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 17,175 | [3],[27],[28] | 17,175 | [9],[10],[44] | 17,175 | [3],[27],[28] | 17,175 | [3],[27],[28] | 17,175 | [9],[10],[44]
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.05%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.05% |  |  |  |  |  | 0.05% |
Investment cost | [5] |  |  | $ 2,150 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 937 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.15%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.15% |  |  |  | 0.15% |  | 0.15% |  |  |
Investment cost | [2] | $ 4,400 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 3,060 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 650 | [2] | 650 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 267 |  | $ 294 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 17, 2022 | [3] | Nov. 17, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 15,116 |  | 15,116 |  | 15,116 |  | 15,116 |  | 15,116 |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Shield AI, Inc., Equity, Acquisition Date 2/7/2025, Series Preferred Series F1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[33] | $ 2,250 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [33] | $ 2,250 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[33] | Feb. 07, 2025 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [33] | 28,900 |  |  |  | 28,900 |  | 28,900 |  |  |
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,500 | [2] | $ 1,500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 543 |  | $ 643 |  |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 08, 2022 | [3] | Mar. 08, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 248,900 |  | 248,900 |  | 248,900 |  | 248,900 |  | 248,900 |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.37%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.37% |  |  |  | 0.37% |  | 0.37% |  |  |
Investment cost | [2] | $ 13,639 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 7,436 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.38%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.38% |  |  |  |  |  | 0.38% |
Investment cost | [5] |  |  | $ 13,417 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 7,503 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 5,094 | [2] | 5,094 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 134 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 11, 2019 | [3] | Mar. 11, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 41,286 |  | 41,286 | [44] | 41,286 |  | 41,286 |  | 41,286 | [44]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 1,910 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Mar. 30, 2021 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 390,809 |  |  |  | 390,809 |  | 390,809 |  |  |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 1,687 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Mar. 30, 2021 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 217,880 |  |  |  |  |  | 217,880 |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Click Therapeutics, Inc., Equity, Acquisition Date 5/20/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,662 | [1],[2] | $ 1,662 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,900 | [1] | $ 1,825 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | May 20, 2024 | [1],[3] | May 20, 2024 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 560,000 | [1] | 560,000 | [6] | 560,000 | [1] | 560,000 | [1] | 560,000 | [6]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Curana Health Holdings, LLC, Equity, Acquisition Date 5/13/2024, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,500 | [2] | $ 2,500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,983 |  | $ 2,603 |  |  |  |  |  |  |
Investments owned acquisition date |  | May 13, 2024 | [3] | May 13, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,114,380 |  | 1,114,380 |  | 1,114,380 |  | 1,114,380 |  | 1,114,380 |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Main Street Rural, Inc., Equity, Acquisition Date 10/28/2024, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 873 | [2] | $ 874 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,018 |  | $ 874 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 28, 2024 | [3] | Oct. 28, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 496 |  | 496 |  | 496 |  | 496 |  | 496 |
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Equity, Acquisition Date 6/10/2024, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,600 | [2] | $ 1,600 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,535 |  | $ 2,065 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 10, 2024 | [3] | Jun. 10, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 181,163 |  | 181,163 |  | 181,163 |  | 181,163 |  | 181,163 |
Investment, Identifier [Axis]: Equity Investments Information Services (0.20%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.20% |  |  |  |  |  | 0.20% |
Investment cost | [5] |  |  | $ 3,825 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 3,898 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Information Services (0.23%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.23% |  |  |  | 0.23% |  | 0.23% |  |  |
Investment cost | [2] | $ 3,825 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 4,604 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 3,825 | [2] | 3,825 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 4,604 |  | $ 3,898 |  |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 30, 2021 | [3] | Dec. 30, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 41,021 |  | 41,021 |  | 41,021 |  | 41,021 |  | 41,021 |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.00%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.00% | [20] | 0.00% | [4] | 0.00% | [20] | 0.00% | [20] | 0.00% | [4]
Investment cost |  | $ 250 | [2] | $ 250 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 47 |  | 69 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 0 | [2],[34] | 0 | [5],[16] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [34] | $ 0 | [16] |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 15, 2021 | [3],[34] | Oct. 15, 2021 | [16],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 180,000 | [34] | 180,000 | [16] | 180,000 | [34] | 180,000 | [34] | 180,000 | [16]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 250 | [2],[34] | $ 250 | [5],[16] |  |  |  |  |  |
Investments, at fair value: |  | $ 47 | [34] | $ 69 | [16] |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 15, 2021 | [3],[34] | Oct. 15, 2021 | [16],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 5,000,000 | [34] | 5,000,000 | [16] | 5,000,000 | [34] | 5,000,000 | [34] | 5,000,000 | [16]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Total Coronado Aesthetics, LLC |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 250 | [2] | $ 250 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 47 |  | $ 69 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 5,180,000 |  | 5,180,000 |  | 5,180,000 |  | 5,180,000 |  | 5,180,000 |
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.00%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.00% |  |  |  | 0.00% |  | 0.00% |  |  |
Investment cost | [2] | $ 160 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 97 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.01%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.01% |  |  |  |  |  | 0.01% |
Investment cost | [5] |  |  | $ 160 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 210 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 160 | [2] | 160 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 97 |  | $ 210 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jul. 01, 2011 | [3] | Jul. 01, 2011 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 277,995 |  | 277,995 |  | 277,995 |  | 277,995 |  | 277,995 |
Investment, Identifier [Axis]: Equity Investments Software (0.81%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.81% |  |  |  | 0.81% |  | 0.81% |  |  |
Investment cost | [2] | $ 22,524 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 16,203 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Software (0.99%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.99% |  |  |  |  |  | 0.99% |
Investment cost | [5] |  |  | $ 23,524 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 19,665 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | 1,000 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 666 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Aug. 09, 2021 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 1,000,000 |  |  |  |  |  | 1,000,000 |
Investment, Identifier [Axis]: Equity Investments Software and Armis, Inc., Equity, Acquisition Date 10/18/2024, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 2,000 | [2] | $ 2,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,765 |  | $ 2,000 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 18, 2024 | [3] | Oct. 18, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 294,213 |  | 294,213 |  | 294,213 |  | 294,213 |  | 294,213 |
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,406 | [2],[46] | $ 2,406 | [5],[47] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,406 | [46] | $ 2,406 | [47] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 24, 2021 | [3],[46] | Mar. 24, 2021 | [44],[47] |  |  |  |  |  |
Shares (in shares) | shares |  | 3 | [46] | 3 | [47] | 3 | [46] | 3 | [46] | 3 | [47]
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 51 | [2] | $ 51 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 26, 2012 | [3] | Oct. 26, 2012 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 53,614 |  | 53,614 |  | 53,614 |  | 53,614 |  | 53,614 |
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500 | [2],[27],[28] | $ 500 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 759 | [27],[28] | $ 722 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 20, 2018 | [3],[27],[28] | Nov. 20, 2018 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 108,500 | [27],[28] | 108,500 | [9],[10] | 108,500 | [27],[28] | 108,500 | [27],[28] | 108,500 | [9],[10]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 138 | [2],[27],[28] | $ 138 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 270 | [27],[28] | $ 257 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 22, 2020 | [3],[27],[28] | Dec. 22, 2020 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 41,000 | [27],[28] | 41,000 | [9],[10] | 41,000 | [27],[28] | 41,000 | [27],[28] | 41,000 | [9],[10]
Investment, Identifier [Axis]: Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 97 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 4 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Mar. 21, 2014 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 51,948 |  |  |  | 51,948 |  | 51,948 |  |  |
Investment, Identifier [Axis]: Equity Investments Software and DNAnexus, Inc., Equity, Acquisition Date 3/21/2014, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 97 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 5 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Mar. 21, 2014 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 51,948 |  |  |  |  |  | 51,948 |
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,284 | [2] | $ 4,284 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 164 |  | $ 198 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 29, 2018 | [3] | Nov. 29, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 20,000 |  | 20,000 |  | 20,000 |  | 20,000 |  | 20,000 |
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,000 | [2] | $ 1,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 4,481 |  | $ 5,194 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 22, 2015 | [3] | Oct. 22, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 458,841 |  | 458,841 |  | 458,841 |  | 458,841 |  | 458,841 |
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 300 | [2] | $ 300 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 931 |  | $ 1,075 |  |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 24, 2017 | [3] | Aug. 24, 2017 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 93,620 |  | 93,620 |  | 93,620 |  | 93,620 |  | 93,620 |
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 307 | [2] | $ 307 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 18, 2013 | [3] | Jan. 18, 2013 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 190 |  | 190 |  | 190 |  | 190 |  | 190 |
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[10] |  |  | $ 250 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 132 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[10],[44] |  |  | Aug. 25, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[10] |  |  | 183,073 |  |  |  |  |  | 183,073 |
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | $ 250 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 113 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Aug. 25, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [27],[28] | 183,073 |  |  |  | 183,073 |  | 183,073 |  |  |
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 265 | [2] | $ 265 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 26 |  | $ 24 |  |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 04, 2020 | [3] | Dec. 04, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 38,461 |  | 38,461 |  | 38,461 |  | 38,461 |  | 38,461 |
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,854 | [2],[3] | $ 4,854 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,559 | [3] | $ 2,416 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 01, 2018 | [3] | Aug. 01, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,019,255 | [3] | 1,019,255 | [44] | 1,019,255 | [3] | 1,019,255 | [3] | 1,019,255 | [44]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,000 | [2] | $ 2,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,850 |  | $ 1,988 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 25, 2020 | [3] | Nov. 25, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 580,983 |  | 580,983 |  | 580,983 |  | 580,983 |  | 580,983 |
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 280 | [2] | $ 280 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 206 |  | $ 216 |  |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 12, 2021 | [3] | Aug. 12, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 52,956 |  | 52,956 |  | 52,956 |  | 52,956 |  | 52,956 |
Investment, Identifier [Axis]: Equity Investments Software and SirionLabs Pte. Ltd., Equity, Acquisition Date 6/30/2024, Series Preferred Series F1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,792 | [2],[27],[28] | $ 1,792 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,590 | [27],[28] | $ 1,996 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 30, 2024 | [3],[27],[28] | Jun. 30, 2024 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 152,250 | [27],[28] | 152,250 | [9],[10] | 152,250 | [27],[28] | 152,250 | [27],[28] | 152,250 | [9],[10]
Investment, Identifier [Axis]: Equity Investments Software and Total Contentful Global, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 638 | [2] | $ 638 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,029 |  | $ 979 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 149,500 |  | 149,500 |  | 149,500 |  | 149,500 |  | 149,500 |
Investment, Identifier [Axis]: Equity Investments Software and Total Druva Holdings, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,300 | [2] | $ 1,300 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 5,412 |  | $ 6,269 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 552,461 |  | 552,461 |  | 552,461 |  | 552,461 |  | 552,461 |
Investment, Identifier [Axis]: Equity Investments Software and Total SingleStore, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 2,280 | [2] | $ 2,280 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,056 |  | $ 2,204 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 633,939 |  | 633,939 |  | 633,939 |  | 633,939 |  | 633,939 |
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 2,000 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 79 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Jul. 08, 2021 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 23,814 |  |  |  | 23,814 |  | 23,814 |  |  |
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 2,000 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 370 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Jul. 08, 2021 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 952,562 |  |  |  |  |  | 952,562 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.10%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.10% |  |  |  |  |  | 0.10% |
Investment cost | [5] |  |  | $ 10,153 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 1,992 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.11%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.11% |  |  |  | 0.11% |  | 0.11% |  |  |
Investment cost | [2] | $ 10,153 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 2,122 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 2,000 | [2] | 2,000 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 115 |  | $ 106 |  |  |  |  |  |  |
Investments owned acquisition date |  | May 10, 2019 | [3] | May 10, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 188,611 |  | 188,611 |  | 188,611 |  | 188,611 |  | 188,611 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 500 | [2] | $ 500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 01, 2015 | [3] | Jun. 01, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,035 |  | 1,035 |  | 1,035 |  | 1,035 |  | 1,035 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 4,500 | [2] | $ 4,500 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,007 |  | $ 1,885 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 28, 2021 | [3] | Jun. 28, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 593,080 |  | 593,080 |  | 593,080 |  | 593,080 |  | 593,080 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc. (p.k.a. Pineapple Energy LLC), Equity, Acquisition Date 12/10/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 3,153 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 1 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Dec. 10, 2020 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 405 |  |  |  |  |  | 405 |
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc., Equity, Acquisition Date 12/10/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 3,153 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Dec. 10, 2020 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 405 |  |  |  | 405 |  | 405 |  |  |
Investment, Identifier [Axis]: Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 632 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 177 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Oct. 25, 2016 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 108,710 |  |  |  |  |  | 108,710 |
Investment, Identifier [Axis]: Investment Fund After Cash & Cash Equivalents (197.46%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 197.46% |  |  |  | 197.46% |  | 197.46% |  |  |
Investment cost | [2] | $ 4,021,082 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,950,450 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 21,100 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 21,100 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (1.06%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.06% |  |  |  |  |  | 1.06% |
Investment cost | [5] |  |  | $ 21,100 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 21,100 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (1.30%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 1.30% |  |  |  | 1.30% |  | 1.30% |  |  |
Investment cost | [2] | $ 26,000 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 26,000 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.31%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.31% |  |  |  |  |  | 0.31% |
Investment cost | [5] |  |  | $ 4,470 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 6,220 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.35%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.35% |  |  |  | 0.35% |  | 0.35% |  |  |
Investment cost | [2] | $ 4,470 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 6,993 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.29%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.29% |  |  |  |  |  | 0.29% |
Investment cost | [5] |  |  | $ 4,089 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 5,820 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.33%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.33% |  |  |  | 0.33% |  | 0.33% |  |  |
Investment cost | [2] | $ 4,089 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 6,623 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 2,847 | [2],[26],[27],[28] | 2,847 | [5],[9],[10],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 5,236 | [26],[27],[28] | $ 4,382 | [9],[10],[11] |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 16, 2020 | [3],[26],[27],[28] | Nov. 16, 2020 | [9],[10],[11],[44] |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,242 | [2],[26],[27],[28] | $ 1,242 | [5],[9],[10],[11] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,387 | [26],[27],[28] | $ 1,438 | [9],[10],[11] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 23, 2022 | [3],[26],[27],[28] | Jun. 23, 2022 | [9],[10],[11],[44] |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.02% | [20] | 0.02% | [4] | 0.02% | [20] | 0.02% | [20] | 0.02% | [4]
Investment cost |  | $ 381 | [2] | $ 381 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 370 |  | $ 400 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | 381 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 370 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Jul. 21, 2022 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investment Funds and Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 26,000 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 26,000 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments After Cash & Cash Equivalents (185.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 185.02% |  |  |  |  |  | 185.02% |
Investment cost | [5] |  |  | $ 3,729,977 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 3,681,078 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments before Cash & Cash Equivalents (183.96%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 183.96% |  |  |  |  |  | 183.96% |
Investment cost | [5] |  |  | $ 3,708,877 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 3,659,978 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments before Cash & Cash Equivalents (196.16%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 196.16% |  |  |  | 196.16% |  | 196.16% |  |  |
Investment cost | [2] | $ 3,995,082 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,924,450 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments in Securities (183.64%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 183.64% |  |  |  |  |  | 183.64% |
Investment cost | [5] |  |  | $ 3,704,407 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 3,653,758 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Investments in Securities (195.81%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 195.81% |  |  |  | 195.81% |  | 195.81% |  |  |
Investment cost | [2] | $ 3,990,612 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 3,917,457 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Total Debt Investments (175.65%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 175.65% |  |  |  |  |  | 175.65% |
Investment cost | [5] |  |  | $ 3,515,541 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 3,494,601 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Total Warrant Investments (1.53%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 1.53% |  |  |  |  |  | 1.53% |
Investment cost | [5] |  |  | $ 31,154 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 30,500 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments (1.57%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 1.57% |  |  |  | 1.57% |  | 1.57% |  |  |
Investment cost | [2] | $ 31,324 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 31,473 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.01%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% | [20] | 0.01% | [4] | 0.01% | [20] | 0.01% | [20] | 0.01% | [4]
Investment cost |  | $ 496 | [2] | $ 496 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 110 |  | 223 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 36 | [2] | 36 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 60 |  | $ 122 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 21, 2022 | [3] | Jun. 21, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 75,567 |  | 75,567 |  | 75,567 |  | 75,567 |  | 75,567 |
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 460 | [2],[22] | $ 460 | [5],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 50 | [22] | $ 101 | [12] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 23, 2022 | [3],[22] | Dec. 23, 2022 | [12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 53,418 | [22] | 53,418 | [12] | 53,418 | [22] | 53,418 | [22] | 53,418 | [12]
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% | [20] | 0.01% | [4] | 0.01% | [20] | 0.01% | [20] | 0.01% | [4]
Investment cost |  | $ 242 | [2] | $ 242 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 158 |  | 209 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 242 | [2],[22] | 242 | [5],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 158 | [22] | $ 209 | [12] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 28, 2022 | [3],[22] | Jun. 28, 2022 | [12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 486,097 | [22] | 486,097 | [12] | 486,097 | [22] | 486,097 | [22] | 486,097 | [12]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.04%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.04% | [20] | 0.04% | [4] | 0.04% | [20] | 0.04% | [20] | 0.04% | [4]
Investment cost |  | $ 245 | [2] | $ 245 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 773 |  | 714 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 228 | [2] | 228 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 03, 2014 | [3] | Jun. 03, 2014 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 17 | [2] | $ 17 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 773 |  | $ 714 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 27, 2018 | [3] | Jun. 27, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 686,270 |  | 686,270 |  | 686,270 |  | 686,270 |  | 686,270 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.28%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.28% |  |  |  | 0.28% |  | 0.28% |  |  |
Investment cost | [2] | $ 4,690 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 5,700 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.32%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.32% |  |  |  |  |  | 0.32% |
Investment cost | [5] |  |  | $ 4,690 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 6,353 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Altumint, Inc., Warrant, Acquisition Date 10/31/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 127 | [1],[2] | 127 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 97 | [1] | $ 129 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 31, 2024 | [1],[3] | Oct. 31, 2024 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,701 | [1] | 1,701 | [6] | 1,701 | [1] | 1,701 | [1] | 1,701 | [6]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 164 | [2],[27],[28] | $ 164 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 46 | [27],[28] | $ 55 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 14, 2021 | [3],[27],[28] | Dec. 14, 2021 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 174,163 | [27],[28] | 174,163 | [9],[10] | 174,163 | [27],[28] | 174,163 | [27],[28] | 174,163 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 20 | [2],[27],[28] | $ 20 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 8 | [27],[28] | $ 11 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Feb. 13, 2024 | [3],[27],[28] | Feb. 13, 2024 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 109,257 | [27],[28] | 109,257 | [9],[10] | 109,257 | [27],[28] | 109,257 | [27],[28] | 109,257 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 20 | [2] | $ 20 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 29, 2019 | [3] | Oct. 29, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 529,661 |  | 529,661 |  | 529,661 |  | 529,661 |  | 529,661 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 116 | [1],[2] | $ 116 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 101 | [1] | $ 115 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 12, 2021 | [1],[3] | Mar. 12, 2021 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 11,806 | [1] | 11,806 | [6] | 11,806 | [1] | 11,806 | [1] | 11,806 | [6]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 39 | [2] | $ 39 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 8 |  | $ 10 |  |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 29, 2019 | [3] | Mar. 29, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 127,032 |  | 127,032 |  | 127,032 |  | 127,032 |  | 127,032 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | $ 60 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 28 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Oct. 03, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [27],[28] | 27,298 |  |  |  | 27,298 |  | 27,298 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[10] |  |  | $ 60 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 38 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[10],[44] |  |  | Oct. 03, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[10] |  |  | 27,298 |  |  |  |  |  | 27,298 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 166 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 28 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [1],[3] | Dec. 22, 2022 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [1] | 117,042 |  |  |  | 117,042 |  | 117,042 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | $ 166 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 77 |  |  |  |  |  |  |
Investments owned acquisition date | [6],[44] |  |  | Dec. 22, 2022 |  |  |  |  |  |  |
Shares (in shares) | shares | [6] |  |  | 117,042 |  |  |  |  |  | 117,042 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 470 | [1],[2] | $ 470 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [1] | $ 0 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 12, 2021 | [1],[3] | Mar. 12, 2021 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 13,106 | [1] | 13,106 | [6] | 13,106 | [1] | 13,106 | [1] | 13,106 | [6]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,242 | [2],[22],[33] | $ 1,242 | [5],[12],[13] |  |  |  |  |  |
Investments, at fair value: |  | $ 4,342 | [22],[33] | $ 4,901 | [12],[13] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 12, 2019 | [3],[22],[33] | Jun. 12, 2019 | [12],[13],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,604,724 | [22],[33] | 1,604,724 | [12],[13] | 1,604,724 | [22],[33] | 1,604,724 | [22],[33] | 1,604,724 | [12],[13]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 57 | [2] | $ 57 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 9 |  | $ 28 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 14, 2022 | [3] | Nov. 14, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 83 | [2] | $ 83 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1 |  | $ 3 |  |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 23, 2019 | [3] | Aug. 23, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 444,444 |  | 444,444 |  | 444,444 |  | 444,444 |  | 444,444 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 16 | [2] | $ 16 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 20, 2020 | [3] | Apr. 20, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 600,000 |  | 600,000 |  | 600,000 |  | 600,000 |  | 600,000 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 782 | [2] | $ 782 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 30, 2016 | [3] | Jun. 30, 2016 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 62 | [2] | $ 62 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 01, 2018 | [3] | Aug. 01, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 985 | [2] | $ 985 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 938 |  | $ 878 |  |  |  |  |  |  |
Investments owned acquisition date |  | May 01, 2018 | [3] | May 01, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 343,497 |  | 343,497 |  | 343,497 |  | 343,497 |  | 343,497 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Carwow LTD |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 184 | [2] | $ 184 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 54 |  | $ 66 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 283,420 |  | 283,420 |  | 283,420 |  | 283,420 |  | 283,420 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 140 | [2] | $ 140 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 10 |  | $ 31 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 2,051,587 |  | 2,051,587 |  | 2,051,587 |  | 2,051,587 |  | 2,051,587 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 860 | [2] | $ 860 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 3,611,537 |  | 3,611,537 |  | 3,611,537 |  | 3,611,537 |  | 3,611,537 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 155 | [2] | $ 155 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 90 |  | $ 95 |  |  |  |  |  |  |
Shares (in shares) | shares |  | 79,083 |  | 79,083 |  | 79,083 |  | 79,083 |  | 79,083 |
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 126 | [2],[22] | $ 126 | [5],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 4 | [22] | $ 13 | [12] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 31, 2022 | [3],[22] | Mar. 31, 2022 | [12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 98,428 | [22] | 98,428 | [12] | 98,428 | [22] | 98,428 | [22] | 98,428 | [12]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 129 | [2],[27],[28] | $ 129 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 90 | [27],[28] | $ 95 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Feb. 11, 2021 | [3],[27],[28] | Feb. 11, 2021 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 77,215 | [27],[28] | 77,215 | [9],[10] | 77,215 | [27],[28] | 77,215 | [27],[28] | 77,215 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 26 | [2],[27],[28] | $ 26 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [27],[28] | $ 0 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 27, 2021 | [3],[27],[28] | Aug. 27, 2021 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,868 | [27],[28] | 1,868 | [9],[10] | 1,868 | [27],[28] | 1,868 | [27],[28] | 1,868 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 214 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 460 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Feb. 03, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 522,930 |  |  |  |  |  | 522,930 |
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.02% |  |  |  |  |  | 0.02% |
Investment cost | [5] |  |  | $ 214 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 460 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.07%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.07% |  |  |  | 0.07% |  | 0.07% |  |  |
Investment cost | [2] | $ 214 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 1,331 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | 214 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 1,331 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Feb. 03, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 522,930 |  |  |  | 522,930 |  | 522,930 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.35%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.35% |  |  |  |  |  | 0.35% |
Investment cost | [5] |  |  | $ 8,404 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 6,996 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.46%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.46% |  |  |  | 0.46% |  | 0.46% |  |  |
Investment cost | [2] | $ 8,285 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 9,153 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 330 | [2],[3],[27] | 330 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 812 | [3],[27] | $ 519 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 15, 2022 | [3],[27] | Jun. 15, 2022 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 32,129 | [3],[27] | 32,190 | [9],[44] | 32,129 | [3],[27] | 32,129 | [3],[27] | 32,190 | [9],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | $ 238 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 151 |  |  |  |  |  |  |
Investments owned acquisition date | [6],[44] |  |  | Dec. 27, 2022 |  |  |  |  |  |  |
Shares (in shares) | shares | [6] |  |  | 69,239 |  |  |  |  |  | 69,239 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,290 | [2],[3],[22],[27],[33] | $ 1,290 | [5],[9],[12],[13],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,842 | [3],[22],[27],[33] | $ 1,528 | [9],[12],[13],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 25, 2020 | [3],[22],[27],[33] | Sep. 25, 2020 | [9],[12],[13],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 61,004 | [3],[22],[27],[33] | 61,004 | [9],[12],[13],[44] | 61,004 | [3],[22],[27],[33] | 61,004 | [3],[22],[27],[33] | 61,004 | [9],[12],[13],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 278 | [2],[3],[27],[28] | $ 278 | [5],[9],[10],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 21 | [3],[27],[28] | $ 48 | [9],[10],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 30, 2023 | [3],[27],[28] | Jun. 30, 2023 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 75,376 | [3],[27],[28] | 75,376 | [9],[10],[44] | 75,376 | [3],[27],[28] | 75,376 | [3],[27],[28] | 75,376 | [9],[10],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 287 | [1],[2] | $ 287 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 27 | [1] | $ 103 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 08, 2021 | [1],[3] | Dec. 08, 2021 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 100,000 | [1] | 100,000 | [6] | 100,000 | [1] | 100,000 | [1] | 100,000 | [6]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 37 | [2],[3] | $ 37 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 14, 2020 | [3] | Sep. 14, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 16,112 | [3] | 16,112 | [44] | 16,112 | [3] | 16,112 | [3] | 16,112 | [44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | $ 233 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 154 |  |  |  |  |  |  |
Investments owned acquisition date | [6],[44] |  |  | Jun. 09, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [6] |  |  | 95,221 |  |  |  |  |  | 95,221 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 233 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 313 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [1],[3] | Jun. 09, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [1] | 95,221 |  |  |  | 95,221 |  | 95,221 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc., Warrant, Acquisition Date 2/18/2016, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 119 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Feb. 18, 2016 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 201 |  |  |  |  |  | 201 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 228 | [1],[2],[3] | $ 228 | [5],[6],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 257 | [1],[3] | $ 166 | [6],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 09, 2023 | [1],[3] | Aug. 09, 2023 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 238,095 | [1],[3] | 238,095 | [6],[44] | 238,095 | [1],[3] | 238,095 | [1],[3] | 238,095 | [6],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 110 | [2],[3] | $ 110 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 20, 2019 | [3] | Dec. 20, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 2,202 | [3] | 2,202 | [44] | 2,202 | [3] | 2,202 | [3] | 2,202 | [44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 88 | [1],[2],[3],[27] | $ 88 | [5],[6],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 6 | [1],[3],[27] | $ 16 | [6],[9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 02, 2022 | [1],[3],[27] | Nov. 02, 2022 | [6],[9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 14,342 | [1],[3],[27] | 14,342 | [6],[9],[44] | 14,342 | [1],[3],[27] | 14,342 | [1],[3],[27] | 14,342 | [6],[9],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 570 | [2],[3],[27] | $ 570 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,309 | [3],[27] | $ 2,133 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | May 09, 2022 | [3],[27] | May 09, 2022 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 13,229 | [3],[27] | 13,229 | [9],[44] | 13,229 | [3],[27] | 13,229 | [3],[27] | 13,229 | [9],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 848 | [1],[2],[3],[22],[27],[33] | $ 848 | [5],[6],[9],[12],[13],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 5 | [1],[3],[22],[27],[33] | $ 22 | [6],[9],[12],[13],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 17, 2021 | [1],[3],[22],[27],[33] | Sep. 17, 2021 | [6],[9],[12],[13],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 64,687 | [1],[3],[22],[27],[33] | 64,687 | [6],[9],[12],[13],[44] | 64,687 | [1],[3],[22],[27],[33] | 64,687 | [1],[3],[22],[27],[33] | 64,687 | [6],[9],[12],[13],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 20 | [1],[2] | $ 20 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 17 | [1] | $ 22 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 23, 2022 | [1],[3] | Mar. 23, 2022 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 475,510 | [1] | 475,510 | [6] | 475,510 | [1] | 475,510 | [1] | 475,510 | [6]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 296 | [2],[3] | $ 296 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 2 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | May 14, 2021 | [3] | May 14, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 106,035 | [3] | 106,035 | [44] | 106,035 | [3] | 106,035 | [3] | 106,035 | [44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and SynOx Therapeutics Limited, Warrant, Acquisition Date 4/18/2024, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 83 | [2],[27],[28] | $ 83 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 68 | [27],[28] | $ 76 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 18, 2024 | [3],[27],[28] | Apr. 18, 2024 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 251,195 | [27],[28] | 251,195 | [9],[10] | 251,195 | [27],[28] | 251,195 | [27],[28] | 251,195 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 12/30/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 721 | [2],[3],[27] | $ 721 | [5],[9],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 2,387 | [3],[27] | $ 1,730 | [9],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 30, 2021 | [3],[27] | Dec. 30, 2021 | [9],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 117,168 | [3],[27] | 117,168 | [9],[44] | 117,168 | [3],[27] | 117,168 | [3],[27] | 117,168 | [9],[44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 256 | [2] | $ 256 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 18 |  | $ 39 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 15, 2020 | [3] | Jun. 15, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 102,216 |  | 102,216 |  | 102,216 |  | 102,216 |  | 102,216 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 510 | [2],[3] | $ 510 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 19 | [3] | $ 185 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 18, 2019 | [3] | Mar. 18, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,392,787 | [3] | 1,392,787 | [44] | 1,392,787 | [3] | 1,392,787 | [3] | 1,392,787 | [44]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 1,744 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Mar. 15, 2024 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 111,206 |  |  |  | 111,206 |  | 111,206 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and bluebird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 1,744 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Mar. 15, 2024 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 111,206 |  |  |  |  |  | 111,206 |
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 118 | [2],[3],[27],[28] | $ 118 | [5],[9],[10],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 52 | [3],[27],[28] | $ 102 | [9],[10],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 22, 2023 | [3],[27],[28] | Dec. 22, 2023 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 43,689 | [3],[27],[28] | 43,689 | [9],[10],[44] | 43,689 | [3],[27],[28] | 43,689 | [3],[27],[28] | 43,689 | [9],[10],[44]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.01%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.01% | [20] | 0.01% | [4] | 0.01% | [20] | 0.01% | [20] | 0.01% | [4]
Investment cost |  | $ 692 | [2] | $ 692 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 267 |  | 264 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 101 | [2],[3] | 101 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 21 | [3] | $ 1 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 15, 2017 | [3] | Mar. 15, 2017 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 49,078 | [3] | 49,078 | [44] | 49,078 | [3] | 49,078 | [3] | 49,078 | [44]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 34 | [2] | $ 34 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 45 |  | $ 51 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 21, 2022 | [3] | Jun. 21, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 8,503 |  | 8,503 |  | 8,503 |  | 8,503 |  | 8,503 |
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 557 | [2] | $ 557 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 201 |  | $ 212 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 08, 2021 | [3] | Nov. 08, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 622,255 |  | 622,255 |  | 622,255 |  | 622,255 |  | 622,255 |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.11%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.11% | [20] | 0.11% | [4] | 0.11% | [20] | 0.11% | [20] | 0.11% | [4]
Investment cost |  | $ 1,863 | [2] | $ 1,863 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 2,209 |  | 2,099 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC, Warrant, Acquisition Date 1/4/2024, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | 156 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 492 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Jan. 04, 2024 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 447,410 |  |  |  |  |  | 447,410 |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | 156 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 666 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Jan. 04, 2024 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 447,410 |  |  |  | 447,410 |  | 447,410 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 210 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 169 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Mar. 30, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 52,665 |  |  |  |  |  | 52,665 |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 210 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 117 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Mar. 30, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 52,665 |  |  |  | 52,665 |  | 52,665 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and NeueHealth, Inc., Warrant, Acquisition Date 6/21/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 716 | [2],[3],[22] | $ 716 | [5],[12],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 940 | [3],[22] | $ 1,032 | [12],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 21, 2024 | [3],[22] | Jun. 21, 2024 | [12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 185,625 | [3],[22] | 185,625 | [12],[44] | 185,625 | [3],[22] | 185,625 | [3],[22] | 185,625 | [12],[44]
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc., Warrant, Acquisition Date 7/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 382 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 79 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Jul. 03, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 194,830 |  |  |  |  |  | 194,830 |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 382 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 128 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Jul. 03, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 194,830 |  |  |  | 194,830 |  | 194,830 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Acquisition Date 9/28/2023, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | $ 278 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 325 |  |  |  |  |  |  |
Investments owned acquisition date | [6],[44] |  |  | Sep. 28, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [6] |  |  | 129,400 |  |  |  |  |  | 129,400 |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 278 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 358 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [1],[3] | Sep. 28, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [1] | 129,400 |  |  |  | 129,400 |  | 129,400 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 121 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Mar. 28, 2022 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 192,431 |  |  |  | 192,431 |  | 192,431 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 121 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 2 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Mar. 28, 2022 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 192,431 |  |  |  |  |  | 192,431 |
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.00%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.00% | [20] | 0.00% | [4] | 0.00% | [20] | 0.00% | [20] | 0.00% | [4]
Investment cost |  | $ 413 | [2] | $ 413 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 6 |  | 13 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | 356 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Aug. 22, 2017 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 60,000 |  |  |  |  |  | 60,000 |
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | 356 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Aug. 22, 2017 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 60,000 |  |  |  | 60,000 |  | 60,000 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 57 | [2],[27],[28] | $ 57 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 6 | [27],[28] | $ 13 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 29, 2022 | [3],[27],[28] | Jun. 29, 2022 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 129,638 | [27],[28] | 129,638 | [9],[10] | 129,638 | [27],[28] | 129,638 | [27],[28] | 129,638 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.04%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.04% |  |  |  | 0.04% |  | 0.04% |  |  |
Investment cost | [2] | $ 1,102 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 793 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.06%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.06% |  |  |  |  |  | 0.06% |
Investment cost | [5] |  |  | $ 1,065 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 1,162 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 537 | [2] | 537 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 615 |  | $ 871 |  |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 31, 2022 | [3] | Mar. 31, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 392,308 |  | 392,308 |  | 392,308 |  | 392,308 |  | 392,308 |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 528 | [2] | $ 528 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 147 |  | $ 291 |  |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 23, 2022 | [3] | Mar. 23, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and VulcanForms Inc., Warrant, Acquisition Date 1/30/2025, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 37 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 31 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Jan. 30, 2025 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 83,262 |  |  |  | 83,262 |  | 83,262 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.00%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.00% |  |  |  |  |  | 0.00% |
Investment cost | [5] |  |  | $ 67 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 63 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.01%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.01% |  |  |  | 0.01% |  | 0.01% |  |  |
Investment cost | [2] | $ 67 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 114 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 67 | [2] | 67 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 114 |  | $ 63 |  |  |  |  |  |  |
Investments owned acquisition date |  | Dec. 30, 2022 | [3] | Dec. 30, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 369,370 |  | 369,370 |  | 369,370 |  | 369,370 |  | 369,370 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.03%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.03% | [20] | 0.03% | [4] | 0.03% | [20] | 0.03% | [20] | 0.03% | [4]
Investment cost |  | $ 1,281 | [2] | $ 1,281 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 519 |  | 507 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Warrant, Acquisition Date 11/6/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 180 | [1],[2],[3],[38] | 180 | [5],[6],[37],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 105 | [1],[3],[38] | $ 102 | [6],[37],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 06, 2024 | [1],[3],[38] | Nov. 06, 2024 | [6],[37],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 52,264 | [1],[3],[38] | 52,264 | [6],[37],[44] | 52,264 | [1],[3],[38] | 52,264 | [1],[3],[38] | 52,264 | [6],[37],[44]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 401 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 7 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Sep. 27, 2013 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 62,794 |  |  |  |  |  | 62,794 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 401 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 4 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Sep. 27, 2013 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 4,185 |  |  |  | 4,185 |  | 4,185 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[44] |  |  | $ 276 |  |  |  |  |  |  |
Investments, at fair value: | [44] |  |  | $ 203 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Sep. 08, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [44] |  |  | 1,032,718 |  |  |  |  |  | 1,032,718 |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[3] | $ 276 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [3] | $ 302 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Sep. 08, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [3] | 1,032,718 |  |  |  | 1,032,718 |  | 1,032,718 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 363 | [2],[3],[38] | $ 363 | [5],[37],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 108 | [3],[38] | $ 195 | [37],[44] |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 22, 2024 | [3],[38] | Jan. 22, 2024 | [37],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 113,247 | [3],[38] | 113,247 | [37],[44] | 113,247 | [3],[38] | 113,247 | [3],[38] | 113,247 | [37],[44]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 61 | [2],[3] | $ 61 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 | [3] | $ 0 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 31, 2017 | [3] | Mar. 31, 2017 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 15,712 | [3] | 15,712 | [44] | 15,712 | [3] | 15,712 | [3] | 15,712 | [44]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.02% | [20] | 0.02% | [4] | 0.02% | [20] | 0.02% | [20] | 0.02% | [4]
Investment cost |  | $ 99 | [2] | $ 99 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 328 |  | 494 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 99 | [2] | 99 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 328 |  | $ 494 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 26, 2015 | [3] | Jun. 26, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 750,000 |  | 750,000 |  | 750,000 |  | 750,000 |  | 750,000 |
Investment, Identifier [Axis]: Warrant Investments and Software (0.48%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [20] | 0.48% |  |  |  | 0.48% |  | 0.48% |  |  |
Investment cost | [2] | $ 10,869 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | 9,619 |  |  |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software (0.53%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets | [4] |  |  | 0.53% |  |  |  |  |  | 0.53% |
Investment cost | [5] |  |  | $ 10,554 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | 10,472 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 74 | [2] | 74 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | May 22, 2015 | [3] | May 22, 2015 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 231,535 |  | 231,535 |  | 231,535 |  | 231,535 |  | 231,535 |
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 448 | [2] | $ 448 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 277 |  | $ 421 |  |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 23, 2022 | [3] | Sep. 23, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 254,778 |  | 254,778 |  | 254,778 |  | 254,778 |  | 254,778 |
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 284 | [2] | $ 284 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 581 |  | $ 442 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 18, 2020 | [3] | Nov. 18, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 29,691 |  | 29,691 |  | 29,691 |  | 29,691 |  | 29,691 |
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 215 | [2] | $ 215 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 118 |  | $ 84 |  |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 04, 2021 | [3] | Oct. 04, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 435,396 |  | 435,396 |  | 435,396 |  | 435,396 |  | 435,396 |
Investment, Identifier [Axis]: Warrant Investments and Software and Carbyne, Inc., Warrant, Acquisition Date 2/24/2025 Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 24 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 19 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Feb. 24, 2025 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 11,408 |  |  |  | 11,408 |  | 11,408 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 117 | [2] | $ 117 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 52 |  | $ 9 |  |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 30, 2020 | [3] | Sep. 30, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 211,342 |  | 211,342 |  | 211,342 |  | 211,342 |  | 211,342 |
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 71 | [2] | $ 71 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date |  | Nov. 06, 2018 | [3] | Nov. 06, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 477,454 |  | 477,454 |  | 477,454 |  | 477,454 |  | 477,454 |
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 54 | [2],[27],[28] | $ 54 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 790 | [27],[28] | $ 908 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 10, 2018 | [3],[27],[28] | Apr. 10, 2018 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 6,763 | [27],[28] | 6,763 | [9],[10] | 6,763 | [27],[28] | 6,763 | [27],[28] | 6,763 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Software and Coronet Cyber Security Ltd., Warrant, Acquisition Date 9/26/2024, Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 254 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 208 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Sep. 26, 2024 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 39,183 |  |  |  | 39,183 |  | 39,183 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Coronet Cyber Security Ltd., Warrant, Acquisition Date 9/26/2024, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 254 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 266 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Sep. 26, 2024 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 39,183 |  |  |  |  |  | 39,183 |
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 462 | [2],[3] | $ 462 | [5],[44] |  |  |  |  |  |
Investments, at fair value: |  | $ 698 | [3] | $ 686 | [44] |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 25, 2019 | [3] | Apr. 25, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 105,350 | [3] | 105,350 | [44] | 105,350 | [3] | 105,350 | [3] | 105,350 | [44]
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 26 | [2],[22],[27],[28] | $ 26 | [5],[9],[10],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 51 | [22],[27],[28] | $ 83 | [9],[10],[12] |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 21, 2022 | [3],[22],[27],[28] | Sep. 21, 2022 | [9],[10],[12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 102,898 | [22],[27],[28] | 102,898 | [9],[10],[12] | 102,898 | [22],[27],[28] | 102,898 | [22],[27],[28] | 102,898 | [9],[10],[12]
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 461 | [2] | $ 461 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 1,149 |  | $ 1,102 |  |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 11, 2019 | [3] | Mar. 11, 2019 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 770,838 |  | 770,838 |  | 770,838 |  | 770,838 |  | 770,838 |
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 545 | [2] | $ 545 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 74 |  | $ 234 |  |  |  |  |  |  |
Investments owned acquisition date |  | Aug. 02, 2021 | [3] | Aug. 02, 2021 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 727,047 |  | 727,047 |  | 727,047 |  | 727,047 |  | 727,047 |
Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,575 | [2] | $ 1,575 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 936 |  | $ 984 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 28, 2023 | [3] | Jun. 28, 2023 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 57,528 |  | 57,528 |  | 57,528 |  | 57,528 |  | 57,528 |
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 278 | [2] | $ 278 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 339 |  | $ 417 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 30, 2022 | [3] | Jun. 30, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 95,911 |  | 95,911 |  | 95,911 |  | 95,911 |  | 95,911 |
Investment, Identifier [Axis]: Warrant Investments and Software and Earnix, Inc., Warrant, Acquisition Date 6/6/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 219 | [2] | $ 220 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 313 |  | $ 327 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 06, 2024 | [3] | Jun. 06, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 20,762 |  | 20,762 |  | 20,762 |  | 20,762 |  | 20,762 |
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 739 | [2] | $ 583 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 382 |  | $ 236 |  |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 12, 2022 | [3] | Sep. 12, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 612,166 |  | 362,837 |  | 612,166 |  | 612,166 |  | 362,837 |
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 96 | [2] | $ 96 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 10 |  | $ 33 |  |  |  |  |  |  |
Investments owned acquisition date |  | May 10, 2018 | [3] | May 10, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 75,917 |  | 75,917 |  | 75,917 |  | 75,917 |  | 75,917 |
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 325 | [2] | $ 325 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 231 |  | $ 274 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jul. 29, 2022 | [3] | Jul. 29, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 84,995 |  | 84,995 |  | 84,995 |  | 84,995 |  | 84,995 |
Investment, Identifier [Axis]: Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 534 | [2] | $ 534 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 480 |  | $ 632 |  |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 12, 2024 | [3] | Mar. 12, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 193,618 |  | 193,618 |  | 193,618 |  | 193,618 |  | 193,618 |
Investment, Identifier [Axis]: Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 208 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 142 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Mar. 31, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 64,293 |  |  |  |  |  | 64,293 |
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 208 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 79 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3] | Mar. 31, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 64,293 |  |  |  | 64,293 |  | 64,293 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 39 | [2],[22],[27],[28] | $ 39 | [5],[9],[10],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 24 | [22],[27],[28] | $ 35 | [9],[10],[12] |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 23, 2023 | [3],[22],[27],[28] | Jan. 23, 2023 | [9],[10],[12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 93,211 | [22],[27],[28] | 93,211 | [9],[10],[12] | 93,211 | [22],[27],[28] | 93,211 | [22],[27],[28] | 93,211 | [9],[10],[12]
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series LB-2 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 131 | [2] | $ 131 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 26 |  | $ 26 |  |  |  |  |  |  |
Investments owned acquisition date |  | Feb. 14, 2018 | [3] | Feb. 14, 2018 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 86,984 |  | 86,984 |  | 86,984 |  | 86,984 |  | 86,984 |
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 252 | [2] | $ 252 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 275 |  | $ 264 |  |  |  |  |  |  |
Investments owned acquisition date |  | Sep. 30, 2020 | [3] | Sep. 30, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 82,362 |  | 82,362 |  | 82,362 |  | 82,362 |  | 82,362 |
Investment, Identifier [Axis]: Warrant Investments and Software and Morphisec Information Security 2014 Ltd., Warrant, Acquisition Date 10/1/2024, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | $ 104 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 120 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Oct. 01, 2024 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [27],[28] | 200,115 |  |  |  | 200,115 |  | 200,115 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Pindrop Security, Inc., Warrant, Acquisition Date 6/26/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 494 | [1],[2] | $ 494 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 417 | [1] | $ 496 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 26, 2024 | [1],[3] | Jun. 26, 2024 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 134,542 | [1] | 134,542 | [6] | 134,542 | [1] | 134,542 | [1] | 134,542 | [6]
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 215 | [2] | $ 215 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 589 |  | $ 698 |  |  |  |  |  |  |
Investments owned acquisition date |  | Jun. 30, 2020 | [3] | Jun. 30, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 69,120 |  | 69,120 |  | 69,120 |  | 69,120 |  | 69,120 |
Investment, Identifier [Axis]: Warrant Investments and Software and Semperis Technologies Inc., Warrant, Acquisition Date 4/23/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 114 | [2] | $ 115 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 191 |  | $ 213 |  |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 23, 2024 | [3] | Apr. 23, 2024 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 72,122 |  | 72,122 |  | 72,122 |  | 72,122 |  | 72,122 |
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 96 | [2],[22] | $ 96 | [5],[12] |  |  |  |  |  |
Investments, at fair value: |  | $ 14 | [22] | $ 22 | [12] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 22, 2023 | [3],[22] | Mar. 22, 2023 | [12],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 77,934 | [22] | 77,934 | [12] | 77,934 | [22] | 77,934 | [22] | 77,934 | [12]
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 103 | [2] | $ 103 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 452 |  | $ 551 |  |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 28, 2020 | [3] | Apr. 28, 2020 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 312,596 |  | 312,596 |  | 312,596 |  | 312,596 |  | 312,596 |
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[27],[28] | $ 174 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [27],[28] | $ 62 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[27],[28] | Jun. 08, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [27],[28] | 321,956 |  |  |  | 321,956 |  | 321,956 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[10] |  |  | $ 174 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 61 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[10],[44] |  |  | Jun. 08, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [9],[10] |  |  | 321,956 |  |  |  |  |  | 321,956 |
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[6],[37] |  |  | $ 367 |  |  |  |  |  |  |
Investments, at fair value: | [6],[37] |  |  | $ 291 |  |  |  |  |  |  |
Investments owned acquisition date | [6],[37],[44] |  |  | Aug. 24, 2023 |  |  |  |  |  |  |
Shares (in shares) | shares | [6],[37] |  |  | 292,936 |  |  |  |  |  | 292,936 |
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [1],[2],[38] | $ 367 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1],[38] | $ 256 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [1],[3],[38] | Aug. 24, 2023 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [1],[38] | 292,936 |  |  |  | 292,936 |  | 292,936 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 360 | [2],[27],[33] | $ 359 | [5],[9],[10] |  |  |  |  |  |
Investments, at fair value: |  | $ 274 | [27],[33] | $ 395 | [9],[10] |  |  |  |  |  |
Investments owned acquisition date |  | Mar. 22, 2023 | [3],[27],[33] | Mar. 22, 2023 | [9],[10],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 509,753 | [27],[33] | 509,753 | [9],[10] | 509,753 | [27],[33] | 509,753 | [27],[33] | 509,753 | [9],[10]
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/27/2025, Series Ordinary Shares |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2],[33] | $ 136 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [33] | $ 128 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [3],[33] | Mar. 27, 2025 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [33] | 473,266 |  |  |  | 473,266 |  | 473,266 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and Total Tipalti Solutions Ltd. |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [2] | $ 496 |  |  |  |  |  |  |  |  |
Investments, at fair value: |  | $ 402 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares |  | 983,019 |  |  |  | 983,019 |  | 983,019 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | $ 1,275 | [1],[2] | $ 1,275 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 4 | [1] | $ 32 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Jan. 21, 2022 | [1],[3] | Jan. 21, 2022 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 152,048 | [1] | 152,048 | [6] | 152,048 | [1] | 152,048 | [1] | 152,048 | [6]
Investment, Identifier [Axis]: Warrant Investments and Space Technologies (0.00%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.00% | [20] | 0.00% | [4] | 0.00% | [20] | 0.00% | [20] | 0.00% | [4]
Investment cost |  | $ 207 | [2] | $ 207 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 22 |  | 10 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 207 | [1],[2] | 207 | [5],[6] |  |  |  |  |  |
Investments, at fair value: |  | $ 22 | [1] | $ 10 | [6] |  |  |  |  |  |
Investments owned acquisition date |  | Oct. 21, 2021 | [1],[3] | Oct. 21, 2021 | [6],[44] |  |  |  |  |  |
Shares (in shares) | shares |  | 176,200 | [1] | 176,200 | [6] | 176,200 | [1] | 176,200 | [1] | 176,200 | [6]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.02%) |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment owned, percent of net assets |  | 0.02% | [20] | 0.02% | [4] | 0.02% | [20] | 0.02% | [20] | 0.02% | [4]
Investment cost |  | $ 559 | [2] | $ 622 | [5] |  |  |  |  |  |
Investments, at fair value: |  | 371 |  | 461 |  |  |  |  |  |  |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost |  | 52 | [2] | 52 | [5] |  |  |  |  |  |
Investments, at fair value: |  | $ 83 |  | $ 67 |  |  |  |  |  |  |
Investments owned acquisition date |  | Apr. 15, 2022 | [3] | Apr. 15, 2022 | [44] |  |  |  |  |  |
Shares (in shares) | shares |  | 18,472 |  | 18,472 |  | 18,472 |  | 18,472 |  | 18,472 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[6] |  |  | $ 507 |  |  |  |  |  |  |
Investments, at fair value: | [6] |  |  | $ 394 |  |  |  |  |  |  |
Investments owned acquisition date | [6],[44] |  |  | Mar. 27, 2024 |  |  |  |  |  |  |
Shares (in shares) | shares | [6] |  |  | 246,618 |  |  |  |  |  | 246,618 |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [1],[2] | $ 507 |  |  |  |  |  |  |  |  |
Investments, at fair value: | [1] | $ 288 |  |  |  |  |  |  |  |  |
Investments owned acquisition date | [1],[3] | Mar. 27, 2024 |  |  |  |  |  |  |  |  |
Shares (in shares) | shares | [1] | 246,618 |  |  |  | 246,618 |  | 246,618 |  |  |
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Common Stock |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5] |  |  | $ 63 |  |  |  |  |  |  |
Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |  |  |
Investments owned acquisition date | [44] |  |  | Apr. 07, 2015 |  |  |  |  |  |  |
Shares (in shares) | shares |  |  |  | 144,914 |  |  |  |  |  | 144,914 |
Investment, Identifier [Axis]: nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |  |  |  |  |  |  |  |  |  |  |
Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  |  |
Investment cost | [5],[9],[10] |  |  | $ 381 |  |  |  |  |  |  |
Investments, at fair value: | [9],[10] |  |  | $ 400 |  |  |  |  |  |  |
Investments owned acquisition date | [9],[10],[44] |  |  | Jul. 21, 2022 |  |  |  |  |  |  |
[1] | Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
[2] | Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $110.7 million, $181.0 million and $70.3 million, respectively. The tax cost of investments is $4.0 billion
[3] | Except for warrants in 21 publicly traded companies and common stock in 28 publicly traded companies, all investments are restricted as of March 31, 2025 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”).
[4] | Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
[5] | Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $108.4 million, $156.5 million, and $48.1 million, respectively. The tax cost of investments is $3.7 billion.
[6] | Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
[7] | Prime represents 7.50% as of December 31, 2024. 1-month SOFR, 3-month SOFR, and 6-month SOFR represent 4.33%, 4.31%, and 4.25%, respectively, as of December 31, 2024.
[8] | Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
[9] | Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
[10] | Non-U.S. company or the company’s principal place of business is outside the United States.
[11] | Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2024 (Refer to “Note 11 — Commitments and Contingencies”).
[12] | Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
[13] | Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2024.
[14] | Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
[15] | Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
[16] | Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
[17] | Hercules Adviser LLC is owned by Hercules Capital Management LLC and presented with Hercules Partner Holdings, LLC which are both wholly owned by the Company. Please refer to “Note 1” for additional disclosure.
[18] | Denotes second lien senior secured debt.
[19] | Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
[20] | Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies.
[21] | Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
[22] | Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
[23] | Prime represents 7.50% as of March 31, 2025. 1-month SOFR, 3-month SOFR and 6-month SOFR represent 4.32%, 4.29%, and 4.19%, respectively, as of March 31, 2025.
[24] | Denotes second lien senior secured debt.
[25] | Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
[26] | Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of March 31, 2025 (Refer to “Note 11 - Commitments and Contingencies”).
[27] | Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
[28] | Non-U.S. company or the company’s principal place of business is outside the United States
[29] | Denotes that all or a portion of the debt investment is convertible debt.
[30] | Denotes that all or a portion of the debt investment is convertible debt.
[31] | Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
[32] | Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
[33] | Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of March 31, 2025.
[34] | Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
[35] | Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC.
[36] | Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC.
[37] | Denotes that all or a portion of the investment in this portfolio company is held by SBIC V, L.P., the Company's wholly owned small business investment company.
[38] | Denotes that all or a portion of the investment in this portfolio company is held by Hercules SBIC V, L.P., the Company’s wholly owned small business investment company.
[39] | Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $11.9 million and $11.6 million, respectively.
[40] | Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $11.9 million and $11.7 million, respectively.
[41] | Debt is on non-accrual status as of March 31, 2025, and is therefore considered non-income producing.
[42] | Denotes that the debt investment remains outstanding beyond its stated maturity date as it is subject to an ongoing workout process.
[43] | Debt is on non-accrual status as of December 31, 2024, and is therefore considered non-income producing.
[44] | Except for warrants in 23 publicly traded companies and common stock in 28 publicly traded companies, all investments are restricted as of December 31, 2024 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the "Valuation Committee") and approved by the board of directors (the "Board").
[45] | Hercules Adviser LLC is owned by Hercules Capital Management LLC and presented with Hercules Partner Holdings, LLC which are both wholly owned by the Company. Please refer to “Note 1 – Description of Business” for additional disclosure.
[46] | Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of March 31, 2025, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.4 million.
[47] | Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2024, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.4 million.

X
- Definition Investment exit fee + References No definition available. + Details
Name: | htgc_InvestmentExitFee
Namespace Prefix: | htgc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Investment Interest Rate Cap + References No definition available. + Details
Name: | htgc_InvestmentInterestRateCap
Namespace Prefix: | htgc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Investments Maturity Month and Year. + References No definition available. + Details
Name: | htgc_InvestmentsMaturityMonthAndYear
Namespace Prefix: | htgc_
Data Type: | xbrli:gYearMonthItemType
Balance Type: | na
Period Type: | instant

X
- Definition Investments owned acquisition date. + References No definition available. + Details
Name: | htgc_InvestmentsOwnedAcquisitionDate
Namespace Prefix: | htgc_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in kind on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInKind
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-2 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of investment owned to net assets. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column D)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedPercentOfNetAssets
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-9 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (g)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (g)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478297/946-220-50-3 + Details
Name: | us-gaap_SummaryOfInvestmentHoldingsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis= Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Communications & Networking (1.38%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services (18.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Altumint, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Carwow LTD, Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and GoEuro Travel GmbH, Senior Secured, Maturity Date November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Skyword, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Thumbtack, Inc., Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Total SeatGeek, Inc
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Total Veem, Inc.,
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.00%, Floor rate 12.00%, PIK Interest 1.25%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.70%, Floor rate 12.70%, PIK Interest 1.50%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Diversified Financial Services (2.98%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Diversified Financial Services and Next Insurance, Inc., Senior Secured, Maturity Date February 2028, Prime - 1.50%, Floor rate 4.75%, PIK Interest 5.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Drug Discovery & Development and Akero Therapeutics, Inc., Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investment Software and Total 3GTMS, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments (186.90%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools (1.69%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools (1.70%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 7.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications & Networking (1.37%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services (18.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Altumint, Inc. Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and GoEuro Travel GmbH. Senior Secured, Maturity Date November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 11.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, Maturity Date May 2028, PIK Interest 11.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date October 2028, 1-month SOFR + 0.00%, Floor rate 1.00%, PIK Interest 7.00%, 5.33% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, Maturity Date August 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 2.89% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Plentific Ltd. Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 3-month SOFR + 8.27%, Floor rate 9.27%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date March 2028, 3-month SOFR + 8.27%, Floor rate 9.27%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Total SeatGeek, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.00%, Floor rate 12.00%, PIK Interest 1.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, Maturity Date March 2027, Prime + 4.70%, Floor rate 12.70%, PIK Interest 1.50%.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services, Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Consumer & Business Services, and Total Veem, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services (2.42%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date September 2026, FIXED 11.95%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date September 2026, FIXED 3.45%, PIK Interest 8.05%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime -(1.50%), Floor rate 4.75%, PIK Interest 5.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services and Total Gibraltar Acquisition, LLC,.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Diversified Financial Services, Unsecured, Maturity Date September 2026, Fixed 11.95%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development (52.10%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development (53.38%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V., Senior Secured, Maturity Date August 2026, Prime + 4.30%, Floor rate 9.05%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc, Inc., Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Adaptimmune Therapeutics plc. Senior Secured, Maturity Date June 2029, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.00%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Alector, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Alector, Inc.. Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2029, Prime + 1.95%, Floor rate 10.45%, 7.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2029, Prime + 1.95%, Floor rate 10.45%, 7.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Senior Secured, Maturity Date January 2028, Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Corium, Inc., Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Disc Medicine, Inc., Senior Secured, Maturity Date December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc., Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date May 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and NorthSea Therapeutics, Convertible Debt, Maturity Date December 2025, FIXED 6.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 6.22% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 7.06% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Savara, Inc.. Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and SynOx Therapeutics Limited, Senior Secured, Maturity Date May 2027, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Total Phathom Pharmaceuticals, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and bluebird bio, Inc. Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 6.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and bluebird bio, Inc., Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 6.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and enGene, Inc., Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware (8.13%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware (8.20%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Electronics & Computer Hardware and Shield AI, Inc., Senior Secured, Maturity Date February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other (30.19%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other (30.79%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 3-month SOFR + 5.26%, Floor rate 6.00%, PIK Interest 4.45%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 3-month SOFR + 5.26%, Floor rate 6.00%, PIK Interest 4.45%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Convertible Debt, Maturity Date December 2025, FIXED 12.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date February 2028, Prime + 3.10%, Floor rate 8.10%, 3.78% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date June 2026, Prime -1.50%, Floor rate 7.00%, PIK Interest 7.00%, 5.64% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC, Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Ennoble Care LLC, Senior Secured, Maturity Date February 2030, Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 4.25%, Floor rate 9.50%, PIK Interest 1.55%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 4.25%, Floor rate 9.50%, PIK Interest 1.55%, 1.11% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 0.75%, Floor rate 8.75%, PIK Interest 2.25%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 3.00%, Floor rate 11.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime - 0.90%, Floor rate 7.10%, PIK Interest 4.00%, 3.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Marathon Health, LLC.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and NeueHealth, Inc. Senior Secured, Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and NeueHealth, Inc., Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Total Carbon Health Technologies, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date July 2026, Prime - 2.75% Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date October 2026, Prime - 2.75%, Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and WellBe Senior Medical LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services (1.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services (1.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology (0.99%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Manufacturing Technology and VulcanForms Inc. Secured, Maturity Date January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment (3.73%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment (3.74%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date September 2027 Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Medical Devices & Equipment and Sight Sciences, Inc., Senior Secured, Maturity Date July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Smartsheet Inc.., Senior Secured, Maturity Date January 2031 , 3-month SOFR + 6.50%, Floor rate 7.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Snappt, Inc., Senior Secured, Maturity Date April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software (52.80%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software (61.81%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 10.40%, Floor rate 11.30%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 7.25%, Floor rate 8.15%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 3-month SOFR + 8.14%, Floor rate 9.14%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 6.25%, Floor rate 7.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 6.50%, Floor rate 7.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and AlphaSense, Inc., Senior Secured, Maturity Date June 2029, 3-month SOFR + 6.25%, Floor rate 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 3-month SOFR + 10.00%, Floor rate 11.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 1.25%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime +1.25%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.00%, Floor rate 9.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.01%, Floor rate 9.01%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Behavox Limited, Senior Secured, Maturity Date September 2027, Prime - 0.55%, Floor rate 7.45%, PIK Interest 3.00%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Carbyne, Inc., Senior Secured, Maturity Date February 2029, Prime + 3.50%, Floor rate 10.00%, 3.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 8.99%, Floor rate 9.89%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and CoreView USA, Inc., Senior Secured, Maturity Date January 2029, Prime +2.75%, Floor rate 9.25%, 4.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Coronet Cyber Security Ltd., Senior Secured, Maturity Date October 2028, Prime - 2.95%, Floor rate 3.55%, PIK Interest 5.85%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee, 1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee, 2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.28% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and DocPlanner, Senior Secured, Maturity Date January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Dragos, Inc., Senior Secured, Maturity Date July 2027, Prime + 2.00%, Floor rate 8.75%, PIK Interest 2.00%, 2.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.45%, Floor rate 9.95%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Earnix, Inc., Senior Secured, Maturity Date June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 1-month SOFR + 7.64%, Floor rate 8.54%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Harness, Inc., Senior Secured, Maturity Date March 2029, Prime - 2.25%, Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Khoros, Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Leapwork ApS, Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.00%, PIK Interest 1.95%, 2.70% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.00%, PIK Interest 1.95%, 2.70% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LinenMaster, LLC, Senior Secured, Maturity Date August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LogRhythm, Inc., Senior Secured, Maturity Date July 2029, 1-month SOFR + 7.50%, Floor rate 8.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LogRhythm, Inc., Senior Secured, Maturity Date July 2029, 3-month SOFR + 7.50%, Floor rate 8.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.93%, Floor rate 9.93%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Marigold Group, Inc. (p.k.a. Campaign Monitor Limited), Senior Secured, Maturity Date November 2026, PIK Interest 6-month SOFR + 10.55%, Floor rate 11.55%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Marigold Group, Inc., Senior Secured, Maturity Date November 2026, PIK Interest 6-month SOFR + 10.55%, Floor rate 11.55%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.21%, Floor rate 10.06%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 6-month SOFR + 9.31%, Floor rate 10.06%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Morphisec Information Security 2014 Ltd., Senior Secured, Maturity Date October 2027, Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Morphisec Information Security 2014 Ltd., Warrant, Acquisition Date 10/1/2024, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 1-month SOFR + 6.75%, Floor rate 7.75%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and PayIt, LLC, Senior Secured, Maturity Date December 2028, Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Pindrop Security, Inc., Senior Secured, Maturity Date June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Remodel Health Holdco, LLC, Senior Secured, Maturity Date December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Remodel Health Holdco, LLC., Senior Secured, Maturity Date December 2028 ,Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Semperis Technologies Inc., Senior Secured, Maturity Date April 2028, Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 8.88%, Floor rate 9.78%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.25%, Floor rate 8.25%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date March 2030, 3-month SOFR + 6.50%, Floor rate 7.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 6-month SOFR + 6.50%, Floor rate 7.50%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Suzy, Inc., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and TaxCalc, Senior Secured, Maturity Date November 2029, 3-month SONIA + 8.05%, Floor rate 8.55%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and TaxCalc., Senior Secured, Maturity Date November 2029, Daily SONIA + 8.17%, Floor rate 8.67%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 3-month SOFR + 9.15%, Floor rate 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.00%, 3.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Total Armis, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Total Cutover, Inc.,
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Total Tipalti Solutions Ltd.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and iGrafx, LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.61%, Floor rate 9.51%, 0.47% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Software and iSpot.tv, Inc., Senior Secured, Maturity Date January 2029, Prime + 2.25%, Floor rate 8.75%, PIK Interest 1.00%, 5.70% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Space Technologies (2.30%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Space Technologies (2.47%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Space Technologies and Voyager Space Holdings, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Space Technologies and Voyager Technologies, Inc., Senior Secured, Maturity Date July 2028, Prime + 1.25%, Floor rate 9.75%, PIK Interest 2.50%, 5.50% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology (0.99%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology (1.27%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.89% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.89% Exit Fee
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Sustainable and Renewable Technology and SUNation Energy, Inc. (p.k.a. Pineapple Energy LLC), Senior Secured, Maturity Date June 2027, FIXED 10.00%
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Debt Investments Total Marathon Health, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments (6.47%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments (7.34%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Biotechnology Tools (0.05%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Biotechnology Tools (0.07%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Biotechnology Tools and Alamar Biosciences, Inc., Equity, Acquisition Date 2/21/2024, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Products and Total Fabletics, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services (0.38%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services (0.40%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Jobandtalent USA, Inc., Equity, Acquisition Date 2/11/2025, Series Preferred Series F
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Total OfferUp, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Total Tectura Corporation
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Consumer & Business Services and Worldremit Group Limited, Equity, Acquisition Date 6/24/2024, Series Preferred Series X
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services (2.70%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services (3.38%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Gibraltar Acquisition, Equity, Acquisition Date 3/1/2018, Series Member Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Equity, Acquisition Date 3/1/2018, Series Member Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Delivery and Talphera, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development (1.56%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development (1.81%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Arcus Biosciences, Inc., Equity, Acquisition Date 2/19/2025, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/06/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Rafael Holdings, Inc. (p.k.a. Cyclo Therapeutics, Inc.), Equity, Acquisition Date 4/6/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Total Valo Health LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Total Valo Health, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware (0.05%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware (0.15%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware and Shield AI, Inc., Equity, Acquisition Date 2/7/2025, Series Preferred Series F1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other (0.37%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other (0.38%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and Click Therapeutics, Inc., Equity, Acquisition Date 5/20/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and Curana Health Holdings, LLC, Equity, Acquisition Date 5/13/2024, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and Main Street Rural, Inc., Equity, Acquisition Date 10/28/2024, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Equity, Acquisition Date 6/10/2024, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services (0.20%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services (0.23%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Medical Devices & Equipment and Total Coronado Aesthetics, LLC
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Semiconductors (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Semiconductors (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software (0.81%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software (0.99%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Armis, Inc., Equity, Acquisition Date 10/18/2024, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and DNAnexus, Inc., Equity, Acquisition Date 3/21/2014, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and SirionLabs Pte. Ltd., Equity, Acquisition Date 6/30/2024, Series Preferred Series F1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Total Contentful Global, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Total Druva Holdings, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Total SingleStore, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology (0.10%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology (0.11%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc. (p.k.a. Pineapple Energy LLC), Equity, Acquisition Date 12/10/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc., Equity, Acquisition Date 12/10/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund After Cash & Cash Equivalents (197.46%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund In Cash & Cash Equivalents (1.06%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Fund In Cash & Cash Equivalents (1.30%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments (0.31%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments (0.35%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development (0.29%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development (0.33%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Software (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investment Funds and Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments After Cash & Cash Equivalents (185.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments before Cash & Cash Equivalents (183.96%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments before Cash & Cash Equivalents (196.16%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments in Securities (183.64%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Investments in Securities (195.81%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Total Debt Investments (175.65%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Total Warrant Investments (1.53%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments (1.57%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Communications & Networking (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services (0.28%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services (0.32%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Altumint, Inc., Warrant, Acquisition Date 10/31/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Carwow LTD
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Skyword, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Diversified Financial Services (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Diversified Financial Services (0.07%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development (0.35%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development (0.46%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc., Warrant, Acquisition Date 2/18/2016, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and SynOx Therapeutics Limited, Warrant, Acquisition Date 4/18/2024, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 12/30/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and bluebird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other (0.11%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC, Warrant, Acquisition Date 1/4/2024, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and NeueHealth, Inc., Warrant, Acquisition Date 6/21/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Recover Together, Inc., Warrant, Acquisition Date 7/3/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Acquisition Date 9/28/2023, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and NetBase Quid, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology (0.04%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology (0.06%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Manufacturing Technology and VulcanForms Inc., Warrant, Acquisition Date 1/30/2025, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Media/Content/Info (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Media/Content/Info (0.01%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment (0.03%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Warrant, Acquisition Date 11/6/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Semiconductors (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software (0.48%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software (0.53%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Carbyne, Inc., Warrant, Acquisition Date 2/24/2025 Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Coronet Cyber Security Ltd., Warrant, Acquisition Date 9/26/2024, Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Coronet Cyber Security Ltd., Warrant, Acquisition Date 9/26/2024, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Earnix, Inc., Warrant, Acquisition Date 6/6/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series LB-2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Morphisec Information Security 2014 Ltd., Warrant, Acquisition Date 10/1/2024, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Pindrop Security, Inc., Warrant, Acquisition Date 6/26/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Semperis Technologies Inc., Warrant, Acquisition Date 4/23/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/27/2025, Series Ordinary Shares
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and Total Tipalti Solutions Ltd.
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Space Technologies (0.00%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Space Technologies and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology (0.02%)
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Common Stock
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIdentifierAxis=nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |